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ABSTRACT 
 
CHEMICAL AND BIOLOGICAL INVESTIGATION INTO SOME 
SELECTED AFRICAN INDIGENOUS MEDICINAL PLANTS 
Jelili Olalekan Babajide 
PhD Thesis, Department of Chemistry, University of the Western Cape,  
 
African medicinal plants are commonly used throughout Africa to treat a variety of 
ailments including wounds and ulcers, cough and chest complaints, gingivitis, fever 
and gonorrhoea, indication all related to infection and inflammation. In screening 
several plant species from an inventory of common medicinal plants from both South 
and West Africa for diverse medicinal purposes, 6 plants were selected because of 
their interesting and useful ethnomedicinal values. These plants are (1) Piliostigma 
reticulatum from the family Caesalpiniaceae, (2) Cissampelos capensis (family: 
Menispermaceae) (3) Geranium incanum (family: Geraniaceae) (4) Gethyllis 
gregoriana, (5) Gethyllis multifolia and (6) Gethyllis villosa. The three Gethyllis 
species belong to the Amaryllidaceae family. This study attempt to relate specific 
constituents present in these plants with their widespread ethnomedicinal uses. The 
extractions were carried out using broad spectrum of solvents (hexane, 
dichloromethane, ethyl acetate, methanol and water). Fractionation was carried out 
using standard chromatographic techniques. A total of thirty seven (37) compounds 
were isolated from three of the plants namely: P. reticulatum, C. capensis and G. 
incanum while only extractions were carried out on the Gethyllis species. Total of 18 
isolates were characterised and their structures were unambiguously established by 
spectroscopic methods including infrared and ultraviolet spectroscopy, high 
resolution mass spectrometry and one- and two-dimensional nuclear magnetic 
resonance experiment.  
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(G12) 6, 8-di-C-methylquercetin 3, 7-dimethyl ether (new compound). 
 
Ten (10) of the isolated compounds were novel, including the first ever C-methyl-2-
phenoxychromonol, piliostigmol, 2-O-(p-hydroxyphenyl)-3,5-dihydroxy-6-C-methyl-
7-methoxychromone, the diterpene16α-hydroxy-(-)-kauran-18-oic acid, and five C-
methylflavonols, isoflavanone, aporphine and a dehydromorphinandienone. The 
different extracts, fractions and isolates were tested for cytotoxicity using brine 
shrimp lethality  test and antimicrobial capability using nine microbes with three 
gram –ve and +ve bacteria and three fungi. The gram-negative bacteria were 
Pseudomonas aeruginosa (NCTC 10332), Proteus vulgaris (NCTC 4175) and 
Escherichia coli sero type 1 (NCTC 09001), while the gram-positive were Bacillus 
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subtilis (NCTC 8236), Staphylococcus aureus (NCTC 13134) and Bacillus 
licheniformis (NCTC 01097).  The fungal species used were Candida albicans 
(ATCC 90028), Candida eropiralis (ATCC 750) and Aspergillus niger (ATCC 
10578). G. gregoriana showed the highest cytotoxicity level of LC50 = 0.2229 where 
as it was observed that all the hexane fractions were not active while most activities 
resides in the methanolic extracts. The total tertiary alkaloid (TTA) showed the 
highest activity against B. substillis at 45mm while same trend observed in the 
cytotoxicity test were also observed in the antimicrobial activity, where all the hexane 
fractions showed no activity against any of the nine pathogens. The P. reticulatum 
was also found to exhibit antimicrobial activity against some bacteria and fungi such 
as S. aureus, E. coli, B. subtilis, P. vulgaris, A. niger and C. albicans. Piliostigmol, 
showed the highest activity against E. coli (MIC = 2.57 µg/ml, 0.006 µmol), which 
was found out to be three times more active than the amoxicillin standard used. The 
total antioxidant assay also reveal a huge amount of information into the nature and 
properties of each extracts and isolates in which the distribution of polyphenols, 
flavonoids and anthocyanins present in the plant extracts were reavealed. The ORAC, 
FRAP and TEAC showed intensively the antioxidant capacity of the extracts and 
isolates in which it was evident that the methanolic extracts and isolates obtained 
from them are good antioxidant agents. The results obtained for this study give a 
useful profile for development of a good antimicrobial and antioxidant agents for the 
future from the results obtained. The observed antimicrobial and antioxidant activities 
of the isolated compounds were correlated with their structures, and the structural 
requirements for activity in both test systems were defined. Finally, the traditional use 
of the extracts in infections and inflammatory conditions was rationalized based on 
the content of the isolated compounds, and it has been proposed that the total crude 
extract, with its content of so many bioactive compounds, could be formulated for use 
in skin infections, microbial, viral and inflammatory conditions. 
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CHAPTER 1 
INTRODUCTION  
1.1 The Medicinal Use of Plants: An Overview. 
Disease continues to be a great barrier to progress in the advancement of 
humankind. Problems of ecology, culture and habit peculiarities contribute to making 
people more susceptible to diseases. 
Medicinal plants have been used in many forms over the years to cure, manage or 
control man’s ailments. Any effort to further maximize the output of medicinal or 
natural products from the botanical florals and so to improve health-care delivery 
certainly deserves great attention. 
Plants have been used since antiquity for medicinal purposes by diverse peoples and 
cultures throughout the world. Indeed, the recorded use of natural products as a 
source of relief from illness dates back at least four thousand years, and it can be 
assumed that unrecorded practices are as old as mankind (Christophersen et al., 
1999). The use of plants for medicinal purposes continues to this day, usually in the 
form of traditional medicine, which is now recognized by the World Health 
Organisation (WHO) as a building block for primary health care (Akerele, 1988; 
WHO, 2005). The vibrant healing power of herbs had been recognized since creation 
and hence botanical medicine is one of the oldest practiced professions by mankind 
(Van Wyk and Gericke, 2000; Iwu, 1993).  
 It has been estimated that 25% of prescribed medicines today are substances derived 
from plants (Hamburger and Hostettmann, 1991). These include about 119 plant-
derived chemical compounds of known structures which are currently used as drugs 
or as biodynamic agents that affects human health. Less than a dozen of these 
compounds are produced by chemical synthesis or semi-synthesis, the rest being 
extracted and purified directly from plants (Farnsworth, 1990). Well-known examples 
of drugs with plant origins includes aspirin, atropine, digoxin, ephedrine, morphine, 
quinine, reserpine, vincristine and vinblastine, as well as several plant steroidal 
 
 
 
 
 2
sapogenins which serve as semi-synthetic precursors to the steroidal drugs. The study 
of plants of medicinal importance in the first years of the nineteenth century led to the 
isolation in crystalline form of such complex substances as Strychnine (C21H22O2N2), 
Quinine (C20H24O2N2) and Morphine (C17H19O3N) which have physiological actions 
in man and animals (Farnsworth and Bingel, 1977). 
Herbal medicine has for too long been neglected in favour of synthetic drugs of 
which its misuse or abuse, and cases of side effects have become a social evil 
(Farnsworth, 1990). It has also been reported that ‘nearly’ half the prescriptions 
written annually in the United States of America contain a drug of natural origin, 
either as the sole ingredient or as one of the two main ingredients (WHO, 2002). The 
structure of many synthetic drugs resulted directly from an observation of some 
biologically active plants materials (Farnsworth, 1990). The plant Kingdom has long 
served as a prolific source of useful drugs, foods, additives, flavouring agents, 
lubricants, colouring agents and gums from time immemorial (Keay et al., 1964). 
The World Health Organization (WHO) has reported that about 80% of the world’s 
population depends mainly on traditional medicine and the traditional treatment 
involves mainly the use of plant extracts (WHO, 2005). This practice is commonly 
found in rural areas where synthetic drugs are not available or, where available, are 
not affordable. This estimated 80 percent still relies mainly on herbal medicine for 
primary health care - especially in developing nations and third world countries 
(WHO, 2002). The existence of traditional medicine depends on plant species 
diversity and related knowledge of their use as herbal medicines (Shrestha and 
Dhillion, 2003; Svarstad and Dhillion, 2000; Tabuti et al., 2003). People in Africa are 
known for using the plants growing in their backyards as part of their primary health 
care systems for millennia. In fact, archaeologists have discovered the remains of 
plants used as medicine at different archaeological dig sites all over the world which 
date back to 8000 B.C. (WHO, 2002). There are so many plants used for the primary 
health care needs in our world nowadays and many of these have never been 
subjected to any type of scientific research yet. In South Africa the huge diversity of 
tribes reflected these systems of medicine practised (Van Wyk et al., 1997). Where 
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traditional healers are known by the Zulu people as inyangas or herbalists and 
isangomas or diviners while they are known as ixwele and amaquira (Xhosa), nqaka 
(Sotho) and nanga, mungome or maine (Vhavenda) (Van Wyk et al., 1997).  
The use of a plant in a specific way for a specific purpose for many years and in 
many different geographical areas is most probably an indication that it is an effective 
treatment. It is this rapidly growing discipline (called ethnobotany) that helps 
scientists target which plants to research first and what to study them for. Indigenous 
people originally discovered the medicinal uses of almost three-quarters of the plant-
derived drugs in use today. 
Since synthetic and pharmaceutical drugs continue to be available at high cost, one of 
the most viable alternative medicines is from plant sources. Plant-based medicines are 
often the most accessible and appropriate therapy for a wide diversity of health 
problems experienced by rural and suburban dwellers. On many occasion, people 
cultivate and transplant medicinal plants in and around their homes and villages, for 
use in the treatment of common fevers, fungal infections, respiratory problems, pain 
and gastrointestinal problems, sometimes as antidotes for poisonous snake bites, 
among many others health problems.  
Medicinal plants have been found useful as antimalarial, antisickling, antihelmintic, 
antimicrobial, anticonvulsant, antihypertensive and antischistosomal (molluscicidal) 
agents etc (Coates et al., 2002; Henry, 2000). On the other hand, multiple drug 
resistance has become a very real issue in pharmacotherapeutics as there are an 
increasing number of diseases which are exhibiting various levels of drug resistance, 
including bacterial and fungal infections (Henry, 2000). The search for new drugs to 
combat this problem is nowadays receiving much attention (Coates et al., 2002). 
Plants used in traditional medicine have the potential to provide pharmacologically 
active natural products which can be used to treat various ailments. This could be 
achieved by taking advantage of recorded information available from traditional 
medicine and ethnobotanical knowledge. 
 Thousands of plants are known to be of medicinal importance from their screening 
results and local usage in traditional medicine for one ailment or the the other. In 
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Africa, especially in South Africa, a large part of the day –to – day medicine is still 
derived from plants and large volumes of plants or their extracts are actually sold in 
the informal and commercial sectors of the economy in all the 9 Provinces either 
directly as folkloric remedies or in different indigenous systems of medicine or 
indirectly in the pharmaceutical preparations and formulations of modern medicines 
in the form of creams, gels, tablets, capsules, syrups and suspensions (Mander,1998; 
De Wet and Van Wyk, 2008; Van Wyk, 2008; Van Wyk et al., 2008). According to 
National Health Experts, over 1000 different plant materials are used for medicinal 
preparations for both internal and external use in South Africa (Thring and Weitz, 
2006; Mander,1998; Van Wyk, 2008; Van Wyk et al., 2008). The world health 
organization recently compiled an inventory of more than 20 000 species of 
medicinal plants (Galal et al., 1991; Hoffmann et al., 1993; WHO, 2005, 2002). 
Although some of the plant species have been tested for antimicrobial properties, the 
majority have not yet been adequately evaluated (Balandrin et al., 1985). 
In Africa, natural medicine has never been completely abandoned and the old 
methods of healing are now being revived. Several outstanding examples support the 
value of investigating folkloric medicinal plants, e.g Rauvolfia serpentina has yielded 
a hypotensive alkaloid; Digitalis purpurea and Digitalis lanata have yielded digitoxin 
a powerful cardiotonic agent; Opium has given us the analgesics codeine and 
morphine; the smooth muscle relaxant papaverine Atropa belladona has yielded the 
parasympatholytics atropine, cinchona species have yielded the antimalerial quinine 
and the antirrhythmia quinidine; and Ammimajus has yielded the agent used to treat 
leukoderma (Odebiyi and Sofowora, 1979). All of these drugs are still in current use. 
The extraction of bioactive agents from plants is one of the most intensive areas of 
natural product research today, yet the field is far from exhausted. The majority of 
biologically active plant principles as reported by Farnsworth and Bingel, 1977 were 
alkaloids, terpenes, flavonoids, steriols, coumarins, quinines, Anthraquinones, 
Tannins, Saponins and other simple secondary plants metabolites. 
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 Chromatographic techniques are central to any isolation scheme, and there are 
several available to the natural product chemist (Joustra et al., 1967; Brooks and 
Keates, 1969; Harborne, 1973; Hostettmann et al., 1986; Hamburger and 
Hostettmann, 1991; Marston and Hostettmann, 1991), while the structure elucidation 
of isolated compounds is usually carried out by spectroscopic methods(Voirin, 1983 ; 
Sadler, 1988; Derome, 1989; Martin and Crouch, 1991; Baldwin, 1996). The advent 
of microbial fermentation coupled with advances in synthetic pharmaceutical 
chemistry in the 1950’s and 1960’s led to a decline in medicinal plant research. 
However, the developments of new chromatographic techniques for isolation, and 
spectroscopic methods for structure elucidation, have led to an upsurge in the last 
decade, resulting in the discovery and development of several new agents as 
important pharmacological tools or therapeutic drugs. 
 
1.2 Recent Progress in Phytochemistry. 
Medicinal plant research has been boosted by the clinical success of such plant-
derived drugs as vincristine and vinblastine, the antitumor principles of Catharanthus 
roseus (Apocynaceae). More recently, the diterpene forskolin (I) isolated from 
Coleus forskohlii Brig. (Labiatae) has emerged as an important tool in investigating 
the physiological role of adenosine cyclic3’,5’-(hydrogen) phosphate (cAMP), 
through its stimulation of the enzyme adenylate cyclase (Ammon and Muller, 1985). 
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A drug which has proved clinically effective in the treatment of multi-drug resistant 
falciparum malaria is the sesquiterpene endoperoxide artemisinin (II) also called 
qinghaosu, isolated from the Chinese herb qinghao (Artemisia anmia L., Asteraceae). 
Synthetic derivatives of artemisinin such as artemether® (III) and Sodium artesunate 
(IV) are also available in the market (Trigg, 1989). 
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The search for phytochemicals effective against the human immunodeficiency virus 
(HIV), the causative agent of Acquired Immune Deficiency Syndrome (AIDS) has 
resulted in the isolation of several promising compounds, including the 
tetrahydroxyindolizidine alkaloid castanospermine (V) from Castanospermum 
australe (Leguminosae) and the phorbol ester prostratin (VI) from Homalanthus 
nutans (Euphorbiaceae). Prostratin was already known, but had not been under 
investigation as an antiviral agent (Hamburger and Hostettmann, 1991; Cox and 
Balick, 1994). 
The ginkgolides, which are potent and specific inhibitors of the phospholipid 
mediator of inflammation and platelet activating factor (PAF), were isolated from 
another Chinese medicinal plant Ginkgo biloba L. (Ginkgoaceae). The ginkgolides, 
especially ginkgolide B (BN 52021, VII have been found to possess a wide range of 
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biological activities, and have also proved to be very useful pharmacological tools 
(Braquet, 1987; Smith et al., 1996).   
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Finally, the diterpenoid paclitaxel (Taxol®, Bristol-Myers Squibb) isolated from the 
bark of the pacific yew tree Taxus brevifolia and other Taxus species is a potent 
antitumor agent and has been approved for the treatment of ovarian cancer as well as 
metastatic breast cancer unresponsive to other therapies (Cox and Balick, 1994). 
Taxol (VIII), due to its low concentration in the bark of Taxus species and the high 
worldwide demand which almost result in the extinction of the Pacific yew, is now 
obtained mostly by semi-synthesis form 10-deacetylbaccatin III (IX) isolated from a 
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more sustainable source, the needles of Taxus baccata and other species of Taxus 
(Appendino, 1993; Lenaz and de Furia, 1993). 
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African scientists have only recently begun to play a major role in research into the 
medicinal plants which abound on the continent, and this is yielding good results with 
a vast body of literature already accumulated. Thus, contributions to the 
phytochemistry of African indigenous medicinal plants for the period 1969 – 2008 
have been reviewed by many scientist (Olaniyi, 1981; Olaniyi and Satake, 1992; 
VanWyk et al., 1997; Van Wyk and Gerick, 2000; De Wet and Van Wyk, 2008 ;). 
Recent advances in the flavonoid and alkaloid  chemistry of African medicinal plants 
have also been reviewed (Saleh, 1994, Kauh et al., 2009) while a comprehensive 
bibliography of research on African medicinal plants in the 1984 – 1994 literature has 
also been published (Dagne, 1996).  A major shortcoming of research on African 
medicinal plants has been the limited application of bioactivity screening and 
isolation procedures, resulting in fewer new drugs of proven value being isolated so 
far (Olaniyi and Satake, 1992).  
1.3 Background information and motivation 
There are several reasons why plants should be investigated for bioactive agents.  
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(i) The isolation of bioactive agents helps to provide chemotaxonomic evidence for 
the classification of genera or species, especially those whose classification on 
morphological grounds alone is unclear.   
(ii) It enables structure-related activity studies to be carried out.  
(iii) It also makes it possible to demonstrate that the reported physiological activity of 
the plant under screening is real. 
A major constraint on the continued use of plants for medicinal purposes is the fact 
that the forests where a majority of these plants abound are disappearing at a very 
alarming rate (Cox, 1991). There is also the loss of the associated plant folklore as 
herbalists are not passing on the generations of accumulated knowledge which they 
possess. While policies aimed at ensuring a sustainable use of bioresources are now 
being produced on a global scale (Akerele, 1988; Bonati, 1988; Cunningham, 1988; 
Mander, 1998; Van Wyk, 2008), there is also an urgent need for a systematic study of 
our medicinal plants to isolate their active principles, before they are lost forever 
(Cox and Balick, 1994; Ogungbamila and Ogundaini, 1994; Van Wyk et al., 2008). 
It has been estimated that only about 0.5% of the 250,000 – 500,000 species of higher 
plants have been adequately investigated, either phytochemically, or with respect to 
biological activity (Cox and Balick, 1994). Furthermore the 119 plant derived drugs 
in current use enumerated by Farnsworth (1990) are produced commercially from 
less than 90 species of plants which indicates that a large untapped resource still 
exists containing potential phytochemicals which could be used as new drugs, as 
precursors for the semi synthesis of natural products with complex chemical 
structures, or as potent pharmacological tools.  As highlighted above, in Africa many 
people are still known to use medicinal plant as an alternative or supplement rather 
than visiting a western health care practitioner (orthodox practitioner) (van wyk et al., 
1997). From literature search it has been known that over 500,000 species of 
medicinal plants is in existence all over the African continent which is widely spread 
all over this region (Van Wyk et al., 1997; Van Wyk and Gericke, 2000; Van Wyk 
and Wink, 2004; Irvine, 1961; Smith, 1966; Thring and Weitz, 2006; Van Wyk et al., 
2008). Broad spectrum was chosen from West Africa and South Africa for review 
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purposes only. Among the 60 000 medicinal plants that are available in West Africa, 
550 have been screened and from this total of 13 were selected based on their 
interesting ethnomedicinal uses, ready availability, easy accessibility and 
identification. Extensive literature search shows some interesting overview of the 13 
plants using available data bases which can generate the required information about 
the plants at least up to 80%. The data bases used are (1) Science Finder Scholar 
(Scifinder) (2) Science Direct (3) Scopus and (4) Google Web. The results of the 
search are shown in Table 1. 
The plants are: 
(1) Phyllanthus  niruri                          (Euphorbiaceae) 
(2) Picralima  nitida                           (Apocynaceae) or 
(Asclepiadaceae) 
(3) Tithonia  diversifolia                    (Compositaceae) or 
(Acanthaceae)  
(4) Hibiscus  sabdariffa                     (Malvaceae)  
(5) Hypoestes  rosea                              (Acanthaceae) 
(6) Rauvolfia  vomitoria                      (Apocynaceae) 
(7) Alstonia  bone                               (Apocynaceae) 
(8) Trichilia  emetica                          (Meliaceae) 
(9) Uraria  picta                                 (Leguminoseae) 
(10) Hibiscus  cannabinus                 (Malvaceae) 
(11) Sida  cordifolia                            (Malvaceae) 
(12) Piliostigma  reticulatum                 (Caesalpiniaceae) 
(13) Combretodendron  macrocarpum           (Lecythydaceae) or (Moraceae) 
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Table 1: Analysis of published articles on selected 13 plants using different data  
bases 
 
 
 
 
In South Africa alone there are over 30,000 species of higher plants and over 3000 of 
these plants species have been found to be used in traditional medicine across the 
country (Van Wyk et al., 1997, 2008; Thring and Weitz 2006).  
Knowledge of the biochemistry of these plants is very important, not only due to their 
potential for discovery of newer alternatives for the treatment of illnesses, but also to 
 Medicinal 
plants 
Scifinder 
Scholar 
articles  
Science 
Direct 
articles 
Scopus 
articles 
No of 
Patents  
No. of 
reports on 
Chemistry 
No. in 
Google 
Web. 
1. P. niruri (3) (25) (110) (85) (30) (736) 
2. P. nitida (63) (8) (23) (5) (8) (170) 
3. T. diversifolia (91) (25) (116) (18) (27) (779) 
4. H. sabdariffa (472) (45) (182) (144) (38) (1377) 
5. H. rosea (9) (2) (2) (16) (1) (166) 
6. R. vomitoria (27) (5) (9) (3) (3) (157) 
7. A. bone (3) (3) (2) (9) (1) (105) 
8. T. emetica (33) (10) (16) (2) (4) (243) 
9. U. picta (6) (1) (7) (3) (4) (47) 
10. H. cannabinus (1169) (85) (249) (104) (3) (1294) 
11. S. cordifolia (58) (8) (29) (44) (1) (1253) 
12. P. reticulatum (10) (4) (17) (0) (0) (159) 
13. C. 
macrocarpum 
(5) (6) (4) (0) (2) (75) 
 
 
 
 
 12
have the blue prints of the biochemical composition of the medicinal plants. A Data 
bank of any plants that may be under threat due to a high demand for medicinal 
purposes may thus be created before the plant becomes extinct. The data bank could 
then be used to recreate similar biochemical composition through the diverse 
available Synthetic methods. (Brown, 2002; Watt and Breyer-Brandwijk, 1962; Van 
Wyk and Gericke, 2000; Smith, 1966; Tabuti et al., 2003; Van Wyk and Wink, 2004; 
Van Wyk et al., 1997; Hutchings, 1989; Cunningham, 1988; Hutchings et al., 1996). 
The survey of the medicinal plants of South Africa was confined to the Western Cape 
Province alone for reason of easy accessibility. 
The literature shows that there are over 800 medicinal plants of high value in the 
Western Cape; however only 70 were selected based on the nature of their uses as 
well as percentage distribution throughout the Province (Table 2).  
 
Table 2: The names of the 70 selected medicinal plants in Western Cape 
Province 
SN Name of plant Family it belongs % Distribution 
1. Acacia karroo (Fabaceae) 80% 
2. Acokanthera  oppositifolia (Apocynaceae) 10% 
3.* Agathosma  betulina (Rutaceae) 40% 
4. Aloe  ferox (Asphodelaceae) 30% 
5.* Arctopus  echinatus (Apiaceae) 35% 
6. Artemisia  afra (Asteraceae) 25% 
7. Asclepias  fructicosa (Asclepiadaceae) 100% 
8.* Aspalathus  linearis (Fabaceae) 30% 
9. Aster  bakeranus (Asteraceae) 25% 
10. Ballota  africana (Lamiaceae) 80% 
11. Berula  erecta (Apiaceae) 15% 
12. Boophane  disticha (Amaryllidaceae) 40% 
13. Carpobrotus  edulis (Mesembryanthemaceae) 30% 
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14. Centella  asiatica (Apiaceae) 15% 
15. Chironia baccifera (Gentianaceae) 70% 
16. Cichorium intybus  (Asteraceae) 25% 
17. Cissampelos capensis (Menispermaceae) 100% 
18. Cnicus benedictus (Asteraceae) 10% 
19. Cotyledon orbiculata (Crassulaceae) 100% 
20. Curtisia dentata (Cornaceae) 15% 
21. Cyclopia intermedia (Fabaceae) 10% 
22. Datura stramonium (Solanaceae) 55% 
23. Dicoma capensis (Asteraceae) 15% 
24. Dodonaea angustifolia (Sapindaceae) 90% 
25. Elytropappus rhinocerotis (Asteraceae) 100% 
26. Eriocephalus africanus (Asteraceae) 85% 
27 Euclea undulata (Ebenaceae) 50% 
28. Foeniculum vulgare (Apiaceae) 60% 
29. Geranium incanum (Geraniaceae) 25% 
30.* Gethyllis species (Amaryllidaceae) 20% 
31. Glycyrrhiza glabra (Fabaceae) 10% 
32. Gunnera perpensa (Gunneraceae) 40% 
33. Helichrysum species (Asteraceae) 50% 
34. Heteromorpha  arborescens (Apiaceae) 50% 
35.* Hypericum perforatum (Clusiaceae) 10% 
36. Knowltonia vesicatoria (ranunculaceae) 40% 
37. Leonotis leonurus (Lamiaceae) 40% 
38. Lobostemon fructicosus (Boraginaceae) 50% 
39. Melianthus comosus (Melianthaceae) 50% 
40. Mentha longifolia (Lamiaceae) 100% 
41. Ocotea bullata (Lauraceae) 30% 
42. Olea europaea (Oleaceae) 60% 
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43.* Osmitopsis asteriscoides (Asteraceae) 15% 
44. Pelargonium luridum (Geraniaceae) 20% 
45. Pellaea calomelanos  (Adiantaceae) 60% 
46.* Peucedanum galbanum (Apiaceae) 10% 
47. Pittosporum viridiflorum (Pittosporaceae) 20% 
48. Plumbago auriculata (Plumbaginaceae) 10% 
49. Polygala fruticosa (Polygalaceae) 40% 
50. Protea repens (Proteaceae) 50% 
51. Prunus africana (Rosaceae) 05% 
52. Rapanea melanophloeos (Myrsinaceae) 40% 
53. Rhoicissus tridentata (Vitaceae) 15% 
54. Rhus undulata (Anacardiaceae) 40% 
55. Ricinus communis (Euphorbiaceae) 90% 
56. Rumex lanceolatus  (Polygonaceae) 100% 
7. Ruta graveolens (Rutaceae) 05% 
58. Salix mucronata (Salicaceae) 100% 
59. Scabiosa columbaria (Dipsacaceae) 95% 
60. Scadoxus puniceus (Amaryllidaceae) 05% 
61. Sutherlandia frutescens (Fabaceae) 70% 
62. Tarchonanthus camphoratus (Asteraceae) 30% 
63. Tulbaghia violacea (Alliaceae) 10% 
64. Typha capensis (Typhaceae) 40% 
65. Valeriana capensis (Valerianaceae) 20% 
66. Viscum capense (Viscaceae) 40% 
67. Withania somnifera (Solanaceae) 50% 
68. Zantedeschia aethiopica (Araceae) 40% 
69. Zanthoxylum capense (Rutaceae) 05% 
 (*) indicates that the medicinal plant is found only in Western Cape Province. 
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The extensive literature search for the above plants shows the overview of the results 
below using the same databases as that used for plants of West Africa (Table 3) 
 
Table 3: Analysis of published articles on selected 70 plants using different data 
bases 
 
 Medicinal plants Scifinder 
Scholar 
articles  
Science 
Direct 
articles 
Scopus 
articles 
No of 
Patents  
No. of 
works in 
Chemistry 
No. in 
Google 
Web. 
1. A. karro (26) (19) (69) (2) (1) (511) 
2. A. oppositifolia (4) (0) (0) (0) (0) (43) 
3. A. betulina (10) (0) (8) (7) (3) (117) 
4. A. ferox (18) (9) (33) (135) (9) (1065) 
5. A. echinatus (5) (2) (3) (0) (0) (9) 
6. A. afra (10) (15) (29) (2) (12) (308) 
7. A. fructicosa (8) (12) (17) (10) (7) (1736) 
8. A. linearis (35) (19) (75) (172) (19) (544) 
9. A. bakeranus (1) (1) (0) (1) (0) (4) 
10. B. africana (5) (1) (2) (2) (1) (146) 
11. B. erecta (16) (1) (20) (1) (1) (776) 
12. B. disticha (9) (4) (8) (0) (0) (70) 
13. C. edulis (25) (5) (31) (3) (1) (1043) 
14. C. asiatica (89) (230) (299) (867) (51) (2859) 
15. C. baccifera (7) (1) (3) (0) (1) (35) 
16. C. intybus (310) (211) (474) (341) (57) (7336) 
17. C. capensis (1) (0) (1) (0) (0) (81) 
18. C. benedictus (11) (9) (13) (67) (6) (821) 
19. C. orbiculata (14) (1) (9) (2) (0) (211) 
20. C. dentata (2) (0) (0) (0) (0) (85) 
21. C. intermedia (8) (10) (13) (13) (4) (78) 
22. D. stramonium (456) (280) (716) (1717) (54) (5955) 
23. D. capensis (1) (2) (2) (0) (0) (21) 
24. D. angustifolia (6) (3) (0) (0) (0) (12) 
25. E. rhinocerotis  (6) (3) (5) (0) (0) (55) 
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26. E. africanus (7) (2) (3) (11) (1) (54) 
27. E. undulata (3) (0) (5) (0) (0) (99) 
28. F. vulgare (129) (210) (320) (344) (97) (4277) 
29. G. incanum  (1) (0) (0) (6) (0) (527) 
30. G. species (1) (1) (5) (0) (0) (32) 
31. G. glabra (234) (87) (313) (1211) (91) (3927) 
32. G. perpensa (6) (15) (11) (1) (2) (62) 
33. H. species (56) (110) (107) (174) (12) (2499) 
34. H. arborescens (3) (0) (2) (0) (0) (96) 
35. H. perforatum (899) (678) (1446) (721) (251) (13486) 
36. K. vesicatoria (0) (0) (0) (0) (0) (19) 
37.  L. leonurus (12) (8) (11) (6) (2) (683) 
38. L. fructicosus (1) (0) (0) (2) (0) (8) 
39. M. comosus (13) (2) (3) (4) (0) (82) 
40. M. longifolia (160) (12) (1) (6) (0) (1) 
41. O. bullata (10) (8) (14) (0) (3) (240) 
42. O. europaea (993) (1002) (1119) (2031) (160) (5613) 
43. O. asteriscoides (9) (1) (3) (0) (1) (22) 
44. P. luridum (3) (0) (0) (0) (0) (32) 
45. P. calomelanos (1) (0) (0) (0) (0) (117) 
46. P. galbanum (4) (0) (1) (0) (1) (29) 
47. P. viridiflorum (6) (5) (5) (5) (3) (257) 
48. P. auriculata (13) (8) (16) (9) (3) (899) 
49. P. fruticosa (2) (0) (2) (4) (1) (1082) 
50. P. repens (12) (1) (19) (9) (0) (502) 
51. P. Africana (29) (37) (53) (49) (6) (2617) 
52. R. melanophloeos (3) (3) (5) (3) (1) (124) 
53. R. tridentate (6) (11) (12) (0) (3) (61) 
54. R. undulata (3) (1) (3) (8) (1) (446) 
55. R. communis (1199) (1087) (2290) (3311) (111) (8998) 
56. R. lanceolatus (29) (0) (0) (0) (0) (676) 
57. R. graveolens (123) (167) (222) (105) (63) (2485) 
58. S. mucronata (0) (0) (11) (0) (0) (852) 
59.    S. columbaria  (19) (3) (40) (11) (1) (1017) 
60. S. puniceus (3) (0) (0) (0) (0) (114) 
61. S. frutescens (19) (11) (18) (2) (1) (250) 
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62. T. camphoratus (29) (2) (8) (10) (2) (101) 
63. T. violacea (19) (8) (16) (3) (4) (463) 
64. T. capensis (2) (3) (3) (1) (2) (1156) 
65.  V. capensis (0) (0) (0) (11) (0) (341) 
66. V. capense (3) (1) (1) (3) (0) (44) 
67. W. somnifera (301) (144) (331) (162) (72) (1822) 
68. Z. aethiopica (29) (17) (33) (85) (3) (1325) 
69. Z. capense (3) (1) (3) (0) (0) (86) 
70.  H. asiatica (88) (240) (299) (866) (50) (2850) 
 
The final selection of plants from both West and South Africa was made based on (1) 
the ready availability of the plant in the sizable amount needed for the work (2) 
literature review (3) interest in their recorded ethnomedicinal uses (4) volume of 
work in chemistry that was recorded for the selected plants. These plants are (1) 
Piliostigma reticulatum, (2) Cissampelos capensis, (3) Geranium incanum and (4) 
Gethyllis species. 
 
1.4 Justification of the study 
The present study involves the screening of some selected African medicinal plants 
for the diverse ethnomedicinal uses acclaimed. The results obtained were used to rank 
the four selected plants: Piliostigma reticulatum, Cissampelos capensis, Geranium 
incanum and Gethyllis species. Each plant has specific but diverse ethnomedicinal 
uses which are well documented (Irvine, 1961; Gill, 1988; Hostettmann, 1997; 
Hutchinson and Dalziel, 1963; Bonati, 1988; Ogungbamila and Ogundaini,1994; 
Sofowora,1982; Van Wyk, and Gericke, 2000; Van Wyk et al., 1997; Smith, 1966; 
Watt and Breyer-Brandwijk, 1962; Levyns, 1934; Botha, 1980; Hilliard and Burtt, 
1985; Muller-Doblies, 1986; Du Plessis and Duncan, 1989; Van Wyk and Wink, 
2004; Ganguly et al., 2007; Amresh et al., 2007). There is comparatively little work 
which has been done on the evaluation of their chemical and biological actions, and 
even less on the isolation of active constituents which may explain their traditional 
 
 
 
 
 18
uses, especially the Gethyllis species. Very little work has been carried out on the 
chemistry of C. capensis and Gethyllis species to the best of our knowledge. 
 
 
 
1.5 Aims and Objectives 
The main aims of this study are:  
(1) To derive useful informative data about the numerous active constituents in the 
four selected medicinal plants. 
(2) To demostrate and identify the different spectrum of activities on diverse diseases 
and to provide a rationale for the widespread ethnomedicinal uses of the plants in 
infections and inflammatory conditions by relating their activities to the presence of 
specific isolated compounds.  
(3) To equally contribute to the growing body of knowledge relating to the 
phytochemistry of some selected African medicinal plants in which these bioactive 
compounds can equally serve as templates for other new potent drugs (Ojo, 2001; 
Reinhard and Wagner, 1987; Mc Laughlin et al, 1991; Harbone et al, 1994, 1996 and 
1997). 
(4) To use the bioactivity guided protocol for isolating and purifying active agents 
contained in some of the plant extracts. 
(5) To test for the antioxidant capabilities of the plants. 
 
1.6 Scope of the present investigation  
1.6.1  Experimental overview  
In order to achieve the above objectives, this research will involve 
(A) Collection, authentication, extractions and preliminary evaluation of the crude 
extracts for the four plants. Solvent extraction involves use of different organic 
solvents followed by bioassay evaluation of the extracts using the quick benchtop 
brine shrimp lethality test bioassay (Babajide, 1994; Adesanya, 1994). 
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(B) Isolation using various modern separation techniques such as Thin Layer 
Chromatography (TLC), Column Chromatography (CC), Vacuum Liquid 
Chromatography (VLC), Minimum Effort Liquid Chromatography (MELC) 
(Bækström, 1994; Babajide, 1994). 
 
(C) Characterization and structure elucidation of the isolated constituents of the 
plants using all the  available spectroscopic methods such as Infra red Spectroscopy 
(IR), Ultra Violet/Visible Spectroscopy (UV-Vis), Nuclear Magnetic Resonance 
Spectroscopy (NMR) and Mass Spectroscopy (MS) etc. 
 
(D)  Biochemical evaluation of the fractions and isolates for cytotoxicity using brine 
shrimp lethality test bioassay, antimicrobial and total antioxidant evaluation.  
 
1.6.2 Brine shrimp cytotoxicity 
It is very necessary that medicinal plants cytotoxicity and microbial properties are 
well documented to have a broad base data bank as highlighted earlier on. The 
cytotoxicity bioassay was carried out using the brine shrimp lethality method where 
the nauplii (larvae) of Artemisia salina were used in the analysis (Pelka et al., 2000; 
Chan-Bacab et al., 2003). The (LD50) Lethality of substances to brine shrimp nauplii 
has been linked to the probable ability of such compounds to kill cancer cells 
(antitumor activity), possibly pesticidal and antimicrobial activity (Mc Laughlin et 
al., 1991; Adesanya, 1994; Babajide et al., 2008). Padmaja et al., 2002; Kapadia et 
al., 2002 and Moreno-Murillo et al., 2001 also showed the application of this method 
in screening different plant materials because of the sensitivity of the nauplii to toxic 
substances. This was achieved by looking at the ratio between dead larvae (no 
motility) and living larvae (high motility) in comparison to a control without any 
toxic substances which was used in estimating the toxicity of the test solutions. 
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1.6.3  Antioxidant evaluation 
The in vitro chemical antioxidant evaluations were also carried out due to its 
importance in our day to day living because of its linkage to oxygen. Oxygen is 
essential to human life at the same time is also involved in toxic reactions and is 
therefore a constant threat to the well-being of all living things. This imperfection is 
known to induce damage to body tissues which usually accumulate with time 
(Langseth, 1995). This damage has been hypothesized to be a major contributor to 
many of the degenerative diseases of ageing, including cardiovascular disease, 
cancer, cataracts, the age-related decline in the immune system and degenerative 
diseases of the nervous system (Eric, 1993; Ames et al., 1993). In the past decade, 
researchers have made major strides in looking for substances that may possibly 
prevent, postpone or limit the severity of these diseases by enhancing the body's 
antioxidant defence mechanisms through improved nutrition (Packer and Glazer 
1990; Langseth, 1995). 
Most of the potentially harmful free radical (oxidants) generated by both endogenous 
and environmental factors such as exercise, Inflammation, cigarette smoke, 
environmental pollutants, radiation, ultraviolet light, certain drugs, pesticides, 
anaesthetics, industrial solvents and ozone can be prevented or eliminated by 
antioxidant (Machlin, 1992 ; Papas, 1992; Frei, 1994; Sies, 1991; Halliwell and 
Gutteridge, 1989; Yagi, 1993;  Packer and Glazer, 1990; Aruoma et al., 1991; 
Diplock, 1991; Pfeifer, 1993; Block et al., 1992; Singh and Gaby, 1991; Ames et al., 
1993).  
Aruoma 2003 showed that the study of these free radicals and antioxidants in biology 
is producing medical revolution that promises a new age of health and disease 
management. Cancer, one of the diseases caused by free radical as shown by the 
multistep processes in figure 1 can be prevented by antioxidant as shown in figure 2.  
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         NORMAL CELL 
 
 
                     INITIATED CELL (Initiation) 
 
 
                        PREMALIGNANT LESIONS (Promotion) 
 
 
                                        CANCER   (Progression)                
Fig 1: A multistep model for carcinogenesis  
 
It has been known that antioxidants may be able to cause the regression of 
premalignant lesions or inhibit their development into cancer by chemoprevention. 
 
 
Repair                        Regression                            Inhibition 
Fig 2: A chemoprevention scheme 
 
An impressive body of scientific evidence shows that people with high dietary intakes 
of fruits and vegetables are less likely to develop cancer than people who have low 
dietary intakes of these foods. Over 300 epidemiologic studies of fruits, vegetables 
and cancer have been published, and their results are remarkably consistent (Beecher, 
2003; Langseth, 1995). 
Young and Woodside, 2001 showed the effect of antioxidants on health and diseases 
with respect to the basic chemistry of free radical formation in the body while several 
literature showed how medicinal plant extracts and isolates, teas, beverages, fruits 
and seeds containing flavonoids and polyphenolic derivatives can be used as a 
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remedy and antioxidants in these free radical- scavenging capabilities (Langseth, 
1995; Eric, 1993; seeram et al., 2006). 
Diet is believed to play an important role in four major diseases of advanced and 
transitional economies: cardiovascular disease, cancer, hypertension and obesity 
(Silalahi 2002).  
Several classes of dietary compounds have been suggested to reduce the risk of some 
cancers, especially those of the gut, and there is some evidence that consumption of 
certain foods leads to a reduction in biomarkers of oxidative damage. The active 
principles in extracts from a variety of plant sources, such as cocoa shells, oats, tea, 
olives, garlic, ginger, red onion skin, grapes, apple cuticle, wheat gliadin, licorice, 
nutmeg, clove, thyme and a variety of medicinal plants and seeds extracts from 
tropical and sub-tropical regions of the world continue to be of interest for use in 
complementary medicine supplements because of the fact that it contain the 
important antioxidants such as Vitamin E, Vitamin C, Carotene, flavonoids, alkaloids 
and other polyphenols (Aruoma 2003). 
The major antioxidants in plants can be in form of polyphenols, flavonols, flavanols, 
anthocyanins and flavanones derivatives. Their measurement can be carried out 
using standard methods and different reference standards. The amount of total 
phenolics in a herb extracts can be determined with the Folin- Ciocalteu reagent 
according to the method of Slinkard and Singleton, 1977 using gallic acid as a 
standard (Waterhouse, 2005) while catechins can be use as standard for flavonoids 
(Delcour and Janssens, 1985; Treutter, 1989; Waterhouse, 2005; McMurrough and 
McDowell, 1978; Seeram et al., 2006; Cao et al., 1996; Beecher, 2003).  
Anthocyanins on the other hand are pigments responsible for the attractive red to 
purple to blue colours of many fruits and vegetables and they are also known as good 
antioxidant.  Interest in the anthocyanin content of foods has intensified because of 
their possible health benefits. They are known for their role in reduction of coronary 
heart disease, increased visual acuity and cancer properties (Eric, 1993; Ames et al., 
1993; Francis, 1989).   
 
 
 
 
 23
Measurement of total anthocyanin pigment content is carried out by measuring 
absorptivity of the solution at a single wavelength. This is possible because 
anthocyanins have a typical absorption band in the 490 to 550 nm region of the 
visible spectra. (Francis, 1982 and 1989; Fuleki and Francis, 1968a and 1968b; 
Jackman et al., 1987; Sondheimer and Kertesz, 1948; Wrolstad et al., 1982, 1995; 
Somers and Evans, 1974; Swain and Hillis, 1959; Giusti et al., 1998).  
The chemistry involved in the antioxidant capacity assays were highlighted by Huang 
et al., 2005 and Prior et al., 2005 which highlighted three major methods of 
evaluating the antioxidant capacity of any material. These methods include  
1. ORAC (Oxygen radical absorption capacity) by H+ ion transfer. 
2. FRAP (Ferric reducing antioxidant power) by the movement of e- electron. 
3. TEAC (Trolox (a well known standard) equivalent antioxidant capacity)   
ORAC assay is a fluorescence-based method which was first developed by Glazer et 
al. in 1989 and is based on the discovery that the fluorescence of phycoerythrin (PE) 
changes with respect to time upon damage caused by peroxyl or hydroxyl radical 
attack (Glazer and DeLange, 1989).  This assay measures the ability of antioxidant 
compounds in test materials to inhibit the decline of R-PE fluorescence that is 
induced by a peroxyl radical generator, AAPH (Cao et al. 1993a and b; 1995; Cao 
and Prior, 1998; Prior et al., 2003; 2005; Wang and Lin, 2000). The FRAP assay uses 
an oxidation/reduction reaction to measure the ability of a sample to reduce FeIII to 
FeII. It is assumed that the FRAP assay is a method for evaluating antioxidant 
capacity (Benzie and Strain, 1996; 1999).  
The ABTS (2,2’-azino-di-3-ethylbenzthialozine sulphonate) TEAC assay is a radical 
cation scavenging assay which was first developed by Miller et al., 1993 for the 
determination of the total antioxidant status (TAS) of a material.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 PILIOSTIGMA RETICULATUM 
2.1.1 Piliostigma reticulatum (DC.) Hochst).  
Plant description  
The family leguminosae has 16,000 -19,000 species in about 750 genera, and is 
conventionally divided into three distinct subfamilies: Mimosoidaeae, 
Caesalpiniodeae and Papilionoideae. More recent taxonomic restructuring has 
accorded full family status to each of the three subdivisions, as Mimosaceae, 
Caesalpiniaceae and Fabaceae in order Leguminales (Allen and Allen, 1981).  
The caesalpiniaceae, to which P. reticulatum belongs, is a pantropical family of about 
150 genera and 2000 species, and consists of about 200 species of 58 genera in 
tropical Africa. The Caesalpiniaceae species are usually trees or shrubs, and rarely 
herbs or vines. The leaves are often large and brightly coloured (Figure 3). The fruits 
are usually pods (Assi and Guinko, 1991). 
The genus Piliostigma which is now recognized as distinctive from Bauhinia type 
which it was segregated from, consist of three species which are trees, evergreen, 
small to medium and generally grow up to 10 metres high as shown in Figure 4 
(Index kewensis, 1953; Allen and Allen, 1981). The leaves are simple, broad, deeply 
bilobed at the middle and the apex, typically bauhina-like, with 9 – 15 prominent 
main veins radiating from the base, at the point of attachment with the long petiole 
(Figure 3). Members of the genus Piliostigma occur in tropical Africa and Indo-
Malaya. P. malabarium (Roxb.) Benth. Var acidum de Wit, is confined to Asia, in the 
drier monsoon belt of India, Malaysia and the Philippiness (Djuma, 2003; Schultes 
and Hofmann, 1973), although it has reportedly been recently introduced into Sierra 
Leone (Burkill, 1995). The two African species P. reticulatum (DC.) Hochst. and P. 
thonningii (Schum.) Milne-Redhead, inhabit dry and moist savannahs, respectively 
(Allen and Allen, 1981). P. reticulatum has close resemblance to P. thonningii to the 
extent that they can be easily confused with each other during identification, although 
at very close range distinguishing morphological features become observable. P. 
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reticulatum has smaller leaves and smoothness on the lower side whereas P. 
thonningii has larger leaves and hairiness on the lower side.  When they enjoys 
damped climate, they readily colonises abandoned land (Burkill, 1995). 
Piliostigma reticulatum is a shrubs or small tree 5 – 10m high (Figure 4), with a trunk 
that is often twisted, and possessing a dark brown, fibrous and deeply longitudinally 
fissured bark. The leaves are bilobate and covered below by a reddish pubescence and 
are 7.5-16 cm long and 10- 18 cm broad (Figure 3). The flowers are white and 
fragrant (Fig. 3), while the pods are woody, flat and dark brown when ripe 
(Adjanohoun et al., 1991; Assi and Guinko, 1991). Other synonyms of P. reticulatum 
which were used in the past include Bauhinia thonningii (Schumach.), Bauhinia 
reticulata (DC.), Bauhinia abyssinica (A. Rich.), Bauhinia pyrrhocarpa (Hochst.), 
Locellaria bauhinioides (Welw.) and Piliostigma pyrrhocarpum (Hochst) (Watt and 
Breyer-Brandwijk, 1962). The traditional Nigerian names of P. reticulatum are Kalgo 
(or Kargo) in Hausa (Northern Nigeria), Abafe in Yoruba (Western Nigeria) and 
Okpo-atu in Igbo (Eastern Nigeria) (Dalziel, 1937; Burkill, 1995). The Yoruba name 
implies people choice because of its multipurpose usage while the Igbo name implies 
that a person who takes the plant cannot be infected with worms (Asuzu and Onu, 
1994). 
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Fig 3: Leaves of P. reticulatum 
 
 
Fig4:  P. reticulatum tree in the background. 
 
2.1.2  Ethnomedicinal uses of Piliostigma reticulatum. 
P. reticulatum is used as a medicinal plant to treat various ailments throughout 
tropical Africa. The available data are summarized in Table 4. It can be seen that the 
plant has a widespread area of use, and that the indications are similar. The most 
common indications are cough and chest complaints (upper respiratory problems), 
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diarrhoea and dysentery, fever, headache, toothache, gingivitis. It is also used to treat 
wounds and chronic ulcers. As it may be obseved, most of these indications are 
related to inflammatory conditions or infections.  
Ethnomedically, the bark, root, pod, young stem or leaves have been used for treating 
leprosy, smallpox, coughs, ulcer, heart pain, gingivitis, snake bite, dysentery, fever, 
wounds and a variety of closely related disease conditions.  (Irvine, 1961; Asuzu and 
Onu, 1994; Bombardelli et al., 1994; Dalziel, 1937; Watt and Breyer-Brandwijk, 
1962; Bombardelli et al., 1973;  McGaw et al., 1997; Bombardelli et al., 1992; 
Okwute et al., 1986).  
 
2.1.3 Reported biological activities of Piliostigma reticulatum 
2.1.3.1 Actions on smooth muscles. 
Most of the literature available reported work done on Piliostigma thonningii.  A 
normal saline extract of the fruit of Piliostigma reticulatum had no effect on the 
isolated uterus preparation (Anokbonggo, 1972). Asuzu and Ugwuja (1989) found 
that the 70% ethanol extract of the bark induced persistent contractions of the isolated 
guinea pig ileum which were completely blocked by atropine. 
 
2.1.3.2 Antimicrobial activity.  
 An aqueous decoction of the stem bark of P. thonningii when tested for activity 
against the Gram-positive organisma Sarcina lutea, Staphylococcus aureus and 
Mycobacterium phlei using the agar diffusion hole-in-plate method showed activity 
only against S. lutea (Malcolm and Sofowora, 1969). The 60% methanol extract of 
the root bark of same plant showed activity against the yeast Saccharomyces 
cerevisiae at a test concentration of 100µg/ml (Taniguchi et al., 1978). This extract 
however had low activity against Escherichia coli, Bacillus subtilis and Penicillium 
crustosum at the same test concentration. The 10% methanol extract of the leaves of 
P. thonningii had no activity against Escherichia coli and Sarcina lutea at a test 
concentration of 15 mg/ml (Laurens et al., 1985). The methanol extract of the dried 
leaf was active at a concentration of 2 mg/ml against Pseudomonas aeruginosa and 
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Streptococcus species in the agar plate method (Hussain and Deeni, 1991) in the same 
study, the extract had no activity against Corynebacterium diptheriae, Neisseria 
species, Salmonella species, Staphylococcus aureus and Streptobacillus species. 
Finally, le Grand et al., (1988) found that the 95% ethanol extract of the leaves and 
stem bark had activity against Staphylococcus aureus and Aspergillus niger, but no 
activity against Bacillus subtilis, all at a concentration of 50 mg/ml. From the above, 
extracts of Piliostigma thonningii seem to be active mostly against Gram-positive 
organisms although the literature does not show consistency as to its spectrum of 
activity.  
Akinpelu and Obuotor (2000) showed that the methanolic extract of Piliostigma 
thonningii stem bark exhibited activity against six out of eight bacterial isolates at a 
concentration of 20 mg/ml. In a survey of 84 medicinal plants used locally in the 
treatment of various diseases in Bauchi State—Nigeria,  Adamua et al., 2005 showed 
that Piliostigma extracts were found to show potentially interesting activity against 
Proteus mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia 
coli at a concentration of 200 mg/ml  
 
Table 4: Uses of Piliostigma reticulatum 
Locality Plant part Use  Indications  References  
Kano, 
Northern 
Nigeria 
Leaves and young buds  Decoction Eye wounds and 
infection  
Hussain and 
Karatela, 1989 
West Africa  
 
 
Leaves(+ leaves of 
Xylopia aethiopica, 
Annonaceae) 
Decoction 
taken as 
beverage 
Fever   Assi and 
Guinko, 1991 
West Africa Raw shoots  Eaten raw Dysentery Assi and 
Guinko, 1991 
West Africa Leaves  Decoction Gastric pains and 
as tonic 
Assi and 
Guinko, 1991 
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West Africa Crushed flower buds Diluted in 
water in water  
Heart pain Assi and 
Guinko, 1991 
West Africa Young leaves  Chewed and 
applied as 
paste 
Gingivitis Assi and 
Guinko, 1991 
Western 
Nigeria  
Leaves and stem bark (in 
multiple plant recipe)  
Decoction Dermatomycosis 
and malaria  
Adjanohoun et 
al., 1991 
Nigeria Powdered bark; leaves External 
dressing; 
infusion used 
as wash 
Wounds and 
chronic ulcers 
Dalziel, 1937 
Nigeria  Bark Infusion Toothache; 
astringent for 
diarrhoea and 
dysentery 
Dalziel, 1937 
Nigeria Bark, root and leaves Decoction  Leprosy; 
smallpox 
Dalziel, 1937 
East Africa  Bark Boiled in milk 
or soup 
Gonorrhea Watt and 
Breyer-
Brandwijk, 
1962 
East Africa Bark Concentration 
infusion  
Antipyretic; as 
mouthwash for 
inflammation of 
the gums 
 
Watt and 
Breyer-
Brandwijk, 
1962 
East Africa  Leaves  Decoction  Cough and chest 
complaints  
Watt and 
Breyer-
Brandwijk, 
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1962 
Enda, 
southern 
Africa 
Root and bark (+ root and 
bark of faurea saligna, 
proteaceae) 
Decoction Venereal disease 
and bilharzia 
Arnold and 
Gulumian, 
1984 
Tanzania  Root (part of multiple 
plant recipe) 
Decoction Insanity and 
epilepsy 
Mathias, 1982 
East Africa Root (+ root of vigna 
phaseolloides,papillionac
eae  
Infusion Contraceptive Brondegaard, 
1973 
Eastern 
Nigeria 
Bark Infusion  Anthelmintic Asuzu and 
Onu, 1989 
Senegal Dried leaves, bark, and 
flowers 
Hot water 
extract 
Phadegenic 
ulcers, odontalgia, 
diarrhoea amd 
dysentery , cough  
Le Grand, 
1989 
Senegal Dried flowers Powder is 
smoked 
Cough Le Grand and 
Wondergem, 
1987 
Nigeria Roots and fruits Decoction (2 
:1 ratio of root 
: fruit ) 
Fever, skin 
diseases 
Bhat et 
al.,1990 
Ivory coast Fresh leaves Crushed and 
applied 
externally 
Hemostatic Kone-Bamba 
et al.,1987 
Senegal Dried leaves Hot infusion Conjunctivitis and 
headache 
Tignokpa et 
al., 1986 
Uganda Unspecified Decoction Diarrhoea Anokbonggo 
et al., 1990 
East Africa Root Infusion  Miscarriage; Kokwaro, 
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prolonged 
menstruation  
1976 
Tanzania Root Decoction Stomachache, 
rectal prolapse, 
menorrhagia, 
malignant ulcers 
Chhabra et al., 
1987 
West Africa Leaves, stem, roots Infusion Toothache; 
cough; wounds; 
ulcers 
Ayensu, 1978 
West Africa Leaves  Not stated  Snakebite Houghton and 
Osibogun, 
1993 
Angola Bark Internally, bark 
is ‘cooked’ 
while the 
macerated bark 
is used 
externally 
Tuberculosis, 
cough, bronchitis, 
asthma; paludism 
and as a piscicide 
Bossard, 1993 
Nigeria Stem bark, leaves Decoction Skin infections, 
smallpox, 
chickenpox 
Burkill, 1995 
Gambia, 
Tanganyika 
Stem bark External 
dressing 
Wound healing Burkill, 1995 
West Africa  Stem bark, leaves Decoction Inflammation of 
the eyes, guinea 
worm, sore-
throat, toothache 
and gum troubles 
Burkill, 1995 
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2.1.4 Other activities   
The leaves, pods and root of piliostigma reticulatum (DC.) Hochst was found to 
exhibit no molluscicidal activity at the test concentration of 100 ppm (Adewunmi and 
Sofowora. 1980). On the other hand, the 70% ethanol extract of the bark of 
piliostigma reticulatum showed significant broad spectrum of activity against the 
larvae of common intestinal parasites of cattle (Asuzu and Onu, 1993). The 70% 
ethanol extract also showed concentration-dependent anthelmintic activity in vivo in 
chickens, and also induced concentration-dependent contraction of Ascaridia galli in 
vitro (Asuzu and Onu, 1994). These observed activities thus supported the traditional 
use of the bark as an anthelmintic (Asuzu and Ugwuja, 1989). Aderogba et al., 2006 
confirmed the antimicrobial and anti-inflammatory Effects of Piliostigma reticulatum 
Leaf Extract by its comparison with that of Piliostigma thonningii. 
The 70% ethanol extract of the bark also significantly reduced pentobarbitone-
induced sleeping time in mice following intraperitoneal injection, but had no 
significant effect on leptazole and strychnine induced convulsions (Asuzu and 
Ugwuja, 1989). The extract also had an oral LD50 of 1862 mg/kg in mice. The 
methanol extract of the leaves and stem bark of Piliostigma thonningii had an LC50 of 
10 - 50µg/ml in an in vitro antimalarial test using the multidrug resistant k1 strain of 
Plasmodium falciparum (Weenen et al., 1990). This is significant, as Adjanohoun et 
al., (1991) reported the use of Piliostigma reticulatum as part of a multiple plant 
regimen used to treat malaria. 
Mandibaya and Chihora, 1999 and Babajide et al., 2006 showed that Piliostigma pod 
meal has lower nutritive value but can be very useful feed supplement to communal 
cattle grazing poor quality forage during the tropical dry season. Akhtar et al., 2000 
showed its usefulness as an antihelmintic in livestock. In a recent survey of plants 
used ethnomedically against cancer, Piliostigma reticulatum was found to be one of 
them as shown by the NAPRALERT database currently maintained by the Program 
for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, and 
University of Illinois-Chicago, USA. Which are part of the work of Jonathan 
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Hartwell, ‘‘Plants used against cancer: a survey’’, including previously unrepresented 
genera and families (Graham et al., 2000). 
 Extracts of 23 plant species used popularly against schistosomiasis in Zimbabwe 
were screened for their anthelmintic effect. Schistosomules of the trematode 
Schistosoma mansoni and cysticercoids of the cestode Hymenolepis diminuta were 
studied in vitro. The material consisted of 58 plant extracts, of which piliostigma is 
one of the 37 that killed the newly excysted cysticercoids within an hour, when 
incubated in a culture medium (Mølgaard et al., 2001).  Ajaiyeoba et al., 2006 
showed the antimalarial potentials in the plant while Rochfort et al., 2008 explain its 
bioactive contents for ruminant health and productivity. Because it combine 
reproductive efficiency, milk and meat quality improvement as well as serving as 
antibiotics (Mlambo et al., 2008). Asuzu (1999) showed the antihelmintic activity of 
D-3-O methylchiroinositol isolated from Piliostigma thonningii stem bark.  
Finally, Bombardelli et al., (1992) found that the 50% acetone extract of Piliostgma 
reticulatum leaves produced a statistically significant reduction of ammonia aerosol 
induced cough in guinea pigs, as well as cough induced by electrical stimulation of 
the trachea in the anaesthetized guinea pig. This observed antitussive activity has 
been linked to the catechin oligomers in the polyphenolic fraction of the plant extract 
(Bomnardelli et al., 1994) and explains the widespread use of the plant in the 
treatment of cough (Table 4; Watt and Breyer-Brandwijk, 1962; le Grand, 1989; 
Ayensu, 1978; Bossard. 1993). 
 
2.1.5 Chemical constituents of Piliostigma reticulatum.  
 Piliostigma reticulatum is a plant which is rich in tannins, and the bark is used for 
tanning leather. Dalziel (1937) reported that the bark of the smaller twigs contain 
over 20% of tannin, while the bark of larger branches and the root have up to 18% 
tannin, and the immature pods contain lesser amounts decreasing towards maturity. 
 The first systematic investigation of the chemical constituents of Piliostigma 
thonningii was by Ferreira et al., (1963) who found that the bark contained sucrose, 
pyrocatechic tannins, tartaric acid, citric acid, rhamnitol as well as a carotenoid and 
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an unidentified sterol.  Subsequently, the leaves of P. thonningii were found to 
contain quercetin(X), quercitrin (XI) and quercetin-3-O-glucoside (XII) (Bombardelli 
et al., 1973).  
   
OOH
OH O
OR
OH
OH
 
                                                     X        R = H 
XI R = rhamnose 
XII R = glucose 
Further investigations by Bombardelli et al. (1992; 1994) showed that the plant 
contains (-)-epicatechin, proanthocyanidin B2 as well as catechin trimers, tetramers 
and higher oligomers. 
Okwute et al. (1986) isolated griffonilide (XIII) from the stem bark. Griffonilide, a γ-
lactone, had previously been isolated from Griffonia simplicifolia (Baill.) 
(Caesalpiniaceae) by Dwuma-Badu et al, (1976). 
 
O
OH
OH
O
 
XIII 
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Snatzke and Wolff (1989) isolated 5α-stigmasta -7,2,2-dien-3β-ol and four labdane 
derivatives from the petroleum ether extract of the root. The labdane derivatives were 
lambertianic acid (XIV), lambertianol (XV), lambertianol methyl stearate (XVI) and 
trans-communic acid (XVII). 
 
 
 
 
 
CH2
R2
CH3
CH3
R1
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Finally, literature showed that established isolated constituents include flavonoids and 
proanthocyanidins (Snatzke and Wolff, 1989; Lamikanra et al., 1990; Komiya et al., 
1975), labdane derivatives (Hashidoko et al., 1991; Huang et al., 1993), a kaurane 
diterpene (Roitman and James, 1985; Martin et al., 1997), C- methylflavonols 
(Breitmeier and Voelter, 1990; Harborne et al., 1994; Rabesa and Voirin, 1985; 
Voirin, 1983; Aderogba et al., 2003;  Rasamoelisendra et al., 1989) and 
phenoxychromones (Ibewuike et al., 1996; 1997), while broad  phytochemical 
analysis showed the presence of other classes of constituents such as saponins, 
tannins and polyphenols (Irvine, 1961;  Bombardelli et al., 1994). Asuzu (1999) 
showed the isolation of D-3-O-methylchiroinositol from Piliostigma thonningii stem 
bark. 
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2.2 CISSAMPELOS CAPENSIS 
2.2.1 Plant description 1 
Cissampelos capensis is one out of 520 species in 75 genera (Watson and Dallwitz, 
1992). This plant belongs to the family Menispermaceae. Well notable synonyms to 
Cissampelos capensis are Cissempelos pareira, C. acuminate, C. cordata, C. 
cordifolia, C. hirsuta, C. orbiculata, Antizoma capensis (L.f.) Diels, pulverulenta 
(Harv.) Diels, Cissampelos fruticosa (L.f.) Diels, and Cissampelos humilis (Poir). It is 
widely distributed in the Sandy slopes and scrub of the Northern, Western and 
Eastern Cape Provinces of South Africa and northwards into Namibia. It is called by 
different local name such as Dawidjiewortel (Afrikaans) and Mayisake (Xkhosa). 
Due to of its richness in bisbenzylisoquinoline alkaloids, this family is used 
worldwide in traditional medicine to treat a variety of ailments (Barbosa- Filho et al., 
2000; DeWet et al., 2004, 2005). The literature revealed that out of the 75 genera in 
the Menispermaceae, twenty-one genera are used for medicinal purposes in Africa 
and twenty-nine genera in the rest of the world. (Neuwinger, 2000; Duke, 2007;De 
Wet, 2006). The southern Africa Menispermaceae comprises of seven genera and 
thirteen species, and among these one genus and three species are endemic to the 
region. In South Africa, some ethnobotanical information has been recorded 
(summarized in Arnold et al., 2002) but only one species, Cissampelos capensis (L.f.) 
Diels [dawidjies (wortel)], is a well-known and much used medicinal plant, 
particularly in the Eastern and Western Cape Provinces (Watt and Breyer-Brandwijk, 
1962; Smith, 1966; Rood, 1994; Cillie, 1992; Dykman, 1891; Iwu, 1993). 
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Fig 5:  Dawidjiewortel (Cissampelos capensis woody shrub) 
2.2.2 Plant description 2 
Dawidjiewortel is a woody dioecious perennial climbing vine with a sprawling or 
twining stem shrublet without tendrils but supports itself by twining around the stems 
of other plants, fence or walls (Figure 5). The vine is blackish-brown and tough. 
When this is freshly cut it has a waxy luster. The leaves are rounded, bright green, 
entire, alternate, almost without hairs. It posses an ovate to heart-shape and up to 
2.5cm wide by 2.5cm long, on thin petioles up to 3cm long. The flowers which 
usually sprout between the month of February and May are an axillary, velvety-hairy, 
greenish in colour. The female flowers which are 1 to 2 are with 1 sepal and petal 
while the male in cymose inflorescences are produced in clusters. The fruit is 
inedible, dark, grape-sized berries or sometimes they are small fleshy orange berries. 
The root is up to 2.5cm in diameter with grey-brown bark, cream in transverse 
section with distinct brown medullary rays (Botha, 1980). The plant is usually 
confused with Zehneria scabra (Cucurbitaceae), which is in some parts known by the 
same local name (Smith, 1966). The latter resembles a cucumber and can be 
distinguished by the spirally coiled tendrils. Under the microscope the leaf showed 
the absence of calcium oxalate crystals in the lamina and the occasional unicellular 
clothing hairs of leaf and stem, up to 240µm long, with thin slightly roughened walls. 
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The cells of the leaf epidermis are with striated cuticle and thickened walls. The 
presence of anomocytic stomata found on both leaf surfaces with papillated cells 
making up the leaf margin (Botha, 1980).  
  
2.2.3 Ethnomedicinal uses of Cissampelos capensis 
Nearly all the parts of the plant were put to use, from the whole vine, seed, bark, leaf 
to the root. The general ethnomedicinal uses of Cissampelos species all over the 
world is as shown in Table 5. It is traditionally used in South Africa to treat variety of 
ailments such as gravel and glandular swelling, gall stones.  A weak brandy tincture 
for dysentery, mucous membrane infection,  menstrual problems,  prevention of 
miscarriage,  difficult labour,  expelling the placenta,  appetite stimulant,  blood 
purification, antisyphilitic use, cholera, colic, erypsipelas internally and externally, 
bladder problems, snakebite, stomach pain, influenza. Toothache: chew root and a 
sedative effect by chewing the rhizome. For treating pain, using infusions, bilious 
complaints, measles: mix root with half a teaspoon Epsom salt, fever: mixed root 
with “grandpa powder” (a headache powder, which contains aspirin, paracetamol and 
caffeine), vinegar and sugar, headache: smoke inhaled through nostrils to treat 
headache,  diabetes, tuberculosis, stomach and skin cancers, purgative, good-luck 
charm: root is carried around, the leaves are used for: ulcers and syphilis sores: paste 
is used, snakebite wound: paste is used (Smith, 1895; Watt and Breyer-Brandwijk, 
1962; Rood, 1994; Von Koenen, 2001; Van Wyk and Gericke, 2000; VanWyk et al., 
1997; De Wet and Van Wyk, 2008;; Barbosa- Filho et al., 2000; DeWet et al., 2004, 
2005). 
It sometimes administered as leaf infusion or the tincture is taken orally and a 
poultice or paste applied externally for various ailments. Preparations of the root of 
this species are also extensively used, both internally and externally but it is worthy 
to note that high precautions must be maintained because of the presence of highly 
bioactive alkaloids which are known to be toxic. The vine or root is used in tropical 
countries to prevent a threatened miscarriage and to stop uterine hemorrhages after 
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childbirth. The plant extract is also believed to aid poor digestion, drowsiness after 
meals, and constipation.  
 
2.2.4 Reported biological activities of Cissampelos species 
In 1962, it was reported that C. pareira demonstrated anti-inflammatory, smooth 
muscle relaxant, antispasmodic, and uterine relaxant actions in various laboratory 
animals. Subsequent studies with animals confirmed the plant's antispasmodic and 
anti-inflammatory actions. These documented effects are quite similar to Cissampelos 
species traditional uses for menstrual disorders (including cramping and pain) (Pillay 
et al., 2008; Taylor, 2005). In other animal studies, a root extract was reported to have 
a diuretic effect, a finding that confirms another of its traditional medicine uses 
(Taylor, 2005; Ssegawa and Kasenene, 2007). Other in vivo studies on the extracts of 
Cissampelos species indicated that the leaf has antiulcerous actions and that the root 
has a very mild hypoglycemic action (only at high dosages). Studies have also shown 
that the Cissampelos species root has other possible therapeutic uses: it demonstrated 
anticonvulsant actions in mice; and, in dogs, it was shown to significantly lower 
blood pressure. In addition, test-tube (in vitro) studies over the years of related 
Cissampelos species has reported that they have antioxidant properties; antibacterial 
actions against Staphylococcus, Pseudomonas, Salmonella, and Klebsiella; and 
antimalarial effects. One of these in vitro studies also reported that a root extract 
demonstrated a toxic effect against colon cancer cells. Alkaloids constituents have 
been ascribed to posess sedative, antispasmodic and antitumour properties (Dic. Nat. 
prod., 1996; Bruneton, J., 1995) 
 
 
 
2.2.5 Major chemical constituents  
Phytochemical tests showed the presence of alkaloids, saponins and tannins but 
cardiac glycosides and anthraquinone were absent. The chemical profile of the family 
typically includes benzylisoquinoline, bisbenzylisoquinoline (e.g. tubocurarine, 
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cissampareine), diterpene and triterpene alkaloids, as well as saponins. A large 
number of biologically active alkaloids of the bisbenzylterahydroisoqunoline type 
have been isolated from several Cissampelos species and various other genera of the 
Menispermaceae, and among these cissampareine (XVIII) is a typical example (Dic. 
Nat. prod., 1996; Jittra et al., 2005; Maria et al., 1995) 
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                                            Cissampareine    (XVIII)  
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Cissampelos plants, including C. pareira, contain a group of plant chemicals called 
isoquinoline alkaloids. Since the late 1960s, it has been found that these chemicals 
have received a great deal of attention and research. One, out of thirty-eight alkaloids 
thus far discovered in Cissampelos species, called Tetrandrine (XIX) is the best 
documented.   
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                                             Tetrandrine (XIX)  
Clinical research over the years has found Tetrandrine to have pain-relieving, anti-
inflammatory, and fever-reducing properties. More than one hundred recent clinical 
studies also describe this chemical's promising actions against leukemia and some 
other cancer cells. However, the therapeutic dosages of Tetrandrine used in these 
animal studies are much higher than one can reasonably obtain from natural C. 
pareira root or vine. Another well-known alkaloid Berberine (XX) has been 
documented to have hypotensive, antifungal, and antimicrobial actions. This chemical 
has been used for the treatment of irregular heartbeat, cancer, Candida, diarrhea, and 
irritable bowel syndrome. Another alkaloid called Cissampeline is sold as a skeletal 
muscle relaxant drug in Ecuador. The main chemicals in Cissampelos species, 
especially C. pareira which is well documented are alkaloids, arachidic acid (XXI), 
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bebeerines(XXVI) , berberine (XX), bulbocapnine (XXVII), cissacapine (XXVIII), 
cissampareine(XVIII) , corytuberine, curine, 4-methylcurine, cyclanoline, 
cycleanine, dicentrine, dehydrodicentrine,  dimethyltetrandrinium, essential oil, 
grandirubrine, hayatine, hayatinine, insularine, isochondodendrine, isomerubrine, 
laudanosine, linoleic acid, magnoflorine (XXIV), menismine, norimeluteine, nor-
ruffscine, nuciferine, pareirine, pareirubrine alkaloids, pareitropone (XXIX), 
quercitol, stearic acid, and tetrandrine (XIX)  (Taylor, 2005).  
Hydrocolloids, an important thickeners and gelling stabilizers in food system were 
isolated from C. Pareira and characterized by Vardhanabhuti and Ikeda (2006). A 
red-brown amorphous aporphine alkaloid powder, Cissaglaberrimine (XXIII),    
Magnoflorine (XXIV) and Oxobuxifoline (XXV) were isolated from C. glaberrima 
(Barbosa-filho et al., 1997) while Milonine (XXII), an 8, 14-
dihydromorphinandienone alkaloid was also isolated from the dried leaves of C. 
sympodialis (Freitas et al., 1995). Similarly pareitropone (XXIX), a condensed 
tropone-isoquinoline alkaloid with high antileukemic activity was also isolated from 
C. pareira (Morlta et al., 1995).  
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                       Arachidic acid (Eicosanoic acid) (XXI) 
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                                                Pareitropone (XXIX) 
 
2.2.6 Current Uses 
Cissampelos is still in use in many part of the world where it can be found used for 
the same purposes it has been used traditionally for centuries - as a childbirth aid and 
for general women's ailments. South and North American natural health practitioners 
commonly rely on Cissampelos as an excellent natural remedy for menstrual 
difficulties, including cramping and pain, premenstrual syndrome (PMS), excessive 
bleeding, and fibroid tumors. Its ability to curb excessive menstrual bleeding very 
quickly can be quite remarkable. It is often employed in overall female balancing 
formulas, in kidney formulas (for its diuretic and smooth-muscle relaxant effects), 
and in combination with other plants, in heart tonics and hypertension remedies. 
Toxicity studies with animals confirm the safety of the plant; rats given 10 g of the 
plant per kilogram of body weight evidenced no toxic effects (Wu, 2007; Amresh et 
al., 2007a and b; Amresh et al., 2004; Gessler et al., 1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001; Taylor, 2005; Graham et al., 2000). 
Hamill et al., 2003 showed the antimicrobial properties in Cissampelos while Amresh 
et al., 2007b showed the antioxidant potential in which the roots of C. pareira were 
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found to contain a large amount of polyphenols and exhibit significant and dose-
dependent reducing ability, indicative of potent antioxidant ability both in vitro and in 
vivo. It was also found to significantly scavenge superoxide, hydrogen peroxide, 
hydroxyl radicals, and nitric oxide at a dose regimen of 50 to 400 µg/kg in vitro. The 
Antinociceptive and antiarthritic activity of Cissampelos pareira roots were equally 
highlighted by Amresh et al., 2007c while the antifertility activity and anti-
inflammatory activity were showed by Ganguly et al., 2007 and Amresh et al., 2007b 
respectively. 
The Khoi-San or Cape Dutch showed the importance of this plant in Cape herbal 
medicine as one of the major distinct plant used for treatment of most diseases 
(VanWyk, 2008) while in the evaluation of some South African medicinal plants for 
antimalarial properties it was discovered that C. capensis posses antiplasmodial 
activity (Pillay et al., 2008). The medicinal values of Cissampelos species in Sango 
bay area in Southern Uganda was also recorded by Ssegawa and Kasenene (2007). 
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                                TABLE 5: Uses of Cissampelos capensis 
Locality Plant part Indications  References  
Amazonia  Leaves and 
young buds 
whole vine, 
seed, bark, 
leaf, root.  
Childbirth, colic, fever, 
muscle spasms and pain, 
nervous children, pinta, 
snakebite.  
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Gessler et al., 
1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
 
Argentina  Whole vine, 
seed, bark, 
leaf, root. 
Diarrhoea, menstrual 
disorders, respiratory tract 
infections, urinary tract 
infections. 
 
 Taylor, L., 2005; Feng et al., 
1962; Wu, 2007; Amresh et al., 
2006; Adesina, 1982; Amresh et 
al., 2004; Caceres et al., 1987; 
Gessler et al., 1995 Ramirez et al., 
2003; Sanchez Medina et al., 2001.   
 
Brazil Whole vine, 
seed, bark, 
leaf, root. 
Abortions, anemia, 
asthma, bladder problems, 
colic, congestion, 
constipation, contusions, 
cramps, cystitis, digestive 
problems, detoxification 
(by inducing sweating), 
dysentery, dyspepsia, 
drowsiness, edema, 
excessive phlegm and 
mucous, fever, gallbladder 
problems (to stimulate 
bile), hepatitis, 
inflammation, kidney 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Amresh et al., 
2004; Caceres et al., 1987; Gessler 
et al., 1995; Morita et al., 1993; 
Morita et al., 1993b; Chapuis et al., 
1988; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
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stones, menstrual 
disorders, muscle aches, 
pains and spasms, 
testicular inflammation, 
threatened miscarriage, 
pre-and postnatal pain, 
rheumatism, snakebite, 
stomach problems, urinary 
tract disorders, uterine 
hemorrhages, water 
retention.  
 
Guatemal
a   
Leaves 
whole vine, 
seed, bark, 
leaf, root. 
Cramps, erysipelas, fever, 
menstrual disorders, 
rheumatism, snakebite, 
water retention, and to 
increase perspiration. 
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Gessler et al., 
1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
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Mexico Crushed 
flower 
buds, whole 
vine, seed, 
bark, leaf, 
root. 
Bladder problems, 
dermatitis, diarrhea, 
dysentery, edema, 
excessive phlegm and 
mucous, fever, insect 
bites, jaundice, menstrual 
disorders, muscle 
inflammation, nephritis, 
pain, pimples, 
rheumatism, snakebite, 
urogenital problems, 
vaginal discharge, water 
retention, and as a female 
balancing aid. 
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Amresh et al., 
2004; Caceres et al., 1987; Gessler 
et al., 1995; Morita et al., 1993; 
Morita et al., 1993b; Chapuis et al., 
1988; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
 
Nicaragua  Young 
leaves, 
whole vine, 
seed, bark, 
leaf, root. 
 Bites, fever, skin rash, 
sores, stings, venereal 
disease. 
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Gessler et al., 
1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
  
South 
Africa 
Leaves and 
stem bark 
(in multiple 
plant 
recipe) 
whole vine, 
seed, bark, 
leaf, root. 
 Gravel and glandular 
swelling, Gall stones, 
dysentery, infections, 
Menstrual problems, 
Prevention of miscarriage, 
Appetite stimulant, Blood 
purification, Cholera, 
Colic, Bladder problems, 
Barbosa- Filho et al., 2000; DeWet 
et al., 2004, 2005; VanWyk et al., 
1997;  De Wet and Van Wyk, 
2008; Van Wyk and Gerick, 2000. 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Amresh et al., 
2004; Caceres et al., 1987; Gessler 
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Snakebite, pains, 
Toothache, Measles, 
Fever, Diabete, 
Tuberculosis Stomach and 
skin cancers,Purgative, 
Good-luck charm, Ulcers 
and syphilis sores.  
 
et al., 1995; Morita et al., 
1993;Chapuis et al., 1988; Ramirez 
et al., 2003; Sanchez Medina et al., 
2001.   
 
United 
States 
Powdered 
bark,  
leaves,  
whole vine, 
seed, bark, 
leaf, root. 
 hemorrhages and 
excessive bleeding, 
constipation, kidney 
stones, menstrual 
disorders, muscle spasms, 
premenstrual syndrome 
(PMS), testicular 
inflammation, urinary 
tract irritation, water 
retention. 
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Gessler et al., 
1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
  
Venzuela   Bark, whole 
vine, seed, 
bark, leaf, 
root. 
Bladder problems, kidney 
stones, snakebite, also 
used as a diuretic. 
 
 
Taylor, L., 2005; Feng et al., 1962; 
Amresh et al., 2004; Caceres et al., 
1987; Gessler et al., 1995; Ramirez 
et al., 2003; Sanchez Medina et al., 
2001.   
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Other 
places 
Bark, root 
and leaves, 
whole vine, 
seed, bark, 
leaf, root. 
Abortions, anemia, arrow 
poisoning, asthma, boil, 
childbirth, constipation, 
cough, cystitis, diabetes, 
diarrhea, dyspepsia, 
excessive phlegm and 
mucous, edema, eye 
problems, fetal growth 
problems, fever, 
hemorrhages, 
hypertension, indigestion, 
itch, kidney stones, 
malaria, menstrual 
disorders, pain, post-
menstrual hemorrhages, 
rheumatism, snakebite, 
sores, sterility, threatened 
miscarriage, urogenital 
inflammation, uterine 
hemorrhage, venereal 
disease, water retention, 
wounds and as a female 
balancing aid.  
 
Taylor, L., 2005; Feng et al., 1962; 
Wu, 2007; Amresh et al., 2006; 
Adesina, 1982; Amresh et al., 
2004; Caceres et al., 1987; Gessler 
et al., 1995; Ramirez et al., 2003; 
Sanchez Medina et al., 2001.   
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2.3 GERANIUM INCANUM 
2.3.1 Plant description 1 
Geranium incanum is a shrublet plant that belongs to the family Geraniaceae. It is 
refered to as Vrouebossie – amarabossie (Afrikaans) and Ngope-sethsoha, Tlako 
(Sotho). This plant is commonly found along the southern coastal areas of the 
Western and Eastern Cape Provinces of South Africa (Hilliard and Burtt, 1985). 
 
Fig 6: Geranium incanum plant 
2.3.2  Plant description 2  
This is an attractive plant and is a sprawling perennial shrublets with finely divided 
silvery leaves (Figure 6). The white, pale pink, violet or magenta flowers are borne 
on long, slender stalks, followed by a characteristically elongated fruit resembling a 
stork’s bill (Figure 6). The hairs on the exterior of the flowers and flower stalks lie 
flat and are not spreading as in related species (Hilliard and Burtt, 1985).  
Species of Geranium are all very similar and have been much confused in the past 
(Hilliard and Burtt, 1985). It is therefore possible that some medicinal records apply 
to species other than true G. incanum and G. canescens. G. incanum has been divided 
into two varieties: var. incanum, with small, white or pale pink flowers, and var. 
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multifidum, with larger, light violet to magenta pink flowers (Hilliard and Burtt, 
1985). 
Akpulat and Celik 2005, Clark et al., 2009 and Alireza et al., 2009 showed how the 
climatic environment, soil structure, the water and mineral intake that is available in 
the soil can affect both the floristic diversity and characteristic as well as the 
phytochemical composition in a plant. This phytochemical variation is found to be 
due to soil pH, the slope of the terrain which can affect the amount of nutrient it can 
retain due to wash off of nutrients and altitudinal belts. 
  
2.3.3 Ethnomedicinal uses of Geranium incanum 
The leaves have been used as a tea substitute (Rood, B., 1994; Watt and Breyer-
Brandwijk 1962) for treating bladder infections, venereal diseases and menstruation-
related ailment, hence the common name vrouebossie (“vroue” = women; “bossie” = 
small bush) (Smith, C.A., 1966). It is used also for colic, diarrhoea, fever and 
bronchitis (Watt and Breyer-Brandwijk 1962). It is very interesting to note that other 
Geranium species such as G. robertianum (Robert Herb) are traditionally used in 
Europe and America to treat diarrhoea (Bruneton, J., 1995; Grieve, M., 1967). The 
indication common to all tannin-containing drugs is the symptomatic treatment of 
diarrhoea (Bruneton, J., 1995; Amabeoku, G.J., 2009).  Steenkamp, 2003 highlighted 
the fact that traditional remedies are part of the cultural and religious life of the 
African people and that G. incanum is used extensively for gynaecological 
complaints in South Africa which confirm the earlier observation of VanWyk for use 
of the plant extract for menstruation associated problem (Van Wyk and Gericke 
(2000), Van Wyk et al. (1997). 
  
 
2.3.4 Major chemical constituents  
Phytochemical tests reveal the presence of saponins, flavonoids and tannins such as 
Ellagic acid (XXXI) and Gallic acid derivatives (XXXII) but alkaloid, cardiac 
glycosides and anthraquinone were absent. The chemical profile of the leaves of 
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Geranium species is known to contain tannins, in which geraniin (XXX) is likely to 
be one of the compound in the plant (Dic. Nat. prod., 1996; Bruneton, J., 1995; 
Amabeoku, G.J., 2009). Several flavonoids have also been presumed to be present in 
Geranium species. Amabeoku, (2009) also showed that the aqueous leaf extract of 
Geranium incanum possess antidiarrhoeal activity. 
 
                                             
GERANIIN (XXX) 
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2.4 GETHYLLIS SPECIES 
2.4.1 Plant description 
Gethyllis species are from the family Amaryllidaceae and the species are gregoriana, 
multifolia and villosa. They are generally referred to as Koekemakranka (Khoi, 
Afrikaans) or Kukumakranka (English).  It is noteworthy that Gethyllis is considered 
a rare and endangered genus in the Amaryllidaceae family that are found mostly in 
the winter rainfall region of southern Africa and they are most numerous in the 
Western and Northern Cape Provinces (Muller – Doblies, 1986; Du Plessis and 
Duncan, 1989; Elgorashi and Van staden, 2004; Elgorashi et al., 2007). 
 
Fig 7 Gethyllis plant showing the spiral appearance of the leaves 
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Fig 8 Gethyllis plant showing the flowering time without the leaves 
 
 
It has an unusual foliage, flowers and fruits that are very fascinating because of the 
fact that they produces their leaves, flowers and fruit all at different times of the year 
which never co-occur (Van Wyk and Gericke, 2000). Koekemakranka is an 
underground bulb of which the scales form a distinctive neck at ground level (Figure 
7). The long, thin leaves are usually spirally twisted, tattooed or coiled (Figure 7). 
The attractive flowers appear in summer when the leaves have already died. They 
have a narrow tube which extends below the ground, where the fruit eventually 
develop. Gethyllis flowers (Figure 8) are produced in summer and have a 
subterranean ovary which remains cool and protected underground. The attractive 
white or pink flowers (Figure 8) are followed by fragrant club-shaped berries that 
emerge in mid-winter, long after the flowers and leaves have wilted (Van Wyk and 
Gericke, 2000). There are about 38 Gethyllis species, in which G. afra (also called 
“bramakranka”) and G. spiralis are perhaps the most fragrant and commonly 
available. (Muller – Doblies, 1986; Du Plessis and Duncan, 1989) but more and more 
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new gethyllis are being discovered and the list is increasing by the day (Smith, 1966). 
G. spiralis is perhaps the most fragrant and commonly used one. 
 
2.4.2 Ethnomedicinal uses of Gethyllis species 
Koekemakranka brandy is one of the early Cape remedies used in traditional 
medicine to treat colic, flatulence and indigestion (Smith, C.A., 1966; Cillie, A.M., 
1992; Rood, B., 1994; Watt and Breyer-Brandwijk 1962; Du Plessis and Duncan, 
1989; Forbes, V.S., 1986). The ripe edible fruit was highly valued to perfume rooms 
and linen because of their powerful sweet and fruity odour (Watt and Breyer-
Brandwijk 1962; Forbes, V.S., 1986). For children, the gathering of the 
inconspicuous fruit (which they refer to as “koekemakrankies”) is a special occasion, 
and success depends to a large extent on a good sense of smell. (Smith, C.A., 1966). 
The fruits of many species of Gethyllis are administered as an alcohol infusion or as a 
brandy to treat stomach disorders. The fruits are much sought after for their fragrance 
and reported medicinal properties. In the past, the odourous dried fruits were often 
used to scent handkerchiefs and cupboards (Van Wyk and Gericke, 2000). Today the 
edible fruits of Gethyllis are still used to make “kukumakranka” brandy, a popular 
drink (Van Wyk and Gericke, 2000).  
Traditionally, an alcoholic infusion or tincture is made from a few ripe fruits (Dic. 
Nat. prod., 1996) which are presumed to contains some oils and esters of low 
molecular weight alcohols (Watt and Breyer-Brandwijk 1962),  
 
2.4.3 Major chemical constituents  
Kamatou et al 2008 reported the presence of 29 volatile organic compounds in the 
fruit of G. ciliaris which represented 96.5% of the total composition. The major 
compounds detected include pentacosane (19.2%); ethyl octanoate (18.0%); ethyl 
isovalerate (11.7%); ethyl hexanoate (9.1%) and ethyl benzoate (7.4%). It was 
concluded that these compounds may be the major contributors to the fruity-sweet 
odour of G. ciliaris. 43 compounds were identified in the fruit of G. afra which 
represented 87.9% of the total composition with α-pinene (11.2%), n-butyl n-butyrate 
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(8.5%), isoamyl acetate (8.1%), β-pinene (6.4%) and 2-methylbutyl butyrate (5.8%) 
as its main constituents. These major constituents were equally associated with the 
banana/piney/fruity odours found in G. afra.  
Elgorashi et al., 2007 showed how bioassay guided fractionation of the 
dichloromethane extract of the underground parts of Gethyllis ciliaris, using a 
cyclooxygenase-1 enzyme assay, has resulted in the isolation of the 
dihydroxydimethylbenzopyran-4-one (isoeugenitol) (XXXIII) and how  90% 
methanolic extract of same plant yielded 9Z-octadec-9-enamide (XXXV) and 
isoeugenitol glycoside (XXXIV) respectively.  
         
 
Isoeugenitol (XXXIII) 
 
 
Isoeugenitol glycoside (XXXIV) 
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9Z-octadec-9-enamide (XXXV) 
 
It is noteworthy that alkaloids were not detected in either the dichloromethane or 90% 
methanolic extracts using Dragendorff's reagent as a conventional method of 
detection. The majority of compounds found in the Amaryllidaceae family are 
alkaloids (Fennell and Van Staden, 2001). Specific alkaloids, which are unique to the 
family, are associated with its members. Amaryllidaceae alkaloids repeatedly 
indicated antitumour potential and amongst other characteristics, showed in vivo 
activity against various human viruses (Duri et al., 1994; Hutchings et al., 1996). The 
bulbs also contain flavonols, organic acids, carbohydrates and soluble nitrogen 
compounds. Plants belonging to the family Amaryllidaceae, including some Gethyllis 
species, are known to be the exclusive source of Amaryllidaceae alkaloids 
(Viladomat et al., 1997). However, the fact that alkaloids were not detected in G. 
ciliaris, does not necessarily mean that this species does not contain Amaryllidaceae 
alkaloids. More emphasis, in future research, needs to be paid to the ontogenic and 
environmental factors that affect the production of alkaloids just as it was mentioned 
in the case of Geranium incanum (Viladomat et al., 1997).  
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2.4.4  Reported biological activities of Gethyllis species 
The use of Gethyllis species as a potential medicinal plant was broadly highlighted in 
the literature (VanWyk, 2008, Nielsen et al., 2004, Thring and Weitz, 2006, Helme 
and Trinder-Smith, 2006). The anti-inflammatory and antibacterial activities in 
Gethyllis species were confirmed by Elgorashi and Van Staden, 2004 and Louw, et 
al., 2002. Dichloromethane extracts showed high anti-inflammatory activity and a 
moderate antibacterial activity. The detected anti-inflammatory and antibacterial 
activities are in line with the uses of some of these plants as reported in their 
investigation and uses in traditional medicine (Elgorashi et al., 2003). Several 
members of the Amaryllidaceae are toxic and can cause symptoms such as 
headaches, excessive salivation, nausea, dizziness, heartbeat irregularities, visual 
disturbances and dermatitis. Some toxic principles include lycorine and haematin, and 
the inappropriate use of a number of species can be fatal (Hutchings et al., 1996). 
Nevertheless, other species are administered orally as medicine to children or eaten in 
porridge by local people (Crouch et al., 1999). 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 MATERIALS AND INSTRUMENTATION 
Plant Materials:- Piliostigma reticulatum leaves 
                           Cissampelos capensis areial shoot and root 
                           Geranium incanum (whole plant)(winter and summer collections) 
                           Gethyllis gregoriana (whole bulb) 
                           Gethyllis multifolia (whole bulb) 
                           Gethyllis villosa (whole bulb)  
All laboratory grade solvents were distilled prior to use. Spectroscopic grade solvents 
were used as such.  Adsorption column chromatography was performed using the 
following methods: Column Gradient Chromatography (CGC), Vacuum Liquid 
Chromatography (VLC) and Accelerated Gradient Chromatography (AGC). AGC is a 
modification of conventional medium pressure liquid chromatography (Pongprayoon 
et al., 1991a; BaeckstrÖm, 1993; Dunstan, 1995). The ascending mode was 
employed, using Merck Silica gel 60 H (0.040 -0.063 mm particle size, Merck). The 
equipment for the AGC workstation was from BaeckstrÖm Separo AB, LidingÖ, 
Sweden. Unless otherwise specified, a column with internal diameter of 25 mm was 
used and volumes of 10 ml were collected in Pyrex test tubes. Size-exclusion column 
chromatography and Gel filteration were performed using Sephadex LH-20 (Sigma) 
pre-swollen in the specified solvent before loading onto the column. Unless otherwise 
specified, a glass column (2.5 * 50 cm) was used and 5 ml volumes were collected.  
Preparative TLC was performed using Merck Silica gel 60 PF254 on glass plates (20 
cm x 20 cm) and with a thickness of 0.5 mm. Analytical TLC was conducted on 
normal-phase Merck Silica gel 60 PF254 on precoated aluminium plates. Separated 
compounds on TLC and PTLC plates were visualized under UV light at (254 and 366 
nm), and spraying of the plates where required was carried out using 2% vanillin in 
H2SO4 followed by heating at 110oC for 2– 4 mins. Quercetin, Rutin and Catechin 
were used as reference standards for flavonoids, Garlic acid for tannins and Oleanolic 
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acid for essential oils. In the case of the alkaloids, dragendorff was used as the 
spraying reagent while Quinine and Berberine were used as standards.   
 Reversed phase TLC (RPTLC) was performed using pre-coated plates (Merck, RP-
18. F254 2, 0.25 mm thickness) and spots were detected as described above. Rf values 
were determined at room temperature using different solvent systems as applicable to 
each of the plants. Melting points were determined on a Baird and Tatlock laboratory 
melting point apparatus as well as a Fisher – John’s melting point apparatus (Fisher-
Scientific). All melting points are uncorrected. 
 
For P. reticulatum, IR spectra were recorded on a Mat. Galaxy 5000 series FT-IR 
spectrometer. MS were obtained using JEOL JMS-AX505HA double-focusing probe 
at 70 eV, while NMR spectra (both 1D and 2D) were obtained on a Bruker AMX-400 
(at 400 MHz for 1H NMR and 100 MHz for 13C NMR) spectrometer in DMSO-d6. 
Ultraviolet spectra of other isolated compounds were obtained with a Unicam UV 4 -
100 UV/Vis recording spectrophotometer. The spectra were recorded over the range 
of 200 – 550 nm, at a concentration of 0.02 mg/ml in spectroscopic grade methanol. 
All infra-red (IR) spectra were recorded on a Perkin Elmer universal ATR (Precisely) 
Spectrum 100 series FT-IR spectrometer while Nuclear magnetic resonance (NMR) 
spectra were recorded on Bruker   AM-400 or AMX-600 spectrometer, using a triple 
resonance probe head with self-shielded gradient coils and a Bruker Z-gradient 
accessory delivery squared gradients. The chemical shifts are expressed in ppm 
relative to TMS.    
 
3.2 PLANT MATERIALS COLLECTION AND AUTHENTICATION 
3.2.1 Plant materials 
Fresh leaves of P. reticulatum (Schum.) were collected in March 2005 at Ajebambo 
Village, close to Ondo Town, Ondo State (lat. 70 05’ 08.55”N  long. 40 47’ 49.61”E) 
in the South Western part of Nigeria and authenticated by a botanist, Dr. A. Ayoola 
of the Department of Biology, Obafemi Awolowo University, (ACE Campus, Ondo). 
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A voucher specimen (specimen no.: ACEBH 6266) has been prepared and deposited 
at the College Herbarium.  
 
Whole plants of G. multifolia and G. gregoriana were obtained in September 2007 
from Mr Gordon Summerfield of Summerfield's Indigenous Bulbs and Seeds, in 
Summerset West, Cape Town, South Africa. The plants had previously been collected 
from Rawsonville (lat. 330 41’ 16.75”S long. 190 18’ 41.87”E) and Vanrynsdorp (lat. 
310 36’ 50.27”S long. 180 44’ 36.24”E) respectively, both locations found in Western 
Province.  
 Whole plants of G. villosa was obtain from a horticulturist in the Cape Peninsula 
University of Technology in Cape Town, South Africa (lat. 330 55’ 57.96”S long. 180 
25’ 56.50”E). 
 
Whole plants of G.  incanum were collected from an open field close to Erica drive in 
Belhar area of Bellville in Cape Town, South Africa.  One collection was made 
during early March 2007 and another collection was made during late August 
2007(lat. 330 56’ 22.90”S long. 180 38’ 00.41”E)   
 
 Aerial shoot and root of Cissampelos capensis were collected in May 2007 from the 
University of the Western Cape (UWC) Cape Nature Conservation Reserve, Bellville, 
Cape Town, South Africa (lat. 330 56’ 09.94”S  long. 180 37’ 33.01”E). 
 All the plants were authenticated by a taxonomist, Mr Frans Weitz of the Department 
of Biodiversity and Conservation Biology, University of the Western Cape. Voucher 
specimens of all the plants were prepared and deposited at the University Herbarium 
with voucher numbers: - Weitz 1013(UWC) for G. incanum; Weitz 1056(UWC) for 
C. capensis; Summerfield in UWC 6964(UWC) for G. gregoriana; Summerfield in 
UWC 6965(UWC) for G. multifolia; Summerfield in UWC 6966(UWC) for G. 
villosa. 
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3.3 PLANT PREPARATION 
All the plants collected were separately washed with distilled water and dried at room 
temperature in a ventilated room for two to three weeks based on the nature of the 
plant materials viz., bulbs and the roots take a longer time to dry. They were then 
milled separately to a fine powder. All the powdered plant materials were stored in 
well labeled air-tight containers prior to analysis.  
P.  reticulatum Leaves = 2.5Kg 
C.  capensis Areial shoot = 3.5Kg and Root = 2.6Kg 
G.  incanum (whole plant)(winter collections = 3.9Kg and summer collections = 
4.0Kg) 
Gethyllis gregoriana (whole plant) = 342g 
Gethyllis multifolia (whole plant) = 229g 
Gethyllis villosa (whole plant) = 111g  
 
 
3.4 EXTRACTION AND ISOLATION 
General sequential extraction 
The plant materials were sequentially extracted with hexane (Hex) follow by 
dichloromethane (DCM), ethyl acetate (EtOAc), methanol (MeOH) and finally with 
water (H2O). Each extraction was repeated three times for 24 hours respectively by 
continuous stirring with a mechanical stirrer except Piliostigma reticulatum which 
was sequentially extracted with hexane, ethyl acetate and methanol in a soxhlet 
apparatus.  
Each of the extract was separately evaporated under reduced pressure at 40°C while 
the (water) aqueous extracts were concentrated by freeze-drying. The Gethyllis 
species were extracted with methanol, 70% ethanol and water only.  
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3.5. PHYTOCHEMICAL SCREENING  
For the purpose of phytochemical screening, portions of the milled samples were 
soaked separately in four solvents, namely: hexane, dichloromethane, methanol and 
water at room temperature (25°C) for 24 hours, and the extracts so derived were 
evaporated on a rotary evaporator at ≤ 45°C. Phytochemical screening for the 
detection of natural products such as tannins, phenolics, glycosides, saponins, 
flavonoids, alkaloids anthraquinones, steroids, essential oils and terpenes was 
performed according to the method of Wagner (Wagner and Bladt, 2001). 
 
3.6.  PILIOSTIGMA RETICULATUM 
Plant material (2 kg) was sequentially extracted in 4 batches of 500g with hexane, 
ethyl acetate and methanol in a Soxhlet apparatus. The solid residues remaining in the 
Soxhlet extractor were bulked together and extracted by maceration in 6L of water 
for 7days by continuous mechanical stiring at intervals of 8hours. Similar extracts 
were bulked together and concentrated while the water extract was freeze dried. 
These afforded hexane extract (78.45g, 3.92%), ethyl acetate extract (109.27, 5.46%), 
methanol extract (246.28g, 12.31%) and water extract (124.21g, 6.21%). 
 
3.6.1 Fractionation of the hexane extract 
The hexane extract (28.13g) was adsorbed on silica gel 60 (Merck, 50g, 0.040- 0.063 
mm particle size) and fractionated by AGC using the following solvent mixtures X: 
petroleum ether (PE) 200ml and then 100ml each of PE – EtOAc (95 : 5), (90 : 10), 
(80 : 20), (60 : 40) and (20 : 80). This was followed by EtOAc 100ml and 100ml each 
of EtOAc – MeOH (96: 4), (92: 8), (84: 16), (68: 32), (36: 64) and finally washed 
with MeOH.  
Fractions collected were analyzed by TLC using toluene – EtOAc (19: 1) as the 
mobile phase. Fractions showing the same TLC characteristics were bulked together 
and concentrated in vacuo. 4 fractions coded A – D were obtained and the results 
were summarized in Table 6. 
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TABLE 6: Fractions A – D  
Tubes Yield (g) Fractions 
1 – 12 
13 – 26 
27 – 45 
46 – 89 
 
1.91 
0.62 
1.68 
9.67 
 
A 
B 
C 
D 
 
 
Fraction D (8.5g) was rechromatographed using the same solvent mixtures X. 78 
tubes were collected, analysed by TLC and those showing similar characteristics were 
bulked together, giving rise to five fractions coded DI – DV. The results are presented 
in Table 7. 
 
TABLE 7: Fractions DI – DV 
Tubes Yield (g) Fraction 
        1 - 7 
8 – 13 
14 – 29 
30 – 48 
49 - 78 
        0.32 
1.40 
2.13 
0.44 
2.31 
DI 
DII 
DIII 
DIV 
DV 
 
 
Fraction DII (1.20 g) was adsorbed on silica gel 60 (20.0 g) and the constituents 
eluted by AGC, using the following solvent mixtures Y: 100ml of Hex and then 60ml 
each of Hex – Tolu (87.5 : 12.5), (75 : 25) and (50 : 50). This was followed by Tolu 
100ml and 60ml each of  Tolu – EtOAc (99.69 : 0.31), (99.38 : 0.62), (98.75 : 1.25), 
(97.5 : 2.5), (95 : 5), (90 : 10), (80 :20), (60 : 40), (20 : 80)  and finally with 100ml of 
EtOAc.   
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38 tubes were collected and analysed by TLC. These were bulked into three  fractions 
coded DIIa to DIIc as follows DIIa (tubes 1 – 10, 0.23 g ); DIIb ( tubes 11 – 20, 0.41 
g) and DIIc (tubes 21 – 38, 0.32 g). Column chromatography of fraction DIIb (0.38 g) 
on a sephadex LH-20 column, using toluene – EtOH (7: 3 ) as the eluent gave 36 
tubes which were analysed by TLC. Tubes 13 – 23 were found to show one major 
spot on TLC, and were bulked together. Concentration to dryness in vacuo gave a 
residue (0.19 g) which was further purified by preparative TLC using Tolu – EtOAc 
(19 : 1). 
 The compound, a yellow powder (0.08 g) was recrystallized from EtOH (96%), to 
give P1 as yellow waxy powder (0.0272 g). Similar fractionation of fraction DIII (2.0 
g) using Tolu – EtOH (1 : 1) gave three fractions coded DIIIa (tubes 1 – 6, 0.71 g), 
DIIIb (tubes 7 – 9, 0.92 g) and DIIIc (tubes 10 – 30, 0.19 g). Further  chromatography 
on sephadex LH-20 of fraction DIIIb using Tolu – EtOH (7 : 3) gave an off-white 
creamy powder ( 0.136 g) which contained compound P2 as the  major component, as 
shown by TLC analysis in CHCl3 – EtOAc (19 : 1). AGC of this powder using a 
gradient of hexane (100 ml), toluene in hexane (12.5, 25 and 50%, 50ml each), 
toluene (100ml), EtOAc in toluene (0.625 – 80% in doubling concentrations, 50 ml 
each) and EtOAc (100 ml) gave P2 as a creamy powder (0.088 g) which was purified 
by recrystallization from EtOH (96%) to give compound P2 as a creamy needle like 
crystal (0.0133 g). Fraction DIV (0.29g) was subjected to column chromatography on 
silica gel 60 (20.0 g) using MeOH as the eluent. This gave compound P3 as a yellow 
powder which was further purified by preparative TLC in Tolu – EtOAc (19: 1). The 
compound was recrystallized from 96% EtOH (bright yellow needles, 0.027 g).   
Fraction DV (2.0 g) was chromatographed on sephadex LH-20 using Tolu – EtOH (7 
: 3), the fractions were  analysed by TLC in toluene – EtOAc – CH2Cl2 (4 : 5 : 1) and 
bulked into 2 fractions coded DVa and DVb as follows: DVa (tubes 1 – 6, 0.05g) and 
DVb (tubes 7 – 22, 0.41 g).  Fraction DVb (0.41 g) was subjected to AGC using the 
following eluents: Tolu (100 ml) and then 50ml each of Tolu – CHCl3 (95: 5), (90: 
10) (80 : 20), (60 : 40), and (80 : 20). This was followed by CHCl3 50ml and 50ml 
 
 
 
 
 70
each of CHCl3 - EtOAc (90: 10), (80 : 20), (60 : 40), (20 : 80)  and finally with 100ml 
of EtOAc. 51 tubes were collected, analysed by TLC in Tolu -EtOAc (5 : 4) and the 
tubes containing compound P4 were bulked together and concentrated to dryness in 
vacuo (tubes 29 – 46, 0.056 g). Recrystallization of this product from toluene – 
EtOAc afforded P4 as a yellow fluffy powder (0.0105 g). 
3.6.2. Fractionation of the ethyl acetate extract 
The ethyl acetate extract (25.21g) was adsorbed on silica gel 60 and chromatographed 
by AGC using solvent mixtures X. The fractions collected were also analyzed by 
TLC. Fractions showing same TLC characteristics were bulked together and 
concentrated in vacuo. 6 Fractions coded E – J were obtained and the results were 
summarized in Table 8. 
TABLE 8: Fractions E - J 
Tubes Yield (g) Fractions 
1 – 19 
20 – 48 
49 – 82 
81 – 90 
91 – 103 
104 – 123 
1.30 
0.96 
8.79 
1.96 
0.98 
0.65 
E 
F 
G 
H 
I 
J 
   
 Fraction G (8.0 g) was adsorbed on silica gel 60 (40 g) and subjected to AGC, using 
100ml in each step of solvent mixtures Y. Fractions collected were analysed by TLC 
and those showing the same TLC characteristics were bulked together, giving four 
fractions coded GI – GIV as shown in Table 9. 
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TABLE 9: Fractions GI – GIV 
Tubes Yield (g) Fractions 
1 – 13 
14 – 29 
30 – 38 
39 - 66 
1.40 
2.20 
1.10 
2.12 
GI 
GII 
GIII 
GIV 
 
Fraction GI (1.13 g) was adsorbed on silica gel 60 (27.0 g) and the constituents eluted 
by AGC, using solvent mixtures Y.  40 tubes were collected, analysed by TLC and 
bulked into three fractions coded GIa to GIc as follows:-  GIa (tubes 1 – 9, 0.14 g ); 
GIb ( tubes 10 – 22, 0.43 g) and GIc (tubes 23 – 40, 0.34 g). 
Fraction GIb (0.38 g) was chromatographed on a sephadex LH-20 using toluene – 
EtOAc (5: 1), the fractions were analysed by TLC.  Fractions 13 – 23 were found to 
show one major spot on TLC. This residue (0.19 g) was further purified by 
preparative TLC using PE: EtOAc (7: 3) and recrystallized from EtOH (96%). This 
gave compound P5 as a bright yellow amorphous powder (0.0127 g) 
Fraction GII (2.0 g) was eluted on silica gel 60 (30.0 g) using PE : toluene : MeOH 
(2:5: 1). 25 tubes were collected, analysed by TLC and bulked  into three fractions 
coded GIIa (tubes 1 – 7, 0.31 g), GIIb (tubes 8 – 14, 0.83 g) and GIIc (tubes 15 – 25, 
0.19 g).  Successive column chromatography on sephadex LH-20 of fraction GIIb 
using PE: toluene: MeOH (2 : 5 : 1) gave an off-white powder ( 0.128 g) which was 
further purified by preparative TLC using Toluene – EtOAc (19: 1).  Compound P6, a 
yellow waxy powder (0.088 g) was recrystallized from EtOH (96%) to give 
compound P6 as a yellow waxy powder (0.0054 g). 
Fraction GIIc (0.19g) was chromatographed on sephadex LH-20 using PE: toluene: 
MeOH (2: 5: 1) as the eluent. This gave compound P7 as a yellow powder which was 
recrystallized from 96% EtOH. P7 (bright yellow needle like crystal, 0.075 g). 
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 Fraction GIII (0.85 g) was chromatographed on sephadex LH-20 using toluene – 
EtOAc (7: 3).  30 tubes were collected, analysed by TLC and bulked into three 
Fractions coded GIIIa to GIIIc as follows: GIIIa (tubes 1 – 6, 0.05g); GIIIb (tubes 7 – 
16, 0.11 g) and GIIIc (tubes 17 – 30, 0.26 g).  Fraction GIIIc (0.18 g) was further 
subjected to AGC using the following solvent mixtures Z: 100ml of toluene and then 
50ml each of   toluene – EtOAc (99.84 : 0.16), (99.69 : 0.31), (99.38 : 0.62), (98.75 : 
1.25), (97.5 : 2.5), (95 : 5), (90 : 10), (80 : 20), (60 : 40) and (20 : 80). This was 
followed by 100ml of EtOAc and 100ml of EtOAc – MeOH (95: 5) and finally with 
200ml of MeOH.   
50 tubes were collected, analysed by TLC in toluene – EtOAc (5: 4). Fractions 30 – 
46 (0.051 g) was further purified by preparative TLC using PE: EtOAc (7: 3) and 
recrystallized from toluene – EtOAc which afforded compound P8 as a yellow 
powder (0.0084 g). 
AGC of fraction GIV (1.80 g) was performed using solvent mixtures Z. 46 tubes 
collected were  analysed by TLC in toluene -EtOAc (5: 4) and bulked into three 
fraction coded G1Va (tubes 1 – 18, 0.022 g), GIVb (tubes 19 – 26, 0.31 g) and GIVc 
(tubes 27 – 46, 0.208g). Fraction G1Vb (0.20 g) was chromatographed on sephadex 
LH-20 using 5% MeOH in toluene and finally 100% MeOH. Fractions collected were 
analysed by TLC in PE: EtOAc (7:3) and bulked into five fractions coded GIVb1 to 
GIVb5 as follows: GIVb1 (tubes 1- 10, 0.02 g); GIVb2 (tubes 11 – 17, 0.05 g); 
GIVb3 (tubes 18 – 23, 0.04 g); GIVb4 (tubes 24 – 31,0.025 g) and GIVb5 (tubes 32 – 
40, 0.01 g). Fraction GIVb2 give a single spot which was further purified by 
preparative TLC using PE: EtOAc (7 : 3) and recrystallized from 96% EtOH to give 
P9, a bright yellow waxy amorphous solid, (0.0076 g). 
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3.6.3  Fractionation of the methanol extract  
The methanol extract (32.5g) was adsorbed on silica gel 60 (Merck, 70g) and 
subjected to AGC using the following solvent mixtures R: 100ml of toluene and then 
100ml each of   toluene – EtOAc (95 : 5), (90 : 10), (80 : 20), (60 : 40) and (20 : 80). 
This was followed by 100ml of EtOAc and 100ml of EtOAc – MeOH (96 : 4), (92 : 
8), (84 : 16), (68 : 32), (36 : 64) and finally with 200ml of  MeOH. Fractions 
collected were analyzed by TLC using toluene: EtOAc: MeOH (10: 7: 3). Fractions 
showing the same TLC characteristics were bulked together and concentrated in 
vacuo. 4 fractions coded K – N were obtained and the results were summarized in 
Table 10. 
 
 
TABLE10: Fractions K - N.  
 
 
Tubes Yield (g) Fractions 
1 – 14 
15 – 41 
42 – 82 
83 – 95 
 
      2.0 
2.14 
10.3 
3.0 
K 
L 
M 
N 
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Fraction M (9.50 g) was adsorbed on silica gel 60 (45 g) and subjected to AGC using 
solvent mixtures R. 60 tubes were collected, analysed by TLC in toluene: EtOAc: 
MeOH (10 : 7 : 3). Fractions showing same TLC characteristics were bulked into five 
fractions coded MI – MV as shown in Table 11. 
TABLE11: Fractions MI – MV  
Tubes Yield (g) Fractions 
       1 - 10 
11 – 13 
14 – 29 
30 – 38 
39 – 60 
         0.62 
1.30 
2.20 
1.12 
2.16 
MI 
MII 
MIII 
MIV 
MV 
 
 
AGC of fraction MI (0.42 g) was performed using solvent mixtures Z. 38 tubes 
collected were analysed by TLC and bulked into three fractions coded MIa (tubes 1 – 
18, 0.022 g); MIb (tubes 19 – 30, 0.23 g) and MIc (tubes 31 – 38, 0.051g). Fraction 
MIb (0.20 g) was further chromatographed on sephadex LH-20 using toluene-MeOH 
(8: 2). Fractions collected were analysed by TLC and bulked into five fractions coded 
 MIb1 to MIb5 as follows: MIb1 (tubes 1- 10, 0.012 g); MIb2 (tubes 11 – 16, 0.05 g); 
MIb3 (tubes 17 – 22, 0.03 g); MIb4 (tubes 23 – 31, 0.071 g) and MIb5 (tubes 32 – 42, 
0.02 g).  Fraction MIb4 was found to show one major spot on TLC. This fraction was 
further purified by preparative TLC using toluene: EtOAc: MeOH (10: 7: 3). The 
yellow amorphous powder (0.03 g) was recrystallized from EtOH (96%). This gave 
compound P10 as bright yellow amorphous powder (0.0100 g).  
Fraction MII (1.0 g) was eluted on a RP- 18 pre – packed column (lobar Lichroprep 
RP- 18 column) (Merck, size B, 40 – 63 µm) using MeOH-H20 (4: 1). 68 tubes were 
collected, analysed by TLC in toluene : EtOAc : MeOH (10 : 7 : 3). P11 and P12 
were also purified on a Prep pre-coated RP-18 TLC plates (Merck) using 80% 
aqueous methanol. Compound P11 is a yellow needle (0.0189 g) while P12 is a 
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yellow waxy amorphous solid which was recrystallized from EtOH – H20 (1: 1) 
(0.0065 g). 
AGC of fraction MIII (2.0 g) was performed using solvent mixtures R. 48 tubes were 
collected, analysed by TLC and fractions exhibiting similar TLC profiles were bulked 
together. Fractions 15 – 23 on TLC showed essentially one spot and were 
concentrated to dryness in vacuo. This fraction (0.049 g) was purified by RP -18 prep 
TLC using MeOH-H20 (8: 2), compound P13 as a bright yellow powder (0.0073 g) 
was observed. 
AGC of fraction MV (1.60 g) was also performed using solvent mixture R. 91 tubes 
collected reveals dull yellow crystals in fractions 48 – 59. The crystals (0.53g) were 
futher purified by sephadex LH-20 using CHCl3 – MeOH (9 : 1). Fractions analysed 
by TLC. 41 tubes were collected and fractions 25 – 37 showed a single spot. The 
resultant powder (0.18 g) was recrystallized from EtOAc – MeOH, giving compound 
P14 as a yellow powder (0.075 g). 
The final Rf values were similarly determined for all the isolates at room temperature 
using the underlisted solvent systems, and are uncorrected. 
Solvent A:  toluene – ethyl acetate (19: 1); 
Solvent B: toluene – ethyl acetate – methanol (10: 7 : 3); 
Solvent C:  methanol – water (8: 2, RP – 18).    
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3.7 CISSAMPELOS CAPENSIS 
The major targets for Cissampelos capensis were alkaloids and flavonoids. 
A total tertiary alkaloid (TTA) fraction was generated by extracting 500g of the aerial 
shoot with 80% EtOH for 7 days by maceration. The dried ethanolic extract (100 g), 
was redissolved in 3% HCI and extracted several times with CHCI3. The aqueous 
fraction was basified with NH4OH to pH 9 and again extracted with CHCl3. The 
CHCl3 extract was washed with H20, dried (MgSO4) and the solvent evaporated to 
afford the TTA (1.85g, 0.37%). The residual aqueous fraction was neutralized to pH 
7 with 3% HCl and concentrated to dryness to afford BTA (48.7g, 9.74%).  
  
3.7.1. Fractionation of the TTA 
The TTA (1.6g) was adsorbed on silica gel 60 (Merck, 30g) and the 
constituents separated by CGC using the following solvent mixtures E: 200ml of Hex 
and then 100ml each of Hex – CHCl3 (90 : 10), (80 : 20), (70 : 30), (60 : 40) and (20 : 
80). This was followed by 200ml of CHCl3 and 100ml each of CHCl3 – MeOH (90: 
10), (80 : 20), (70 : 30), (50 : 50),  (20 : 80) and finally washed with MeOH. The 
fractions collected were analyzed by TLC using Hex – CHCl3 – MeOH (1 : 5 : 1). 
Tubes showing similar TLC characteristics were bulked together and concentrated in 
vacuo. 7 fractions coded A – G were obtained and the results were summarized in 
Table 12 with their brine shrimp cytotoxicity activities. 
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TABLE 12:   Fractions A – G and their LC50 values 
Tubes Yield (g) Fractions 
 
LC50 value Class activity 
1 – 12 
13 – 48 
49 – 97 
98 – 111 
112 – 130 
131 – 149 
150 – 170   
0.021 
0.320 
0.062 
0.027 
0.300 
0.019 
0.023 
 
A 
B 
C 
D 
E 
F 
G 
989.29 
36.913 
1784.3 
2.4050 
3.6648 
1233.2 
IA 
AC 
IA 
AC 
VA 
VA 
IA 
 
Fraction E (0.25 g) was adsorbed on silica gel 60 (20 g) and subjected to CGC, using 
solvent mixtures E. 62 tubes were collected , analysed by TLC in Hex – CHCl3 – 
MeOH (1 : 5 : 1) and fractions  showing the same TLC characteristics were bulked 
together, giving five fractions coded TI – TV. The results are presented in Table 13. 
 
TABLE 13:  Fractions TI – TV and their LC50 values  
Tubes Yield (g) Fractions LC50 value Class activity 
 
1 - 10 
11 – 15 
16 – 28 
29 – 37 
38 - 62 
 
0.004 
0.0101 
0.122 
0.047 
0.031 
E 
TI 
TII 
TIII 
TIV 
TV 
 
2.4050 
1478.5 
899.79 
3.0226 
0.8655 
65.335 
 
VA 
IA 
IA 
VA 
VA 
AC 
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Successive repeated prep TLC of TIII in Hex – CHCl3 – MeOH (1: 5: 1) was carried 
out until a clean one spot sample was obtained at Rf of 0.72. This gave compound C1 
as a brownish yellow powder (0.058 g). The repeated prep TLC of TIV in Hex – 
CHCl3 – MeOH (1 : 5 : 1) afforded compound C2 as a brown amorphous solid 
(0.021g). 
 
3.7.2 Sequential extraction of the aerial shoot 
The aerial shoot (1 kg) was sequentially extracted with hexane (3L x 2); 
dichloromethane (3L x 2); ethyl acetate (3L x 2) and methanol (3L x 2) by 
maceration for 24hours, 2 times each and finally with 4L of water for 7days as did for 
P. reticulatum.  All extracts were individually bulked together and concentrated. 
These afforded hexane (17.35g, 1.74%), dichloromethane (26.33, 2.63%), ethyl 
acetate (32.84, 3.28%), methanol (56.24g, 5.62%) and water extracts (25.71g, 
2.57%). 
 
3.7.3. Fractionation of the methanol extract of the aerial shoot 
The methanol extract (25.6g) was adsorbed on silica gel 60 (Merck, 60g) and the 
constituents separated by CGC using solvent mixtures E. Fractions collected were 
analysed by TLC using Hex – CHCl3 – MeOH (1 : 5 : 1). Fractions showing the same 
TLC characteristics were bulked together and concentrated in vacuo. 10 fractions 
coded A – J were obtained and the results were summarized in Table 14. 
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TABLE 14: Fractions A – J and their LC50 values  
Tubes Yield (g) Fractions LC50 value Class activity 
1 – 12 
13 – 26 
27 – 35 
36 – 39 
40 – 45 
46 – 48 
49 – 55 
56 – 64 
65 – 70 
71 – 81 
1.91 
0.62 
0.68 
0.67 
1.30 
1.96 
3.29 
1.96 
0.98 
0.65 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
989.29 
1369.13 
17.843 
2405.7 
36.646 
1.2332 
84.346 
1148.23 
997.25 
73.563 
IA 
IA 
AC 
IA 
AC 
VA 
AC 
IA 
IA 
AC 
 
Fraction F (1.5 g) was adsorbed on silica gel 60 (35 g) and subjected to CGC, using 
solvent mixtures E. 62 tubes were collected, analysed by TLC and those showing the 
same TLC characteristics were bulked together into five fractions coded FI – FV as 
shown in Table 15. 
 
TABLE 15: Fractions FI – FV and their LC50 values  
Tubes Yield (g) Fractions LC50 value Class activity 
 
1 - 10 
11 – 15 
16 – 28 
29 – 37 
38 - 62 
 
0.032 
0.520 
0.211 
0.115 
0.106 
F 
FI 
FII 
FIII 
FIV 
FV 
 
1.2332 
1124.6 
66.734 
3.4420 
17.563 
45.455 
 
VA 
IA 
AC 
VA 
AC 
AC 
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 Fraction FII (0.5 g) was adsorbed on silica gel 60 (9.0 g) and the constituents eluted 
by CGC using same solvent mixture E. Fractions collected were analysed by TLC 
and bulked into three  fractions coded FIIa to FIIc as follows: FIIa (tubes 1 – 10, 0.08 
g ); FIIb ( tubes 11 – 20, 0.21 g) and FIIc (tubes 21 – 38, 0.14 g). 
Fraction FIIb (0.20 g) was chromatographed on a sephadex LH-20 using CHCl3 – 
MeOH (7 : 3 ). 35 tubes were analysed by TLC. Fractions 13 – 23 were found to 
show one major spot on TLC and were bulked together. This product (0.19g) was 
further purified by repeated prep TLC in Hex – CHCl3 – MeOH (1 : 5 : 1). This gave 
a golden brown powder (0.04g) as compound C3. 
Fraction FIII (0.20 g) was eluted on silica gel using toluene – CHCl3 – MeOH (7: 5: 3 
). 24 tubes were collected, analysed by TLC and bulked  into three fractions coded 
FIIIa (tubes 1 – 7, 0.013 g), FIIIb (tubes 8 – 15, 0.091 g) and FIIIc (tubes 16 – 24, 
0.024 g). Successive repeated prep TLC of fraction FIIIb using Hex – CHCl3 – 
MeOH (1: 5: 1) gave a brownish yellow powder (0.052 g) which was recrystallized 
from 96% EtOH to give compound C4 (a brownish yellow powder, 0.028 g). 
Fraction FIV (0.10 g) was chromatographed using solvent mixtures E. 50 tubes 
collected were analysed by TLC in CHCl3 – MeOH (5 : 3) and the tubes containing 
compound C5 were bulked together and concentrated to dryness in vacuo (tubes 33 – 
38, 0.038 g). Recrystallization from 96% EtOH afforded C5 as a yellow amorphous 
Powder (0.026 g). 
Fraction FV (0.10 g) was chromatographed, using toluene – CHCl3 – MeOH (3: 5: 1). 
33 tubes were collected, analysed by TLC and bulked into 4 fractions coded FVa to 
FVd as follows:  FVa (tubes 1-12, 0.0120 g); FVb (tubes 13-17, 0.0430 g); FVc 
(tubes 18-23, 0.022 g) and FVd (tubes 24-33, 0.0133 g). Fraction FVb (0.0430g) was 
further purified by prep TLC using CHCl3 – MeOH (9 : 2). This gave compound C6 
as a yellow powder (0.024g). 
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3.7.3.1 Sequential extraction of the root of Cissampelos capensis 
The same extraction procedure was repeated for the root (1 kg). This afforded hexane 
(7.38g, 0.74%), dichloromethane (12.65, 1.27%), ethyl acetate (27.19, 2.72%), 
methanol (53.05g, 5.31%) and water extract (26.44g, 2.64%).  
 
3.7.3.2 Fractionation of the methanol extract of the root 
The methanol extract (30.0g) was adsorbed on silica gel and the constituents 
separated by using solvent mixtures E. Fractions collected were analyzed by TLC and 
fractions showing same TLC characteristics were bulked together. 5 fractions coded 
K – O were obtained and the results are summarized in Table 16. 
 
TABLE 16: Fractions K - O and their LC50 values 
Tubes Yield (g) Fractions LC50 value Class activity 
1 – 12 
13 – 26 
27 – 45 
46 – 102 
103 - 146 
1.81 
2.62 
5.68 
3.67 
1.82 
K 
L 
M 
N 
O 
997.27 
79.458 
5.2375 
19.296 
33.668 
IA 
AC 
VA 
AC 
AC 
 
Fraction M (5.0 g) was adsorbed on silica gel and subjected to CGC, using solvent 
mixtures E. 58 tubes collected were analysed and fractions were bulked together 
based on their TLC characteristics.  Three fractions coded MI – MIII were obtained 
as shown in Table 17. 
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TABLE 17: Fractions K - O and their LC50 values 
Tubes Yield (g) Fractions LC50 value Class activity 
 
1 - 12 
13 – 32 
33 – 58 
 
0.62 
2.10 
1.20 
M 
MI 
MII 
MIII 
5.2375 
15.236 
55.178 
16.776 
VA 
AC 
AC 
AC 
 
Fraction MII (1.7 g) was chromatographed using solvent mixture E. 40 tubes 
collected were analysed by TLC and bulked into three fractions coded MIIa to MIIc 
as follows: MIIa (tubes 1 – 10, 0.14 g ); MIIb ( tubes 11 – 22, 0.41 g) and MIIc (tubes 
23 – 40, 0.64 g). 
Fraction MIIb (0.38 g) was chromatographed using toluene – CHCl3 – MeOH (3: 5: 
1). 36 tubes were analysed by TLC and fractions 13 – 23 were found to show one 
major spot on TLC. These were bulked and concentrated (0.19 g).  The product was 
further purified by repeated prep TLC in Hex – CHCl3 – MeOH (1: 5: 1). This gave a 
brownish yellow powder which was recrystallized from EtOH (96%) to give 
compound C7 (0.078 g). 
Fraction MIIc (0.50 g) was chromatographed using toluene – MeOH (1: 1). 21 tubes 
were collected, analysed by TLC and bulked into three fractions coded MIIc1 (tubes 
1 – 6, 0.071 g), MIIc2 (tubes 7 – 9, 0.24 g) and MIIc3 (tubes 10 – 21, 0.0411 g). The 
repeated prep TLC of MIIc2 afforded compound C8 as a brownish yellow powder 
(0.065 g).  
 Fraction MIII (1.0g) was chromatographed using toluene – MeOH (1: 3). After 
repeated prep TLC in CHCl3 – MeOH (1: 5), a yellow powder was obtained which 
when recrystallized from 96% EtOH afforded compound C9 (bright yellow powder 
(0.088 g). 
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Fraction N (3.2 g) was chromatographed using solvent mixtures E. 80 tubes were 
collected, analysed by TLC and fractions showing same TLC characteristics were 
bulked together. Four fractions coded NI – NIV were obtained as shown in Table 18. 
 
TABLE 18: Fractions NI – NIII and their LC50 values 
Tubes Yield (g) Fractions LC50 value Class activity 
 
1 - 10 
11 – 15 
16 – 53 
54 – 80 
 
1.22 
0.11 
0.73 
0.28 
N 
NI 
NII 
NIII 
NIV 
 
19.296 
20.634 
1688.6 
76.112 
21.225 
 
AC 
AC 
IA 
AC 
AC 
 
 
Fraction NI (1.2 g) was chromatographed using solvent mixtures E. 56 tubes 
collected were analysed by TLC and bulked into three fractions coded NIa to NIc as 
follows: NIa (tubes 1 – 15, 0.14 g); NIb (tubes 16 – 28, 0.43 g) and NIc (tubes 29 – 
56, 0.04 g). 
Fraction NIb (0.40 g) was rechromatographed using toluene – MeOH (7 : 4). 30 tubes 
were analysed by TLC and bulked into four fractions coded NIb1 to NIb4 as follows: 
NIb1 (tubes 1 – 5, 0.0250 g); NIb2 (tubes 6 – 10, 0.043 g); NIb3 (tubes 11 – 19, 
0.215 g) and NIb4 (tubes 20 – 30, 0.014 g). 
Fraction NIb3 (0.20 g) was further purified by prep TLC using toluene – MeOH (7: 
3). Recrystallization of the product from 96% EtOH afforded compound C10 as a 
yellow amorphous Powder (0.068 g).   
CGC of Fraction NIII (0.70 g) was performed using solvent mixtures E. 45 tubes 
collected were analysed by TLC and bulked into three fractions coded NIIIa (tubes 1 
– 18, 0.022 g), NIIIb (tubes 19 – 26, 0.21 g) and NIIIc (tubes 27 – 45, 0.058g). 
Fraction NIIIb (0.20 g) was chromatographed on sephadex LH-20 using toluene – 
MeOH (7: 3). Fractions collected were bulked into four fractions based on their TLC 
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characteristic as follows: NIIIb1 (tubes 1 – 9, 0.0121 g); NIIIb2 (tubes 11 – 18, 0.051 
g); NIIIb3 (tubes 19 – 26, 0.021 g) and NIIIb4 (tubes 27 – 40, 0.0112 g). Repeated 
prep TLC of NIIIb2 using Hex – CHCl3 – MeOH (1: 5 : 1) afforded a creamy yellow 
solid which was labeled  compound C11.  
  
3.8. GERANIUM INCANUM 
3.8.1 Sequential extraction of the summer collections 
The same procedural steps were followed for the extraction of the summer collection 
(2kg) which afforded hexane (29.45g, 1.47%), dichloromethane (37.69g, 1.89%), 
ethyl acetate (125.28g, 6.26%), methanol (183.25g, 9.16%) and water extract 
(86.11g, 4.31%). 
 
3.8.2 Fractionation of the ethyl acetate extract of the summer collections 
The ethyl acetate extract (25.0g) was chromatographed using the following solvent 
mixtures F: 200ml of toluene and then 100ml each of   toluene – EtOAc (95 : 5), (90 : 
10), (80 : 20), (60 : 40) and (20 : 80). This was followed by 100ml of EtOAc and 
100ml of EtOAc – MeOH (96 : 4), (92 : 8), (84 : 16), (68 : 32), (36 : 64) and finally 
with 150ml of  MeOH. Fractions collected were analyzed by TLC using toluene : 
EtOAc : MeOH (7 : 5 : 3). Fractions showing the same TLC characteristics were 
bulked together and concentrated in vacuo. 6 fractions coded A – F were obtained 
and the results were summarized in Table 19. 
TABLE 19: Fractions A – F  
Tubes Yield (g) Fractions 
1 – 11 
12 – 18 
19 – 28 
29 – 40 
41 – 59 
60 – 115 
 
1.31 
1.74 
6.29 
1.14 
2.21 
3.16 
 
A 
B 
C 
D 
E 
F 
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 Fraction C (5.7 g) was chromatographed using solvent mixtures F. 59 tubes were 
collected, analysed by TLC in toluene: EtOAc: MeOH (7: 5: 3) and fractions showing 
the same TLC characteristics were bulked together. Five fractions coded CI – CV was 
obtained and the results are summarized in Table 20.  
 
TABLE 20: Fractions CI – CV 
Tubes Yield (g) Fractions 
       1 – 10 
11 – 13 
14 – 29 
30 – 38 
39 - 59 
        0.120 
0.111 
2.100 
0.610 
0.452 
CI 
CII 
CIII 
CIV 
CV 
 
 
Fraction CIII (1.7g) was chromatographed using solvent mixtures Y. 40 tubes 
collected were analysed by TLC in toluene : EtOAc : MeOH (7 : 5 : 3) and bulked 
into three fractions coded CIIIa to CIIIc as follows : CIIIa (tubes 1 – 12, 0.04 g); 
CIIIb (tubes 13 – 25, 0.64 g) and CIIIc (tubes 26 – 40, 0.31 g). 
Fraction CIIIb (0.60 g) was chromatographed using toluene: EtOAc: MeOH (7: 5: 3). 
38 tubes obtained were analysed by TLC. Tubes 12 – 26 were found to show one 
major spot and were bulked together. The residue (0.19 g) was further purified by 
prep TLC. This gave compound G1 as bright yellow powder (0.049 g).  
Fraction CIV (0.60 g) was chromatographed using Toluene: EtOAc: MeOH (7: 5: 3). 
23 tubes collected were analysed and bulked into three fractions coded CIVa (tubes 1 
– 6, 0.022 g), CIVb (tubes 7 – 9, 0.082 g) and CIVc (tubes 10 – 23, 0.245 g). 
Successive column chromatography of fraction CIVb (0.24 g) using Toluene: EtOAc: 
MeOH (7: 5: 3) gave an off-white powder (0.116 g) which was purified by prep TLC 
in the same solvent system. This gave compound G2 as an off white powder (0.088 
g) after recrystallization from EtOH (96%). 
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Fraction CV (0.45g) was also chromatographed using toluene: EtOAc: MeOH (7: 5: 
3). This gave compound G3 as a creamy powder after repeated prep TLC in same 
eluent. This was recrystallized from 96% EtOH to give G3 a creamy off white 
powder (0.044 g). 
 
3.8.3 Fractionation of the methanol extract of the summer collections 
The methanol extract (20.0g) was chromatographed using the solvent mixtures F. 
Fractions collected were analyzed by TLC using toluene: EtOAc: MeOH (7: 5: 3). 
Fractions showing the same TLC characteristics were bulked together and 
concentrated in vacuo. 4 fractions coded G – J were obtained as summarized in Table 
21. 
TABLE 21: Fractions G - J 
 
 
 
 
 
 
 
 Fraction H (6.0 g) was chromatographed using solvent mixture F. 59 tubes were 
collected, analysed by TLC and fractions showing the same TLC characteristics were 
bulked together. Three fractions coded HI – HIII were obtained as shown in Table 22.  
 
TABLE 22: Fractions HI – HIII  
Tubes Yield (g) 
       1 - 14 
15 – 47 
48 – 59 
 
       0.132 
2.610 
0.622 
 
 
Tubes Yield (g) Fractions 
1 – 15 
16 – 34 
35 – 78 
79 – 116 
  
0.31 
6.33 
3.19 
1.14 
 
G 
H 
I 
J 
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Fraction HII (2.30 g) was chromatographed using toluene : EtOAc : MeOH (7 : 5 : 3).  
Fractions obtained were bulked into three fractions coded HIIa to HIIc as follows: 
HIIa (tubes 1 – 8, 0.14 g); HIIb (tubes 8 – 19, 0.87 g) and HIIc (tubes 20 – 35, 0.35 
g). 
Fraction HIIb (0.7 g) was further rechromatographed and the 50 tubes collected were 
analysed by TLC using toluene: EtOAc: MeOH (5: 4: 3). Fractions 31 – 39 (0.05 g) 
was recrystallized from methanol which afforded compound G4 as a white powder 
(0.048 g). 
CGC of fraction HIII (0.50 g) was performed using the solvent mixtures Z. 56 tubes 
collected were  analysed by TLC and bulked into three fractions coded HIIIa (tubes 1 
– 18, 0.022 g), HIIIb (tubes 19 – 26, 0.21 g) and HIIIc (tubes 27 – 56, 0.058g). 
Fraction HIIIb (0.20 g) was further chromatographed. It was observed that tubes 18 – 
29 showed a single spot which were bulked together and concentrated to dryness in 
vacuo. The recrystallization from methanol of the products formed afforded 
compound G5 as a light yellow amorphous Powder (0.038 g).   
 
3.8.4 Sequential extraction of the winter collections 
The procedure was also repeated for the extraction of the winter collections (2kg) 
which gave hexane (48.35g, 2.42%), dichloromethane (34.43g, 1.72%), ethyl acetate 
(107.26g, 5.36%), methanol (211.77g, 10.59%) and water extract (79.32g, 3.97%). 
 
3.8.5  Fractionation of the ethyl acetate extract of the winter collections 
The ethyl acetate extract (25.0g) was adsorbed on silica gel 60 and the constituents 
separated by CGC using the solvent mixtures R. Fractions collected were analyzed by 
TLC using toluene: EtOAc: MeOH (5: 4: 3). Fractions showing the same TLC 
characteristics were bulked together and concentrated in vacuo. 5 fractions coded K – 
O was obtained and the results were summarized in Table 23. 
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TABLE 23: Fractions K - O. 
Tubes Yield (g) Fractions 
1 – 12 
13 – 26 
27 – 35 
36 – 39 
40 – 98 
0.91 
6.42 
4.18 
2.07 
1.11 
K 
L 
M 
N 
O 
 
Fraction L (6.0g) was chromatographed using the solvent mixtures F. 75 tubes were 
collected, analysed by TLC and bulked into four fractions based on their TLC profile. 
The four fractions were coded LI – LIV as shown in Table 24. 
 
TABLE 24: Fractions LI – LIV  
Tubes Yield (g) Fractions 
 
1 - 9 
10 – 26 
27 – 49 
50 – 75 
 
0.22 
1.21 
2.11 
0.13 
 
LI 
LII 
LIII 
LIV 
 
Fraction LII (1.0 g) was chromatographed using solvent mixtures Y. 77 tubes were 
collected and analysed by TLC. The fractions were bulked into three fractions coded 
LIIa to LIIc as follows: LIIa (tubes 1 – 14, 0.023g); LIIb (tubes 14 – 41, 0.46g) and 
IIc (tubes 42 – 77, 0.041g). 
When fraction LIIb (0.43 g) was rechromatographed using toluene – MeOH (7: 3), 
the 50 tubes analysed by TLC showed that fractions 12 – 23 essentially showed one 
major spot. These were bulked, concentrated and further purified by repeated prep 
TLC ran in toluene: EtOAc: MeOH (5: 4: 3).  
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The compound G6 obtained was recrystallized from EtOH (96%). This gave G6 as a 
brownish yellow powder (0.038 g). 
Fraction LIII (2.0 g) was chromatographed using solvent mixtures F. 74 tubes were 
collected, analysed by TLC  and bulked  into three fractions coded LIIIa (tubes 1 – 8, 
0.05 g), LIIIb (tubes 9 – 32, 0.11 g) and LIIIc (tubes 33 – 74, 0.98 g). Successive 
chromatography followed by prep TLC of fraction LIIIc using toluene – MeOH (7: 3) 
gave an off-white powder which was labeled G7 (0.055 g) after recrystallization from 
EtOH (96%). 
 Fraction M (4.0 g) was chromatographed using solvent mixtures R. 70 tubes 
collected were analysed by TLC and fractions showing same TLC characteristics 
generated three fractions coded MI – MIII as shown in Table 25. 
 
TABLE 25: Fractions MI – MIII. 
Tubes Yield (g) Fractions 
 
1 - 20 
21 – 37 
38 – 70 
 
0.11 
0.25 
1.71 
 
MI 
MII 
MIII 
 
   Fraction MIII (1.5 g) was chromatographed using solvent mixtures Y. 55 tubes 
collected were bulked into three fractions as follows: - MIIIa (tubes 1 – 13, 0.033 g); 
MIIIb (tubes 14 – 29, 0.54 g) and MIIIc (tubes 30 – 55, 0.12 g). 
Fraction MIIIb (0.50 g) was rechromatographed using solvent mixture R. 58 tubes 
were collected, analysed by TLC and the tubes containing compound G8 were bulked 
together and concentrated to dryness in vacuo (tubes 30 – 38, 0.19 g) which showed 
single spot.  
This yellow powder was recrystallized from EtOH (96%) to give compound G8 
(0.077 g) as bright yellow amorphous powder. 
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3.8.6 Fractionation of the methanol extract of the winter collections 
The methanol extract (25.0g) was chromatographed using solvent mixtures F. 
Fractions collected were analyzed by TLC and those showing same characteristics 
were bulked together. 6 fractions coded P – U was obtained and the results were 
summarized in Table 26. 
 
TABLE 26: Fractions P - U 
Tubes Yield (g) Fractions 
1 – 15 
16 – 33 
34 – 55 
56 – 68 
69 – 97 
98 – 146 
0.62 
2.12 
5.28 
3.64 
1.35 
0.44 
P 
Q 
R 
S 
T 
U 
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Fraction Q (2.0g) was chromatographed using the solvent mixtures F. 80 tubes were 
collected, analysed by TLC and those showing the same TLC characteristics were 
bulked into three fractions coded QI – QIII as shown in Table 27. 
TABLE 27: Fractions QI – QIII   
Tubes Yield (g) Fractions 
 
1 - 24 
25 – 50 
51 – 80 
 
 
0.122 
0.801 
0.072 
 
 
QI 
QII 
QIII 
 
 
CGC of fraction QII (0.6 g) was performed using solvent mixtures Z. 56 tubes were 
collected, analysed by TLC and those showing same TLC characteristics were bulked 
together. Three fractions coded QIIa – QIIc as follows:- QIIa (tubes 1- 12, 0.025 g); 
QIIb (tubes 13 – 34, 0.051 g) and QIIc (tubes 35 – 56, 0.241 g) were obtained. 
Further purification of QIIc by repeated prep TLC gave a bright yellow powder 
(0.0911 g) which was recrystallized from EtOH (96%). This gave compound G9 
(0.067g) as a bright yellow powder. 
Fraction R (5.0g) was chromatographed using solvent mixtures F. 79 tubes collected 
were analysed by TLC and those showing the same TLC characteristics were bulked 
together. Four fractions coded RI – RIV were obtained as shown in Table 28.  
TABLE 28: Fractions RI – RIV  
Tubes Yield (g) 
       1 - 12 
13 – 36 
37 – 49 
50 – 79  
       0.022 
1.420 
1.052 
0.116 
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Fraction RII (1.40 g) was chromatographed using toluene: EtOAc: MeOH (7: 5: 3). 
74 tubes were collected, analysed by TLC and bulked into three fractions coded RIIa 
to RIIc as follows: RIIa (tubes 1 – 15, 0.04 g); RIIb (tubes 16 – 39, 0.46 g) and RIIc 
(tubes 40 – 74, 0.15 g). Fraction RIIb (0.45 g) was further rechromatographed, 52 
tubes were collected, analysed by TLC in Toluene: EtOAc: MeOH (5: 4: 3) and the 
tubes containing compound G10 were bulked and concentrated (tubes 30 – 41, 
0.0891g).  The product was recrystallized from methanol which afforded G10 as an 
off white powder (0.0532 g).   
CGC of fraction RIII (1.0 g) was performed using solvent mixtures Z. 70 tubes 
collected were analysed by TLC and bulked into three fractions coded RIIIa (tubes 1 
– 17, 0.023 g), RIIIb (tubes 18 – 37, 0.0152 g) and RIIIc (tubes 38 – 70, 0.48g). On 
further chromatography of fraction RIIIc (0.40 g) it was observed that tubes 21 – 29 
showed a single spot which were bulked together and concentrated to dryness in 
vacuo. The recrystallization from methanol of the products formed afforded G11 as a 
light yellow amorphous powder (0.098 g). 
Fraction S (3.6g) was chromatographed using solvent mixtures F. 98 tubes collected 
were analysed by TLC and those showing the same TLC characteristics were bulked 
together. Five fractions coded SI – SV were obtained as shown in Table 29.  
 
TABLE 29: Fractions SI – SV  
Tubes Yield (g) Fractions 
       1 - 14 
15 – 41 
42 – 59 
60 – 72 
73 – 98   
       0.155 
0.211 
0.422 
1.022 
0.0213 
SI 
SII 
SIII 
SIV 
SV 
 
Fraction SIV (1.0 g) was chromatographed using toluene: EtOAc: MeOH (7: 5: 3).  
55 tubes were collected, analysed by TLC and bulked into three fractions coded SIVa 
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to SIVc as follows: SIVa (tubes 1 – 11, 0.03 g); SIVb (tubes 12 – 32, 0.441 g) and 
SIVc (tubes 33 – 55, 0.102 g). 
Fraction SIVb (0.40 g) was further rechromatographed. The 52 tubes collected were 
analysed by TLC and the fractions were further bulked into three fraction coded 
SIVb1 (tubes 1 – 14, 0.022 g), SIVb2 (tubes 15 – 27, 0.05 g) and SIVb3 (tubes 28 – 
52, 0.125g). Further purification of SIVb3 by repeated prep TLC ran in toluene: 
EtOAc: MeOH (5: 4: 3) gave a creamy yellow powder which was recrystallized from 
methanol. This afforded G12 (0.0658g) as a creamy yellow powder. 
 
 
3.9. GETHYLLIS SPECIES 
3.9.1 Extraction of the constituent in Gethyllis gregoriana 
The whole plant (320g) was extracted with methanol (3L x 2) by maceration for 
24hours, 2 times each and the residue with 3L of water for 4days.  The two extracts 
were individually bulked together and concentrated to afford methanol (26.79g, 
8.37%) and water extracts (18.92g, 5.91%). 
 
3.9.2.  Extraction of the constituent in Gethyllis multifolia  
The above procedure was repeated on 215g of G. multifolia. This afforded methanol 
(17.98g, 8.36%) and water extract (21.11g, 9.82%). 
 
3.9.3. Extraction of the constituent in Gethyllis villosa  
The same procedure as described above was also repeated for G. villosa (105g) in 
which methanol (10.65g, 10.14%) and water extract (7.43g, 7.08%) were also 
obtained.   
 
3.10  BIOLOGICAL EVALUATION 
 3.10.1 Brine shrimp lethality biossay 
The brine shrimp lethality biossay was carried out as previously described (Babajide, 
1994 and Babajide et al., 2008) where about 2g of the brine shrimp eggs (Artemia 
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salina Leach) were hatched in 2L of sea water using a large plastic case as an 
artificially partitioned dam.  
Incubation of the shrimp eggs was conducted at room temperature for 48 hours with 
the help of a light source and an aquarium aerator pump (for agitation and aeration of 
the eggs).  The larvae (nauplii) were observed to be attracted to one side of the vessel 
toward the light source where they were easily collected for the assay after about 24 
hours. 
 All the crude extracts, fractions and isolates of the 6 plants were dissolved in 
dimethyl sulfoxide (DMSO) at a maximum concentration not exceeding 0.05%, and 
then diluted with sea water for testing at final concentrations of 10, 100 and 1000 
µg/ml. Each test was conducted in triplicate where ten nauplii were used for each test. 
Ten nauplii were counted into the vials with the aid of a pasture pipette under a 
magnifying glass after 24 hours of incubation and still maintaining the vials under 
illumination. The control experiment was prepared in the same way except that the 
test samples were omitted.  
The number of dead nauplii were counted and recorded (lethality data) after vials 24 
hours. The numbers of dead nauplii were used for calculating the LC50 at 95% 
confidence limit by the Finney Probit analysis program. LC50 values greater than 
1000 ppm or in that range were considered inactive. (Babajide et al., 2008; Mc 
Laughlin et al., 1991). 
3.10.2 Determination of antimicrobial activity 
Generally two methods were used for the antimicrobial assay 
1. The diffusion method. 
2. The serial dilution method 
The organisms used in the screening tests were obtained from both National 
Collection of Type Cultures (NCTC) and American Type Culture Collection 
(ATCC).  
The Gram-negative bacteria used were 
Pseudomonas aeruginosa (NCTC 10332) 
Proteus vulgaris (NCTC 4175)  
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Escherichia coli Sero type 1 (NCTC 09001),  
Escherchia coli NCTC 10418 
 The Gram-positive bacteria used were 
 Bacillus subtilis (NCTC 8236) 
Staphylococcus aureus (NCTC 13134) 
Bacillus licheniformis (NCTC 01097) 
Staphylococcus aureus NCTC 6571  
The Fungal species used were: 
 Candida albicans (ATCC 90028)   
Candida eropiralis (ATCC 750)  
Candida albicans ATCC 10231 
Aspergillus Niger ATCC 10578  
3.10.3. The diffusion method 
The organisms used in the screening tests are as follows:- The Gram-negative 
bacteria were Pseudomonas aeruginosa (NCTC 10332), Proteus vulgaris (NCTC 
4175) and Escherichia coli Sero type 1 (NCTC 09001), while the Gram-positive were 
Bacillus subtilis (NCTC 8236), Staphylococcus aureus (NCTC 13134) and Bacillus 
licheniformis (NCTC 01097).  These species are considered the most important 
pathogens (NCCLS, 1990). Fungal species used were Candida albicans (ATCC 
90028), Candida eropiralis (ATCC 750) and Aspergillus Niger ATCC 10578. 
Cultures were grown in sabouraud dextrose (SD) broth at 37 ◦C and maintained on 
SD agar at 4 ◦C.  
A colony of each bacterial strain was suspended in 1ml of Mueller–Hinton broth and 
incubated for 18 hrs at 37 ◦C. A subculture was again made after 6 hrs. The 
subculture was diluted 1/50 in the same broth before use. A disc diffusion assay was 
used to determine the inhibition of bacterial growth by the plant extracts, fractions, 
sub fractions and isolates (Rasoanaivo and Ratsimamanga-Urverg, 1993). Plant 
extracts, fractions and isolates were dissolved in appropriate solvents at a 
concentration of 100 mg/ml for extracts and 10 mg/ml for isolates. 20 µl were 
dispensed on a 9mm sterile paper disc (Munktell/Lasec, Numb. FLAS3526009). 
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Amoxicillin was used as a positive control (40µg/ml) for bacteria while Fluconazole 
(120µg/ml) for fungi. The diluted cultures were spread on sterile Muller–Hinton agar 
plates. The plates were then incubated at 37°C for 18–24 hrs for bacterial pathogens 
and 3 days for fungal pathogens. The antimicrobial activity was evaluated by 
measuring the diameter of inhibition zone. The experiment was carried out in 
triplicate and the mean of the diameter of the inhibition zones were calculated. 
Antimicrobial inhibition activities measured were compared to that of Amoxicillin 
and Fluconazole standards (Vlietinck, 1997). 
 3.10.4  The serial microdilution method 
 Antimicrobial analysis was equally carried out using the microdilution titre 
techniques (Drummond and Waigh, 2000; Rahman and Gray, 2005) with little 
modification in which 96 well plates were used for the testing against the Gram-
positive bacteria and Gram-negative bacteria as well as the fungi. All the experiments 
were performed on a laminar flow bench to avoid contamination. 
1 microtitre plate of 96 wells was used per bacteria / fungal species while 4 plant 
extracts were tested per microtitre plate. The positive and negative controls were 
indicated periodically to check the growth of the bacteria and fungi.  All the working 
cultures of the bacteria are not allowed to be older than 14 days. This was attained by 
reculturing them at the beginning of every experiment. Recultured organisms were 
always used. Bacteria were diluted in the ratio of 1:100 (1 ml bacteria and 99 ml fresh 
Mueller Hinton (MH) broth at room temperature. 
Bacterial cells were inoculated into fresh Müller–Hinton (MH) broth (Fluka, 
Switzerland) and incubated at 37 ◦C for 14 h prior to the screening procedures. 
Densities of bacterial cultures after incubation overnight were calculated.  Fungal 
species cultures were grown in sabouraud dextrose (SD) broth at 37 ◦C and 
maintained on SD agar at 4 ◦C. Densities of the fungal cultures used in the assays 
were also calculated.  
The determination of minimum inhibitory concentration (MIC) values was performed 
using the listed microorganisms above, (INT) p-iodonitrotetrazolium violet, (MH) 
Müller–Hinton and (SD) Sabouraud dextrose. All the microplates were clearly 
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labeled. 100µl of distilled H2O was placed in each of the wells and 100µl of the 
extracts (at 10 mg/ml) were added to the first row (A) of the microplate. 100 µl of the 
positive and negative (normally the solvent) controls were put on the microplate, 
similarly to the extracts. Using a multi-channel pipette, a series of two-fold dilutions 
of the extract and controls were made, by mixing the first row (A) 3x, followed by 
removing 100µl from row A to row B. This step was repeated until row H. 100µl was 
then removed from the last row (H) after mixing. 
Thereafter 100µl of the relevant bacterial culture was placed into each well which 
was mixed by squirting bacteria into the wells, but care was taken by not allowing it 
to splash, as well as allowing the pipette tips to touch the solution inside the micro-
well. The microtitre plate was covered, placed inside a plastic bag and incubated 
overnight at 37oC.  The plates were then sprayed with 2mg/mL of p-
iodonitrotetrazolium violet (INT) (Sigma) and incubated for a further 12 h (Begue 
and Kline, 1972). The emergence of purple-red colour resulting from the reduction of 
INT into its respective formazan was a positive indicator of cell viability (Begue and 
Kline, 1972). Clear zones were indicative of antifungal or antibacterial activity of 
compounds. The microplates were examined for colour after 30, 60 120 and 180 
minutes. The MIC values were determined using the serial microplate method in 
which the MIC was taken as the lowest concentration of the test compounds 
inhibiting the growth of microorganisms. The total activity (mL) of the extracts was 
calculated as the total mass (mg) of the extract divided by the MIC value (mg/mL). 
Total activity value indicates the volume to which the extract can be diluted and still 
inhibit the growth of microbial cells (Eloff, 1998, 2004; Masoko et al. 2005). The 
lowest concentration where growth was inhibited (MIC = minimal inhibitory 
concentration) was calculated from the original concentration of the extract e.g. (10 
mg/ml); i.e.  Starting with 10 mg/ml and the growth is inhibited in the first to the fifth 
wells, the MIC would be [10/5/2.5/1.25/0.625] = 0.625 mg/ml. 
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3.11. CHEMICAL EVALUATION 
3.11.1 Antioxidant assay 
Total antioxidant evaluation was carried out on all the 6 plant extracts, fractions and 
isolates by first evaluating the antioxidant content of the following:- 
1. Polyphenols (gallic acid)  
2. Flavonols (quercetin) 
3. Flavanols (catechin) 
4. Anthocyanins 
5. Flavanones (naringenin)  
B. Antioxidant capacity 
1. ORAC (Oxygen radical absorption capacity) by H+ ion transfer. 
2. FRAP (Ferric reducing antioxidant Power) by the movement of e- electron. 
3. TEAC (Trolox (a well known standard) equivalent antioxidant capacity)   
All readings were taken after 40 minutes unless otherwise stated and the 
Microsoft excel workbook program was used in all the analysis and calculations. 
 
3.11.2.  Evaluation of polyphenolic content 
3.11.2.1 Methodology 
The analysis makes use of the Folin Ciocalteu reagent with gallic acid as the standard 
to measure the total polyphenols in the samples. Since a very slight amount of 
turbidity can interfere with the determination, all the samples used was clarified by 
centrifugation and then filtered. All reagents and standards used are prepared freshly 
on the day of analysis unless otherwise stated for use the next day. 
3.11.2.2. Equipment: - Multiskan plate reader 
3.11.2.3.  Sample preparation 
Approximately 30 mg (0.030 g) (noting the exact weight) of the sample was weighed 
into a 50 mL screw-cap tube. IMPORTANT: The sample weight of 30 mg is not 
fixed and this was changed for some samples depending on the nature of the sample. 
This weight was reduced if it was suspected that the sample contains high amounts of 
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antioxidants or increased if it was suspected to contain a low concentration of 
antioxidants. Water or ethanol, 50 mL, was added with the aid of a Gilson pipette 
depending on which of the two dissolved the sample the best. This was then mixed 
thoroughly, sonicated and then centrifuged at 4000 rpm for 5 minutes. The 
supernatants were used directly after a suitable dilution for the entire assay. 
3.11.2.4. Sample analysis  
Preparation of the standard series: - 6 eppendorf tubes marked A-F were used for the 
standard series and prepared as shown in Table 30 below.  
Table 30: Standard series of gallic acid standard wells 
  
Tube gallic acid stock 
solution (µl) 
10% 
EtOH (µl) 
Concentration 
(mg/L) 
Well 
number 
A 0 1000 0 A1-A3 
B 25 975 20 A4-A6 
C 62.5 937.5 50 A7-A9 
D 125 875 100 A10-A12 
E 312 688 250 B1-3 
F 625 375 500 B4-6 
 
Gallic acid standard wells – 25 µl of standard was added (tubes A-E) per well in the 
designated wells in a clear well plate. 
Control wells – 25 µl of the control was added to the wells (B7-B12). 
Sample wells – 25 µl of sample was added IN TRIPLICATE to the wells (C1-H12). 
This was followed by adding 125 µl Folin reagent to each well using the 12 point 
multichannel pipette. After 5 minutes, 100µl Na2CO3 was further added to each well. 
The plate was left for 2 hours at room temperature before taking a reading on the 
multiskan spectrum plate reader. 
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3.11.2.5  Data analysis and calculations 
All the data were expressed as mg Gallic acid equivalents per gram of sample (mg 
Gallic acid/g of sample). Note: - All the sample with high values of polyphenol were 
diluted either to 5-fold or to 10-fold as the case may be. For 10-fold dilution-  the 
samples was diluted by pipetting 100 µl of the sample supernatant into a new 
eppendorf and 900 µl of 10% ethanol was added to effect the 10-fold dilution.  The 
Phenolics assay was then repeated with the diluted sample.  
 
3.11.3 Evaluation of flavonol Content 
3.11.3.1 Methodology 
This analysis makes use of quercetin as the standard for evaluating the amount of 
flavonols in the sample at 360nm.  
3.11.3.2.  Equipment and sample preparation is as in Polyphenols.       
3.11.3.3.  Sample analysis 
The multiskan spectrum plate reader was set to read at a wavelength of 360nm and 
the temperature was equally set at 25°C. 
Preparation of standards – The standard series was prepared as shown in Table 31 
below. 
Table 31: Quercetin standard wells 
Tube Quercetin 
stock (µl) 
95% 
EtOH (µl) 
Quercetin 
(mg/L) 
Wells 
A 0 1000 0 A1-A3 
B 75 925 5 A4-A6 
C 125 875 10 A7-A9 
D 250 750 20 A10-A12 
E 500 500 40 B1-B3 
F 1000 0 80 B4-B6 
 
Quercetin standard wells – 12.5 µl of standard (tubes A-E) was added per well in the 
designated wells in a clear well plate. The same amount (12.5 µl) of sample and 
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control were added to the sample wells and the control wells respectively. 12.5 µl 
0.1% HCl in 95% EtOH was added to each well followed by 225 µl 2% HCl. This 
was left for 30 minutes at room temperature before taking the reading. 
 
3.11.3.4. Data analysis and calculations 
The path was set to the flavonol mode on the multiskan spectrum plate reader 
programme on the computer. The data were expressed as mg of Quercetin equivalents 
per gram of sample (mg Quercetin/g weight of sample). 
3.11.4. Evaluation of flavanol Content  
3.11.4.1  Methodology 
This analysis makes use of 4-dimethylaminocinnamaldehyde (DMACA) which reacts 
with flavanols to form a characteristic light blue colour that can only be measured at 
640nm.  
3.11.4.2 Equipment and sample preparation is as in Polyphenols.  
3.11.4.3.  Sample analysis: 
 The path was set to the flavanol mode on the multiskan programme on the computer 
Preparation of standards – The standard series was prepared as shown in Table 32 
below. 
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Table 32: Catechin standard wells  
 
 
Catechin standard wells – 50 µl of standard (tubes A-F) was added per well in the 
designated wells in a clear well plate. Same 50 µl of sample was added to the 
designated sample wells and control solution to Control wells. The reaction was 
initiated by adding 250 µl of DMACA to all the wells using a multichannel pipette. 
This was left for 30 minutes at room temperature before taking a reading at 640nm. 
3.11.4.4. Data analysis and calculations 
 The data was analysed the same way as in polyphenol and was expressed as µmole 
Catechin equivalents per gram of sample (µmole Catechin/g of sample). 
 
3.11.5. Evaluation of anthocyanins 
3.11.5.1  Methodology 
In this assay the following major precautions were taken: 
(1) All the reagents and standards were prepared fresh on the day of analysis  
(2) The pH of buffers were checked and adjusted prior to use.  
(3) All spectral measurements were made between 15 min and 1 hr after the dilutions 
were prepared. This is because the observed readings tend to increase with time. 
Tube Catechin 
stock (µl) 
Methanol 
(µl) 
Catechin 
(µM) 
Catechin 
(mg/L) 
Wells 
A 0 1000 0 0 A1-A3 
B 5 995 5 1.36 A4-A6 
C 10 990 10 2.72 A7-A9 
D 25 975 25 6.8 A10-A12 
E 50 950 50 13.6 B1-B3 
F 100 900 100 27.2 B4-B6 
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3.11.5.2 Sample preparation:  
The preparation is same as in polyphenols but a 10-fold dilution was made with 10% 
EtOH because of the sensitivity of this assay. 
3.11.5.3.  Sample analysis 
The measurement was made using TOTAL MONOMERIC ANTHOCYANIN 
MEASUREMENT BY THE pH-DIFFERENTIAL METHOD.  This was carried out 
by first determining the appropriate dilution factor for the sample by diluting with 
potassium chloride buffer, pH 1.0, until the absorbance of the sample at the λvis-max 
was within the linear range of the spectrophotometer (i.e. 1 – 1.2). The 
spectrophotometer was then standardized with distilled water at the used wavelengths 
(λvis-max and 700 nm). Two dilutions of the samples were prepared, one with 
potassium chloride buffer, pH 1.0, and the other with sodium acetate buffer, pH 4.5, 
diluting each by the previously determined dilution factor. These dilutions were left 
for 15 min to equilibrate. The absorbance of each dilution at the λvis-max and at 700 nm 
was measured against a blank cell filled with distilled water.  
3.11.5.5.  Data analysis and calculations 
After inputing all the appropriate dilution values for each sample, the absorbance (A) 
values were calculated as follows: A = (Aλ vis-max– A700)pH 1.0 – (Aλ vis-max– A700)pH 4.5  
The monomeric anthocyanin pigment concentration in the original sample was 
calculated using the following formula: Monomeric anthocyanin pigment (mg/liter) = 
(A x MW x DF x 1000)/(ε x1), where MW is the molecular weight, DF is the dilution 
factor (for example, if a 0.2 ml sample is diluted to 3 ml, DF = 15), and ε is the molar 
absorptivity.  
3.11.6.  Evaluation of flavanones  
3.11.6.1.  Methodology 
This analysis makes use of Naringenin as the standard for measuring total flavanones 
in the sample using 2, 4-dinitrophenylhydrazine (DNPH)   
3.11.6.2.1 Sample analysis: 
The standard series was prepared as shown in Table 33 below. 
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Table 33: Naringenin standard 
 
 
Naringenin standard: – 50 µl of standard (tubes A-F) were added per well in the 
designated wells in a clear well plate. 50 µl of samples and control were equally used 
for the sample well and the control well respectively. The reaction was initiated by 
adding 250 µl of DNPH to all the wells. The plate was left for 30 minutes at room 
temperature before taking the reading at 495nm. 
3.11.6.3 Data analysis and calculations 
The data were analysed the same way as in polyphenol and are expressed as µmole 
Naringenin equivalents per gram of sample (µmole Naringenin/g of sample). 
The measurements were carried out using a PU 8625 UV-Visible spectrophotometer 
(Diode-array, Philips, Netherlands). 
Statistical analysis: - The results were expressed as mean SD obtained upon three 
independent analyses. 
Statistical significance of the differences was evaluated using Student’s t-test for all 
the samples (Kosalec et al. 2004). 
Tube Naringenin 
stock (µl) 
Methanol 
(µl) 
Naringenin 
(µM) 
Naringenin 
(mg/L) 
Wells 
A 0 1000 0 0 A1-A3 
B 50 950 5 1.36 A4-A6 
C 100 900 10 2.72 A7-A9 
D 200 800 25 6.8 A10-A12 
E 500 500 50 13.6 B1-B3 
F 1000 0 100 27.2 B4-B6 
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3.11.7. Oxgen radical absorbance capacity assay (ORAC) 
3.11.7.1. Methodology 
The ORAC method was performed using a fluorescence spectrophotometer. 
The chemicals used are:Phosphate buffer: 75mM, pH 7.4 (1.035 g of NaH2PO4.H2O  
in 100 mL H2O as 1st solution; 1.335 g Na2HPO4.2H2O in 100 mL H2O as 2nd 
solution. 18 mL of 1st solution was mixed with 82 mL of 2nd solution). 
Fluorescein sodium salt (0.0225 g C20H10Na2O5 in 50 mL Phosphate buffer). 
Peroxyl radical: AAPH (2,2'-Azobis (2-methylpropionamidine) dihydrochloride 
PCA (70% Perchloric acid 
Trolox (standard): 500 µM Stock solution (0.00625 g 6-Hydroxy-2, 5, 7, 8-tetra-
methylchroman-2-carboxylic acid was added to 50 mL phosphate buffer). 
Trolox (control): 250 µM Stock solution (0.00312 g 6-Hydroxy-2, 5, 7, 8-tetra-
methylchroman-2-carboxylic acid was added to 50 mL phosphate buffer). 
3.11.7.2.  Sample analysis 
For the analysis, “ORAC” is selected and the excitation wavelength is set at 485nm 
while the emission wavelength set at 530nm. Trolox standard series were prepared as 
shown in Table 34 below. 
Table 34: Trolox standard series 
Tube Standard 
concentration 
µM 
Trolox stock 
solution 
µL 
Phosphate 
Buffer 
µL 
Well number 
A 0 0 750 A1-A3 
B 83 125 625 A4-A6 
C 167 250 500 A7-A9 
D 250 375 375 A10-A12 
E 333 500 250 B1-3 
F 417 625 125 B4-6 
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Trolox standard wells – 12 µl of standard (tubes A-E) was added per well in the 
designated wells in a black 96-microwell plate.  Same amount (12 µl) of control were 
added into the control wells (B7-B12) and samples into sample wells (C1-H12) IN 
TRIPLICATE. 10 µl of the fluorescein stock solution was added to 2 mL phosphate 
buffer (in eppendorf tube) and 240 µl of this solution in 15 mL Phosphate buffer. 138 
µl of this solution with a multichannel pipette was added into each well of the black 
microwell plate. 6 mL of the phosphate buffer was now added to the AAPH weighed 
earlier. 50 µl of this solution was transferred into each well. The final volume of the 
assay in each well is 200 µl.  
The multiwell plate was inserted into the fluorometer and the reading was taken.  
3.11.7.3 Data analysis and calculations 
The ORAC values were calculated using a regression equation (Y = a + bX + cX2) 
between Trolox concentration (Y) (µM) and the net area under the fluorescence 
decay curve (X). Data are expressed as micromoles of Trolox equivalents (TE) per 
milligram of sample (µmole Trolox/g of sample). It should be noted that Trolox was 
used as a control sample.   
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3.11.8. Ferric reducing antioxidant power assay (FRAP) 
3.11.8.1.  Methodology 
The FRAP assay uses antioxidants as reductants in a redox-linked colorimetric 
method, employing an easily reduced oxidant present in stoichiometric excess.  
3.11.8.2.  Chemicals required 
Acetate buffer: 300 mM, pH 3.6 (1.627 g Sodium acetate was added to 16 mL Glacial 
acetic acid and make up with distilled water to 1 L).  
TPTZ (2,4,6-tri[2-pyridyl]-s-triazine): 10 mM (0.0093g TPTZ was added to 3 mL of 
40 mM HCl). 
Iron (III) chloride hexahydrate: 20 mM (0.054 g FeCl3.6H2O was added to 10 mL 
distilled water). 
Standard L-Ascorbic acid 1.0 mM solution. 
3.11.8.3   Sample analysis  
  FRAP was selected from the computer programme of the multiskan which was set 
to read at 593nm and the FRAP reagent was prepared by adding together: 30 mL 
Acetate buffer + 3 mL TPTZ solution + 3 mL FeCl3 solution +    6.6 mL distilled 
water. The expected straw colored solution was obtained. 
The FRAP standard series were prepared as shown in Table 35 below. 
Table 35: Ascorbic acid standard wells 
Tube Ascorbic acid 
stock solution 
µL 
Distilled 
water 
µL 
Standard 
concentration 
µM 
Well 
number 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 200 800 200 A10-A12 
E 500 500 500 B1-3 
F 1000 0 1000 B4-6 
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Ascorbic acid standard wells – 10 µl of standard (tubes A-E) were added per well in 
the designated wells in a clear well plate. 10 µl of control solution were equally 
added to the control wells (B7-B12) and samples to the sample wells (C1-H12) IN 
TRIPLICATE. 300µl of the FRAP reagent was added to each well with a 
multichannel pipette. The final volume of the assay in each well was 310 µl. The 
plate was incubated for 30 minutes in the incubating oven set at 37°C after which the 
plate was ran on the machine.  
 
3.11.8.4  Data analysis and calculations 
 The data were expressed as micromoles of Vitamin C equivalents per gram of 
sample (µmole Vitamin C/g of sample). 
 
3.11.9. Abts Trolox equivalent antioxidant capacity (TEAC) assay 
3.11.9.1.  Methodology: - Same as ORAC 
3.11.9.2.  Equipment: - Same as that in Polyphenols 
Chemicals: - ABTS (2, 2’-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) 
Diammonium salt: 7mM (0.0192 g of ABTS to 5 mL distilled water). This was 
prepared over night (24 hours) before starting the assay: 88µl of the potassium-
peroxodisulphate solution was added to 5 mL of the ABTS solution. This was left in 
the dark at room temperature for 24 hours before use. 
3.11.9.3 Sample analysis 
3.11.9.4 Data analysis and calculations  
The TEAC Readings were taken at 734nm on the multiskan spectrum plate readerand 
the TEAC standard series were prepared as shown in Table 36 below. Data was 
expressed as µmole Trolox equivalents per gram of sample (µmole Trolox /g of 
sample). 
 
 
 
 
 109
 
Table 36: TEAC standard series 
Tube Trolox 
standard 
µl 
Ethanol 
µl 
Trolox conc. 
µM 
Well number 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 150 850 150 A10-A12 
E 250 750 250 B1-3 
F 500 500 500 B4-6 
 
Trolox standard wells – 25 µl of standard (tubes A-E) were added per well in the 
designated wells in a clear well plate. 25 µl of control solution and samples were 
added to the Control wells (B7-B12) and Sample wells (C1-H12) respectively IN 
TRIPLICATE. 300µl of this ABTS solution was added to each well using a 
multichannel pipette after a 2X dilution was made to the ABTS by mixing 1ml ABTS 
solution with 20mL EtOH. The plate was run after it was left for 30 minutes at room 
temperature.  
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 PILIOSTIGMA RETICULATUM 
The dried powdered leave material (2 kg) was sequentially extracted with hexane, 
ethyl acetate, methanol and finally with water. The hexane  (78.45g), ethyl acetate 
(109.27g), methanol (246.28g) and water (124.21g) extracts were Phytochemically 
screened for detection of secondary plant metabolites such as tannins, phenolics, 
glycosides, saponins, flavonoids, alkaloids anthraquinones and essential oils using 
Wagner TLC method (Wagner and Bladt, 2001). Results of the screening as shown in 
Table 37 clearly demonstrate the presence of saponins, tannins, flavonoids, phenolics 
as well as cardiac glycosides; while alkaloids, anthraquinones, essential oils, 
phylobatannins and triterpenes were absent. 
Table 37:- Phytochemical screening result of the P. reticulatum extracts  
Test 
materials  Tann Phen Glyc Sapo Flav Alka Anth Esse 
PRH P+ve P+ve P+ve N-ve P+ve N-ve N-ve N-ve 
PRE P+ve P+ve P+ve P+ve P+ve N-ve N-ve N-ve 
PRM P+ve P+ve P+ve P+ve P+ve N-ve N-ve N-ve 
PRW P+ve P+ve P+ve P+ve P+ve N-ve N-ve N-ve 
PRH = P. reticulatum Hexane extract; PRE = P. reticulatum Ethyl acetate extract; PRM = P. 
reticulatum Methanol extract;                PRW = P. reticulatum Water extract.  Tannins (Tann), 
Phenolics (Phen), Glycosides (Glyc), Saponins (Sapo), Flavonoids (Flav), Alkaloids (Alka), 
Anthraquinones (Anth) and Essential oils (Esse) 
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It should be noted that all the plant parts used in this study were air-dried. This avoids 
the decomposition of thermo labile constituents which could occur at high 
temperatures, and is in keeping with the practice whereby handling and processing of 
collected plant materials are usually designed to closely parallel those employed by 
the herbalists (Samuelsson et al., 1985). The sequential extraction method utilized 
was found to be adequate because of the partial preliminary separation that was 
observed in the profile for all the plants from the hexane to water extracts. The 
hexane and ethyl acetate solvents sufficiently retaining the lypophilic compounds 
while methanol and water takes care of the hydrophilic parts (water-soluble 
compounds). 
 
4.1.1 Isolation of constituent of the hexane extract fraction 
 Accelerated gradient chromatography (AGC) of the hexane extract (28.13g) afforded 
four fractions A – D (Table 6) in which A, B and C fractions were presumed to be 
pigments from their TLC profile. Fraction D (8.50g) was rechromatographed because 
it is the only fraction that showed a high presence of flavonoids and is in high yield. 
This afforded compounds P1 (0.0272g) P2 (0.0133g), P3 (0.027g) and P4 (0.0105 g) 
as shown in section 3.6.1.0 – 3.6.1.6. 
 
4.1.2. Isolation of constituent of the ethyl acetate extract 
AGC of the ethyl acetate extract (25.21g) gave 6 fractions coded E – J (Table 8). 
Fraction G (8.0g) was rechromatographed because of the size of the yield and 
evidence of the presence of flavonoids from the TLC analysis. This yielded 
compounds P5 (0.0827g), P6 (0.0054g), P7 (0.075g), P8 (0.0084g) and P9 (0.0076 g) 
as shown in section 3.6.2.0 – 3.6.2.7.   
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4.1.3 Isolation of constituent of the methanol extract 
 On running the AGC of the methanolic extract (32.5g), four fractions were obtained 
which were coded K – N (Table 10). Fraction M was rechromatographed due to its 
high percentage yield. This afforded compounds P10 (0.0198g), P11 (0.0189g), P12 
(0.0065g), P13 (0.0073g) and P14 (0.075g) as shown in section 3.6.3.0 – 3.6.3.5. 
After critical examination and comparison of compounds P1 – P14, it was evident 
that P1 and P6 were identical, likewise P3 and P11, P5 and P10, P8 and P14, P9 and 
P12.  
This resulted in a total of 9 compounds P1, P2, P3 P4, P5, P7, P8, P9 and P13  
Solvent A:  toluene – ethyl acetate (19: 1); 
Solvent B: toluene – ethyl acetate – methanol (10: 7: 3); 
Solvent C:  methanol – water (8: 2, RP – 18).    
 
4.2. PHYSICO-CHEMICAL DATA OF ISOLATED COMPOUNDS 
4.2.1 P1  (6, 8-di-C-methylquercetin- 3, 7, 3’-trimethyl ether)  
Yellow waxy powder with m.p.191-193 °C.  
Rf (Solvent): 0.32 (A), 0.65 (B), 0.14(C)  
UV λmax nm (log ε): 257 (4.64), 355 (4.62); +NaOAc: 270, 365; +NaOH: 276, 342, 
410. +AlCl3: 279, 440.  
IR (ν cm-1) pronounced peaks: 3401, 2932, 1653, 1612 and 1556.     
EIMS: the molecular ion base peak (M)+ m/z  372.1103. ( calculated frag. gave 
C20H20O7 ).  
1H NMR (400 MHz in DMSO-d6): δ 2.12 (3H, s, Me-6), 2.36 (3H, s, Me-8) 3.78 (3H, 
s, OMe-3), 3.97 (3H, s, OMe-3'), 4.03 (3H, s, OMe-7);  6.91 (1H, d, J= 8.5 Hz, H-5'), 
7.60 (1H, dd, J = 2.3, 8.4 Hz, H-6'), 7.70 (1H, d, J= 2.3 Hz, H-2'), 10.20 (1H, s, 4'-
OH), 12.92 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) : see Table 38. 
 
4.2.2 P2  (Piliostigmol)  
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Cream needle-like crystals with m.p. 220-224 °C.  
Rf (Solvent): 0.16 (A), 0.69 (B), 0.28(C) 
UV λmax nm (log ε): 230 (4.89), 286 (4.59); +NaOAc: 232, 287; +NaOH: 244, 288; 
+A1C13: 234, 252 (sh), 308, 351. 
IR (ν cm-1) pronounced peaks: 3435, 3212, 1658, 1606 and 1566.      
EIMS: the molecular ion base peak (M)+ m/z  330.0681. ( calculated frag. gave 
C17H14O7 )  
1H NMR (400 MHz in DMSO-d6) : δ 2.01 (3H, s, Me-6), 3.90 (3H, s, OMe-7), 6.72 
(1H, s, H-8), 6.85 (2H, d, J= 8.8Hz, H-3', 5'), 7.19 (2H, d, J= 8.8Hz, H-2', 6'), 9.78 
(1H, s, 4'-OH), 11.65 (1H, s, 3-OH), 12.95 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6)  see Table 38. 
 
4.2.3  P3  (6, 8-di-C-methylkaempferol- 3,7-dimethyl ether) 
Yellow needles, mp. 285 – 287 oC,  
Rf (Solvent): 0.19 (A), 0.73 (B), 0.18 (C). 
UV λmax nm (log ε): 275.5 (4.79), 332.0 (4.78); +NaOAc: 274.5, 331.5; +AlCl3: 
277.0, 346.0; +NaOH: 274.0, 398.5. 
IR (ν cm-1) pronounced peaks:  3182, 1642, 1602 and 1545. 
EIMS: the molecular ion base peak (M)+ m/z  343.0035. ( calculated frag. gave 
C19H18O6 ).  
¹H NMR (250 MHz, DMSO-d6): δ 2.13 (3H, s, Me-6), 2.30 (3H, s, Me-8), 3.73 (3H, 
s, OMe-7), 3.80 (3H, s, OMe-3), 6.97 (2H, d, J = 8.9 Hz, H-3’,5’), 8.00 (2H, d, J = 
8.9 Hz, H-2’,6’); 12.80 (IH, s, 5-)H). 13C NMR (100 MHz in DMSO-d6): see Table 
38. 
4.2.4 P4  (6, 8-di-C-methylquercetin -3,3'-dimethyl ether)  
Yellow fluffy powder with m.p. 265-267 °C.   
Rf (Solvent): 0.35 (A), 0.47 (B), 0.24(C) 
UV λmax nm (log ε): 262 (4.62), 354 (4.60); +NaOAc: 260, 355; +NaOH: 270, 405; 
+A1C13: 277, 435.  
IR (ν cm-1) pronounced peaks: 3429, 1652, 1613, 1568 and 1556.     
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EIMS: the molecular ion base peak (M)+ m/z  360.0954. ( calculated frag. gave 
C19H18O7 ).  
1H NMR (400 MHz in DMSO-d6) : δ 2.11 (3H, s, Me-6), 2.41 (3H, s, Me-8);  3.89 
(3H, s, OMe-3),  3.98 (3H, s, OMe-3'), 7.03 (1H, d, J=8.6Hz, H-5'), 7.62 (1H, dd, J= 
2.3, 8.6 Hz, H-6'), 7.75 (1H, d, J= 2.3Hz, H-2'), 10.23 (1H, s, 4'-OH), 12.95 (1H, s, 7-
OH).13.05 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) : see Table 38. 
 
4.2.5  P5  (6,8,3'-tri-C-methylquercetin- 3,7-dimethyl ether)  
Yellow amorphous powder with m.p 243-246 °C.  
Rf (Solvent): 0.56 (A), 0.51 (B), 0.35(C). 
UV λmax nm (log ε): 263 (4.65), 363 (4.62); +NaOAc: 262, 367; +NaOH: 267, 412; 
+A1C13: 281, 447.  
IR (ν cm-1) pronounced peaks: 3356, 1642, 1610, 1578, and 1546     
EIMS: the molecular ion base peak (M)+ m/z  356.3821. ( calculated frag. gave 
C20H20O6 ).  
1H NMR (400 MHz in DMSO-d6) : δ 2.16 (3H, s, Me-6), 2.29 (3H, s, Me-3'),  2.42 
(3H, s, Me-8), 3.84 (3H, s, OMe-3), 3.92 (3H, s, OMe-7), 7.02 (1H, d, J= 8.6Hz, H-
5'), 7.62 (1H, dd, J= 2.3, 8.6Hz, H-6'), 7.74 (1H, d, J= 2.3Hz, H-2'), 10.13 (1H, s, 4'-
OH), 13.02 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6)  see Table 38. 
 
4.2.6  P7  (6-C-methylquercetin -3,7,3'-trimethyl ether)   
Yellow needle-like crystals with m.p. 184-187 °C  
Rf (Solvent ): 0.23 (A), 0.58 (B), 0.20 (C). 
UV λmax nm (log ε): 256.5 (4.78), 272.0sh, 346.0 (4.86); +NaOAc: 258.0, 346.0; 
+AlCl3: 268.0, 370.0; +NaOH: 267.5, 410.5.  
IR (ν cm-1) pronounced peaks: 3400, 2953, 1651, 1610, and 1559. 
EIMS: the molecular ion base peak (M)+ m/z  358.4133     ( calculated frag. gave 
C19H18O7 ).  
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1H NMR (400 MHz in DMSO-d6) : δ 2.08 (3H, s, Me-6); 3.91 (3H, s, OMe-3); 3.98 
(3H, s, OMe-3'); 4.01 (3H, s, OMe-7); 6.90 (1H, s, H-8); 7.07 (1H, d, J=8.6Hz, H-5'); 
7.72 (1H, dd, J = 2.3, 8.6 Hz, H-6'); 7.77 (1H, d, J = 2.3 Hz, H-2'). 10.10 (1H, s, 4'-
OH), 12.95 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) : see Table 38. 
There was spectral comparison with that of Ref. (Rabesa and Voirin, 1985).  
4.2.7  P8  (6-C-methylquercetin- 3-methyl ether)  
Yellow powder with m.p. 261-263 °C.  
Rf (Solvent): 0.61 (A), 0.41 (B), 0.44(C) 
UV λmax nm (log ε): 260.5 (4.41), 359.5 (4.45); +NaOAc: 263.5, 377.0; +AlCl3: 
266.5, 376.0; +NaOH: 273.5, 409.5.  
EIMS: the molecular ion base peak (M)+ m/z  330.6242  ( calculated frag. gave 
C17H14O7 ).  
1H MMR (400 MHz in DMSO-d6) : δ 2.17 (3H, s, M-6), 3.92 (3H, s, OMe-3), 6.66 
(1H, s, H-8), 7.10 (1H, d, J= 8.6Hz, H-5'), 7.64 (1H, dd, J = 2.3, 8.6 Hz, H-6'), 7.76 
(1H, d, J= 2.3 Hz, H-2'),  10.23 (1H, s, 4'-OH), 13.10 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) : see Table 38. 
There was spectral comparison with that of Ref. (Harborne et al., 1994).   
 
4.2.8  P9  (6,8-di-C-methylkaempferol- 3-methyl ether)  
Yellow waxy amorphous solid with m.p. 250-253 °C.  
Rf (Solvent): 0.12 (A), 0.60 (B), 0.32(C) 
UV λmax nm (log ε): 275.5 (4.76), 334.5 (4.69); +NaOAc: 277.5; +AlCl3: 282.0, 
359.0;+NaOH: 281.0, 332.0, 407.0.  
EIMS: the molecular ion base peak (M)+ m/z  329.2110  ( calculated frag. gave 
C18H16O6 ).  
1H NMR (400 MHz in DMSO-d6) : δ 2.15 (3H, s, Me-6); 2.35 (3H, s, Me-8); 3.88 
(3H, s, OMe-3); 7.10 (2H, d, J = 9 Hz, H-3',5'); 8.05 (2H, d, J = 9 Hz, H-2', 6'); 13.00 
(1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) : see Table 38. 
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There was spectral comparison with that of Ref. (Voirin, 1983).   
 
4.2.9  P13  (Quercetin) 
Bright yellow powder, m.p. 310 - 311˚C, (Lit. 314˚C, Windholz, 1983),  
Rf(Solvent): 0.76 (A), 0.37 (B), 0.60(C). 
 IR (ν cm-1) pronounced peaks: 3400, 3292, 1672, 1614, 1513.  
UV λmax nm (log ε): 256.0 (4.78), 374.0 (4.82); +NaOAc: 260.5, 387.5; +AlCl3: 
270.0, 436.0; +NaOH: 281.0, 425.0. 
EIMS: the molecular ion base peak (M)+ m/z  302.2112  ( calculated frag. gave 
C15H10O7 ).  
1H NMR (400 MHz in DMSO-d6) : δ 6.74 (1H, d, J = 1.98 Hz, H-8), 6.78 (1H, d, J= 
1.98 Hz, H-6), 7.40 (1H, d, J = 8.25 Hz, H-5'), 8.10 (1H, dd, J = 2.31, 8.25 Hz, H-6'), 
8.64 (1H, d, J = 2.31 Hz, H-2'), 13.36 (1H, s, 5-OH).  
13C NMR (100 MHz in DMSO-d6) see Table 38. 
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TABLE 38: ¹³C NMR data for compounds P1 – 13 
Carbon P1 P2 P3 P4 P5 P7 P8 P9 P13 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1' 
2' 
3' 
4' 
5' 
6' 
3-OMe 
7-OMe 
3'-OMe 
6-Me 
8-Me 
3'-Me 
155.3 
137.5 
178.8 
155.3 
106.6 
162.4 
101.5 
151.4 
103.9 
121.6 
115.3 
147.2 
148.5 
115.8 
120.6 
59.5 
60.2 
56.5 
8.1 
8.5 
 
166.7 
156.8 
182.3 
156.2 
108.5 
161.5 
92.1 
152.4 
101.5 
143.1 
121.5 
116.2 
156.2 
116.2 
121.5 
 
56.4 
 
7.2 
 
 
156.0 
137.7 
178.5 
155.9 
112.5 
162.0 
108.5 
151.4 
107.0 
120.6 
130.1 
115.7 
160.3 
115.7 
130.1 
59.6 
60.3 
 
8.0 
8.2 
155.2 
137.3 
177.9 
157.1 
107.3 
162.1 
101.9 
154.4 
104.8 
120.4 
115.4 
147.6 
148.5 
115.4 
120.8 
59.2 
 
55.9 
7.2 
8.3 
 
155.8 
137.2 
178.4 
155.9 
112.6 
162.5 
108.4 
151.3 
107.1 
120.5 
115.5 
135.6 
148.8 
115.6 
120.2 
59.4 
60.3 
 
8.0 
8.2 
8.7 
155.3 
137.9 
177.8 
157.0 
107.0 
162.9 
90.0 
154.3 
104.7 
120.7 
111.9 
147.4 
149.7 
115.5 
122.1 
59.5 
56.2 
55.7 
7.1 
 
155.3 
137.6 
177.7 
158.1 
106.4 
162.2 
92.6 
153.9 
103.7 
120.8 
115.2 
145.2 
148.6 
115.7 
120.5 
59.6 
 
 
7.3 
155.1 
137.4 
178.0 
155.6 
106.7 
159.7 
101.6 
151.5 
104.0 
120.9 
129.9 
115.7 
160.0 
115.7 
129.9 
59.6 
 
 
8.0 
8.2 
 
147.0 
137.9 
177.3 
157.5 
99.2 
165.4 
94.3 
162.4 
104.4 
123.8 
116.6 
147.7 
149.6 
116.6 
121.0 
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4.3. STRUCTURAL ELUCIDATION OF COMPOUNDS P1 – P13 
4.3.1 COMPOUND P1 (6, 8-di-C-methylquercetin 3, 7, 3'-trimethyl ether) 
Compound P1 showed a molecular ion peak (M) + at m/z 372.1103 leading to a 
molecular formula of C20H2007. The UV spectrum showed two maxima peaks at 355 
and 257 nm respectively which are associated with a flavonoid system. The band at 
270 nm showed a large bathochromic shift in the presence of sodium acetate and an 
additional band appeared at 342 nm in the methanol / NaOH spectrum which 
suggested a flavonol with a 7-OMe group. The 1H NMR spectrum showed  that there 
were two aryl methyl singlets at δ 2.12 and 2.36 and three methoxyl  peaks were 
observed at δ 3.78 ( OMe-3), 3.97 ( OMe-3') and 4.03 ( OMe-7). The spectrum 
further showed the presence of only three aromatic signals at δ 6.91 (1H, d), 7.60 
(1H, dd) and 7.70 (1H, d ) suggesting a 3',4'-disubstituted aromatic ring C and a 
completely substituted aromatic ring A with a correlated typical chemical shift of a 
chelated 5-OH group at δ 12.92 of a flavone. When the 13C  NMR data for P1 in 
Table 38 was compared  with literature (Roitman and James, 1985; Breitmeier and 
Voelter, 1990) it was evident from the analysis that the 4′-substituent was an 
hydroxyl group while that of 3' was a methoxyl group which was confirmed by the 
chemical shifts of their carbons at δ C-3' (147.2) and C-4' (148.5) which also reflect 
in the slight variation observed in the neighboring carbons at δ C-2' (115.3) and C-5' 
(115.8). The methoxyl groups were linked to C-3 (δ 137.5), C-3' (δ 147.2) and to C-7 
(δ 162.4) which were in agreement with the HMBC correlations OMe-3/C-3 with 
OMe-3'/C-3' and OMe-7/C-7 (Table 39). The methyl groups were attached to C-6 and 
C-8, as highlighted by the HMBC cross peaks OH-5/C-5, C-6, C-4a; Me-6/C-5, C-6, 
C-7 and that of Me-8/C-7, C-8, C-8a. Based on the above analysis the structure of 
compound P1 was confirmed to be 3,7,3'-trimethoxy- 6,8-di-C-methyl -5,4'-
dihydroxylflavone (6,8-di-C-methylquercetin 3,7, 3'-trimethyl ether) as shown in Fig. 
9.  
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Fig. 9  Structure of compound P1  
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TABLE 39: NMR spectroscopic data for compound P1  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C Assignment 
155.3 
137.5 
178.8 
155.3 
106.6 
162.4 
101.5 
151.4 
103.9 
121.6 
115.3 
147.2 
148.5 
115.8 
120.6 
 
8.1 
8.5 
56.5 
59.5 
60.2 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
Me-6, Me-8, 7-OMe 
Me-8 
Me-8 
5-OH 
H- 5' 
 
H-2', H-5' 
H-2', H-6' 
H-6' 
H-2'  
 
 
 
 
 
 
 
 
 
 
 
 
 
7.70 (1H, d, 2.3) 
 
 
6.91 (1H, d, 8.5) 
7.60 (1H, dd, 2.3 
and 8.4) 
2.12 (3H, s) 
2.36 (3H, s) 
3.97 (3H, s) 
3.78 (3H, s) 
4.03 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
4a 
8a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
8-Me 
3'-OMe 
3-OMe 
7-OMe 
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4.3.2  COMPOUND P2 (Piliostigmol) 
The mass spectrum of P2 showed a molecular ion base peak (M)+. at m/z 330.0681 
and this together with the mass spectral fragmentation suggested a molecular formula 
of C17H1407. The UV spectrum exhibited two peak maxima at 232 and 287 nm, which 
were in close agreement with those obtained for capillarisin, a closely related 2-O-(p-
hydroxyphenyl) chromone, which was isolated from Artemisia capillaris (Komiya et 
al., 1975),  thus indicating the possible presence of a similar chromophore in P2. The 
1H NMR spectrum showed a characteristic pattern for an A2B2 system, as would be 
expected from a para-disubstituted aromatic system of the phenolic ring C, with 
doublets at δ 6.85 and 7.19 (J= 8.8 Hz), as a well as a singlet at δ 6.72 which could be 
attributed to H-8 in the A ring (Komiya et al., 1975; Hashidoko et al., 1991; Huang et 
al., 1993). Other signals of note were a chelated 5-OH at δ 12.95, a singlet at 11.65 
due to the 3-OH, a methyl singlet at δ 2.01 and a methoxyl singlet at δ 3.90.  In the 
13C NMR spectrum (Table 38), the signal due to C-3 appeared at δ 156.8 while that of 
C-8 was observed at δ 92.1 and this was corroborated by HMQC data (Table 40). The 
observed HMBC correlations for P2 (Fig 11) confirmed that the single ring A proton 
was located at position 8 (cross peaks H-8/C-4, C-6, C-7, C-4a and C-8a) and  that 
the single aryl methyl group was attached  at C-6 (cross peaks OH-5/C- 5, C-4a) and 
Me-6/C-5, C-6, C-7) whereas the methoxyl group was linked to C-7 (cross peak 
OMe/C-7). No HMBC correlations were observed between rings B and C, thus 
confirming the presence of the oxygen bridge C1'-O-C 2 (Table 40). All the above 
data is in agreement with the structure of P2 to have as the structure of  2-O-(p-
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hydroxyphenyl)-3,5- dihydroxy-6-C- methyl-7-methoxychromone, and is hereby 
given the trivial name piliostigmol (Fig. 10). 
O
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H3CO
OH
OH
O
OH
A B
C
 
Figure 10 – Structure of Piliostigmol (P2) 
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Figure 11 - P2 HMBC correlations for Piliostigmol 
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TABLE 40: NMR spectroscopic data for compound P2  
13C Signal (δ) HMQC correlation (δ)       HMBC 13C Assignment 
166.7 
156.8 
182.3 
156.2 
108.5 
161.5 
92.1 
152.4 
101.5 
143.1 
121.5 
 
116.2 
 
156.2 
7.3 
56.4 
 
11.65 s (3-OH) 
 
 
 
 
6.72 s (H-8) 
 
 
 
7.19 d (H-2', H-6') (2H, J 
= 8.8 Hz) 
6.85 d (H-3', H-5') (2H, J 
= 8.8 Hz) 
 
2.01 s (Me-6) 
3.90 s (7-OMe) 
 
3-OH 
 
5-OH, Me-6 
5-OH, Me-6, H-8 
Me-6, 7-OMe, H-8 
 
H-8 
5-OH, 3-OH, H-8 
H-2', 6'; H-3', 5' 
 
 
 
 
H-2', 6'; H-3', 5' 
  
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2', 6' 
 
3',  5' 
 
4' 
6-Me 
7-OMe 
  
2-O-(p-hydroxyphenyl) chromones are relatively rare in nature, and Piliostigmol is 
the first phenoxychromonol reported. The first 2-phenoxychromone to be isolated 
was capillarisin from Artemisiae capillaries (Compositae) (Komiya et al., 1975). 
Subsequently, Hashidoko et al., (1991) isolated two 2-phenoxychromones from the 
leaves of Rosa rugosa (Rosaceae), while Huang et al., (1993) reported three 2-
phenoxychromones from Epimedium sagittatum (Berberidaceae) including an 8-
prenylated derivative. In 1996, Piliostigmin, another 2-phenoxychromone was 
isolated from the leaves of Piliostigma thonningii (Ibewuike et al., 1996). The 
reported biological activities were found more in P.thonningii and it was discovered 
that the 2-phenoxychromones in capillarisin has a biliary excretion stimulating effect 
 
 
 
 
 124
(Komiya et al., 1975) whereas it was observed that Piliostigmin isolated from 
P.thonningii did not exhibit any significant antibacterial or anti-inflammatory (PG 
synthesis inhibitory) activity. On the contrary Piliostigmol was found to possess high 
activity both as an antimicrobial and antioxidant (Babajide et al., 2008). It was 
assumed that the activity observed may be due to the positioning of the 3-OH group 
in the ring B. Although Nakanishi et al., (1983) proposed that 2-phenoxychromones 
may be biosynthesized from the corresponding flavones by a Baeyer- Villiger type of 
oxidation or via an epoxy quinone intermediate in which the main activity reside on 
carbon -3 (Hashidoko et al., 1991).  
 
4.3.3  Compound P3 (6, 8-di-C-methylkaempferol 3, 7-dimethl ether) 
Compound P3, a bright yellow crystalline solid, gave a positive reaction with ferric 
chloride, and a bright yellow colour with vanillin-H2SO4 spray reagent. The infra-red 
spectrum showed a carbonyl absorption band at 1642 cm-1 and –CH aliphatic stretch 
at 3000-2800 cm-1. There was also an OH band at 3182 cm-1.  These results are 
consistent with compound P3 being a flavonoid. The ultraviolet spectrum showed 
two maxima at 332.0 nm (Band I) and275.5 nm (Band II). These values are typical of 
a 3-O-substituted flavonol (Wollenweber, 1982). A Band I bathochromic shift of 
+66.5 nm in the presence of NaOH, and the absence of any shift in the sodium acetate 
spectrum indicated the presence of a free 4'-OH group, as well as the absence of a 
free 7-OH group, respectively.  Compound P3 is therefore a flavonol in which the 3-
OH and 7-OH groups are substituted, and with a free 4'-OH group. The 1H NMR 
spectrum of P3 showed two methyl singlets (δ 2.13 and 2.30) and two methoxyl 
singlets (δ 3.73 and 3.80). The presence of an AA'CC' system due to ring C at δ 6.97 
and 8.00 (J = 8.9 HZ) implied that the free 4'-OH group indicated by the NaOH shift 
was the only substituent on this ring. Also, the presence of a free 5-OH group 
(indicated by the H-bonded proton singlet at δ 12.8) further implied that the two 
methoxyl and two methyl substituens could only be at positions 3, 7, 6 and 8 
respectively. Compound P3 must therefore be 6, 8-di-C-methylkaempferol 3,7-
dimethyl ether (5,4'-dihydroxy-3,7-dimethoxy-6,8-dimethylflavone) (Figure 12). This 
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structure was confirmed by the mass spectrum which showed an (M+H)+  ion at m/z 
343, consistent with the molecular formula C19H18O6. The 13C NMR spectrum (Table 
38) also exhibited 17 signals as expected, corresponding to a C19 -flavoniod in which 
C-2', 6’ and C-3', 5’ are respectively isochronous. The HMBC spectrum of P3 was 
used to assign the individual carbon resonance (Table 41). While the methyl and 
methoxyl signals were assigned by comparison with literature (Tanrisever et al., 
1987).  
Compound P3 had previously been reported from Alluaudia dumosa 
(Rasamoelisendra et al., 1989), and the 1H NMR and UV spectra are in agreement 
with those published. The complete 13C spectral assignment (Table 41) is reported for 
the first time for this plant. 
 
 
 
O
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Fig. 12 -Structure of compound P3 
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TABLE 41:  NMR spectroscopic data for compound P3  
13C Signal (δ) DEPT 1H Signal (δ) HMBC 13C 
Assignment 
156.0 
137.7 
178.5 
155.9 
112.5 
162.0 
108.5 
151.4 
107.0 
120.6 
130.1 
 
115.7 
 
160.3 
8.0 
8.2  
59.6 
60.3 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
CH 
 
CH 
 
C 
CH3 
CH3 
CH3 
CH3 
 
 
 
 
 
 
 
 
 
 
8.00d (2H, J = 8.9 
Hz) 
6.97d (2H, J = 8.9 
Hz) 
 
2.13s 
2.30s 
3.80s 
3.73s 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
7-OMe, Me-6, Me-8 
Me-8 
Me-8 
5-OH 
H-3', 5' 
H-2', 6' 
 
H-3', 5' 
 
H-2', 6'; H-3', 5' 
 
 
 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2', 6' 
 
3',  5' 
 
4' 
6-Me 
8-Me 
3-OMe 
7-OMe 
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4.3.4  COMPOUND P4 (6, 8-di- C- methylquercetin 3,3'- dimethyl ether) 
The molecular formula of P 4 was assigned as C19H1807 from the molecular ion peak 
at m/z 360.0954.  The UV and IR spectra obtained were also analyzed and compared 
with that of literature which showed a similar trend in the UV spectrum at λmax 354 
and 262 nm respectively, but which suggested a flavonol with a free 7-OH group in 
this case. The 1H NMR spectrum exhibited the signals of two aryl methyl groups at δ 
2.11 ( Me-6) and 2.41 ( Me-8); and  two methoxyl groups at δ 3.89 ( OMe-3) and  
3.98 ( OMe-3'), The ring C aromatic signals were typical of a 3',4'-substituted pattern 
similar to that of  P1 viz.,  δ 7.03 (1H, d), 7.62 (1H, dd) and 7.75 (1H, d). The signals 
of three -OH groups were observable at δ 10.23 ( 4'-OH), 12.95 (7-OH) and  13.05 ( 
5-OH).  The 13C spectrum (Table 38) showed a similar trend to that of compound P1, 
in which the tri-substituted C ring has an hydroxyl group at C-4' and a methoxyl 
group at C-3'. The HMBC data (Table 42) for ring A clearly demonstrated a slight 
difference from that of P1 at the C-7 position to which the OH has been assigned.  
The cross peaks observed for OH-5/C-5, C-6, C-4a and Me-6/C-5, C-6, C-7, Me-8/C-
7, C-8, C-8a all of which indicated that the two aryl methyl groups were located at C-
6 and C-8. The two methoxyl groups were located at C-3 and C-3' as corroborated by 
their HMBC correlations with C-3 and C-3’ respectively.  P4 was consequently 
assigned the structure  3,3'-dimethoxy-6,8-di-C-methyl- 5,7,4'-trihydroxyflavone 
(6,8-di- C- methylquercetin 3,3'- dimethyl ether) as shown in Fig. 13 
O
O
CH3
OH
OCH3
OH
CH3
OH
OCH3
 
Fig. 13 – Structure of compound P4 
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TABLE 42: NMR spectroscopic data for compound P4  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C 
Assignment 
155.2 
137.3 
177.9 
157.1 
107.3 
162.1 
101.9 
154.4 
104.8 
120.4 
115.4 
147.6 
148.5 
115.4 
120.8 
 
7.2 
8.3 
55.9 
59.2 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6, Me-8 
Me-6, Me-8 
 
Me-8 
5-OH, Me-8 
H- 5' 
H-6' 
H-2', H-5' 
H-2', H-5', H-6' 
 
H-2'  
 
 
 
 
 
 
 
 
 
 
 
 
 
7.75 (1H, d, 2.3) 
 
 
7.03 (1H, d, 8.6) 
7.62 (1H, dd, 2.3 
and 8.6) 
2.11 (3H, s) 
2.41 (3H, s) 
3.98 (3H, s) 
3.89 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
8-Me 
3'-OMe 
3-OMe  
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4.3.5  COMPOUND P5 (6, 8, 3’-tri-C-methylquercetin 3, 7-dimethyl ether) 
The EIMS of P5 showed the molecular ion peak (M)+ at m/z 356.3821 corresponding 
to  a molecular formula of C20H2006.  The UV and IR spectra obtained were also 
analysed and compared with that of literature which showed similar trend to that of 
P1 in the UV spectrum at λmax 363 and 263 nm respectively, suggesting a flavonol 
with a 7-OMe group in this case. The 1H NMR spectrum exhibited signals due to 
three aryl methyl groups at δ 2.16 (Me-6), 2.29 (Me-3') and 2.42 (Me-8). It also 
showed two methoxyl signals at δ 3.84 (OMe-3) and  3.92 (OMe-7).  The ring C 
aromatic signals again resembled a typical 3',4'-disubstituted pattern similar to that 
experienced in  P1 viz., δ 7.02 (1H, d), 7.62 (1H, dd) and 7.74 (1H, d). Peaks of two 
OH groups were observed at δ 10.13 (4’-OH) and 13.02 (5-OH).  The 1H NMR and 
13C NMR signals of the C ring were similar to that of  P1 except for the peak located 
at δ 2.29 due to the 3′-Me group confirmed in the  13C NMR spectrum for C-3'  at 
δ135.6 and   3'-Me  at  δ 8.7 (Table 38). 
 Further analysis of the 1H NMR spectrum showed that ring A was fully substituted 
and posses an hydroxyl group at C-5, since due to the typical singlet at δ 13.02 and a 
further signal at δ 10.13 was assigned to the 4'-OH on ring C. There were 3 aryl 
methyl groups;  one  at δ 2.16 assigned to C-6 , one at δ 2.42 assigned to C-8 and the 
third on ring C at δ 2.29 assigned to  C-3'. These were further confirmed by the 
HMBC cross peak correlations (Table 43) which appeared very similar to those 
observed for P1 and P4.  From the forgoing, P5 has been identified as 3,7-dimethoxy 
-6,8,3' - tri - C- methyl- 5,4' - dihydroxyflavone (6,8,3'-tri-C-methylquercetin 3,7-
dimethyl ether) Fig. 14. 
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Figure 14 – Structure of compound P5 
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TABLE 43: The NMR spectroscopic data for compound P5  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C 
Assignment 
155.8 
137.2 
178.4 
155.9 
112.6 
162.5 
108.4 
151.3 
107.1 
120.5 
115.5 
135.6 
148.8 
115.6 
120.2 
 
8.0 
8.2 
8.7 
59.4 
60.3 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
Me-6, Me-8, 7-OMe 
Me-8 
Me-8 
5-OH 
H- 5' 
 
Me-3', H-5' 
H-2', H-6', 
 H-6' 
H-2'  
 
 
 
 
 
 
 
 
 
 
 
 
 
7.74 (1H, d, 2.3) 
 
 
7.02 (1H, d, 8.6) 
7.62 (1H, dd, 2.3 
and 8.6) 
2.16 (3H, s) 
2.42 (3H, s) 
2.29 (3H, s) 
3.84 (3H, s) 
3.92 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
8-Me 
3'-Me 
3-OMe 
7-OMe 
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4.3.6  Compound P7 (6-C- methyquercetin 3, 7, 3’-trimethyl ether) 
The IR spectrum of compound P7 exhibited characteristic carbonyl absorption 
at 1651cm-1 and a strong O-H absorption at 3400cm-1. The UV spectrum of the 
compound showed a Band I absorbance at 346 nm, and a Band II absorbance at 256.5 
nm. These absorption bands are consistent with a 3-O-substituted flavonol 
(Wollenweber, 1982). The bathochromic shift of Band I in the presence of NaOH 
(+64 nm) indicated the presence of a free 4'-OH group, while the absence of a similar 
shift in the presence of sodium acetate also showed the absence of a free 7-OH group. 
The 13C NMR and DEPT spectra of compound P7 showed 19 carbon resonances 
consisting of four methyl groups which included three oxygenated methyl groups, 
four methine and eleven quaternary signals. The mass spectrum showed a [MH]+ ion 
at m/z 358.4133. These data are consistent with a molecular formula of C19H18O7 for 
compound P7.  
The 1H NMR spectrum of compound P7 showed an aryl methyl singlet at δ 
2.08, as well as three methoxyl singlets at δ3.91, 3.98, and 4.01. In the aromatic 
region, the presence of one proton singlet at δ6.90 indicated a pentasubstituted ring 
A, while the doublets at δ7.07 and 7.77 as well the doublet of a doublet at δ7.72 
confirmed the presence of a 1,3,4-trisubstituted ring C. Compound P7 is therefore a 
quercetin derivative having the hydroxyl groups at  C-3 and C-7 methylated. 
The electron impact (EI) mass spectrum of compound P7 exhibited prominent 
ions at m/z 358 (M+., 100%), 357 [M-H]+, 343 [M-Me]+ and 315 [M-Me-CO]+, all 
consistent with a 3-methoxyflavonol (Kingston, 1971). The characteristic RDA 
fragment ions m/z 181 [A+H] + and 151 [C] + indicated the presence of both a methyl 
group and a methoxyl substituent on ring A, and a methoxyl group on rign C (Figure 
16). Since the UV spectrum showed no bathchromich shift in the presence of NaOAc, 
the ring A methoxyl substituent must located at C-7, while the ring C methoxyl must 
be located at C-3' supported in the 1H NMR spectrum which indicated a 1', 3', 4'-
trisubstituted pattern, and in addition the NaOH bathochromic shift of Band I 
suggested the presence of a free 4'-OH group. Compound P7 is therefore assigned as 
3, 7, 3’-tri-O-methyllquercetin possessing a methyl group at C- 6 or C-8. The position 
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of the aryl methyl at C-6 was confirmed by the 1H-13C COSY and HMBC spectra. 
The COSY spectrum was used to assign the proton signals to their respective carbon 
resonances (Table 44). The presence of the ring A methyl group at C-6 was 
confirmed by the observed HMBC correlations Me-6/C-5, C-6, C-7 and also by the 
H-8/C-6, C-7, C-8a and C-4a cross-peaks. This allowed the unambiguous assignment 
of compound P7 as 6-C-methyquercetin 3, 7, 3’-trimethyl ether (6-C-methyl-5,4'-
dihydroxy-3,7,3'-trimethoxyflavone) (Figure 15). It has previously been isolated from 
Alluaudia humbertii Choux (Didiereaceae) (Rabesa and Voirin, 1985). The spectra 
(UV, MS) are in excellent agreement with those published in literature (Rabesa and 
Voirin, 1985), while the 13C NMR spectrum and the complete assignment (Table 44) 
are reported here for the first time. 
O
O
CH3
H3CO
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OCH3
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OCH3
 
 
 
Figure 15 – Structure of compound P7 
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TABLE 44: NMR Spectroscopic Data for Compound P7  
13C Signal (δ) DEPT 1H – 13C COSY HMBC 13C 
Assignment 
155.3 
137.9 
177.8 
157.0 
107.0 
162.9 
90.0 
 
154.3 
104.7 
120.7 
111.9 
147.4 
149.7 
115.5 
122.1 
 
7.1 
55.7 
56.2 
59.5 
C 
C 
C 
C 
C 
C 
CH 
 
C 
C 
C 
CH 
C 
C 
CH 
CH 
 
CH3 
CH3 
CH3 
CH3 
 
 
 
 
 
 
6.90s 
 
 
 
 
7.77d (J = 2.3 Hz) 
 
 
7.07d (J = 8.6 Hz) 
7.72dd (J = 2.3 and 
8.6 Hz) 
2.08s 
3.98s 
4.01s 
3.91s 
H-6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
7-OMe 
C-6, C-7, C-9, 
C-10 
H-8 
5-OH 
H- 5' 
H-6' 
3'-OMe, H-5' 
H-5', H-6' 
 
H-2'  
 
C-5, C-6, C-7 
 C-3'  
C-7 
C-3 
2 
3 
4 
5 
6 
7 
8 
 
8a 
4a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
3'-OMe 
7-OMe 
3-OMe 
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Figure 16:  Mass spectral fragmentation pattern for compound P7 
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4.3.7  Compound P8 (6-C-methylquercetin 3-methyl ether)  
Compound P8 exhibited a [MH]+ peak in the CI mass spectrum at m/z 331, 
corresponding to a molecular formula C17H14O7.  The UV spectrum was typical of a 
3-methoxyflavonol with free 7-OH and 4 '-OH groups (Bands I and II at 359.5 and 
260.5, MeOH + NaOH: + 50nm; MeOH+ NaCAc:  +17.5nm). 
The 1H NMR spectrum of P8 displayed an aryl methyl singlet at δ 2.17 and a 
methoxyl singlet at δ 3.92. The aromatic region included a singlet at δ 6.66 as well as 
the signals of a C ring ABC substitution pattern viz., δ 7.10 (1H, d, J = 8.6 Hz); 7.64 
(1H, dd, J = 2.3 and 8.6 Hz) and 7.76 (1H, d, J = 2.3 Hz). The downfield signal at 
δ13.10 was assigned to the strongly H-bonded 5-OH, while the signal at δ 10.23 was 
assigned to 4'-OH. Together with the UV data P8 has been assigned as a 3-
methoxyflavonol with a 3', 4'-disubstituted ring C, and a penta-substituted ring A 
bearing the free 5-OH and 7-OH groups. 
O
O
CH3
OH
OCH3
OH
OH
OH
 
Figure 17 – Structure of compound P8 
 
The 13C NMR spectrum showed the expected 17 resonance lines (Table 38), and was 
nearly similar to that of P2. Since the UV spectrum of P8 indicated the presence of a 
3',4'- dihydroxy aryl substituent supported by the 13C chemical shifts of C-2' and C-5' 
(Roitman and James, 1985), a free 7-OH and a 3-methoxy group, in our view the aryl 
methyl group (δ 2.17),  could only be assigned at either C-6 or C-8. Confirmation that 
its position was at C-6 was derived from the HMBC spectrum (Table 45) which 
showed correlations between 5-OH/C-5, C-6, C-4a, Me-6/C-5, C-6, C-7 and H-8/C-6, 
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C-7, C-8a, C-4a. The location of the methoxyl group at C-3 (δ 137.60) was confirmed 
by the cross-peak OMe-3/C-3.  
 
 
TABLE 45: The NMR spectroscopic data for compound P8  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C 
Assignment 
155.3 
137.6 
177.7 
158.1 
106.4 
162.2 
92.6 
153.9 
103.7 
120.8 
115.2 
145.2 
148.6 
115.7 
120.5 
 
7.3 
59.6 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6, H-8 
Me-6, H-8 
 
H-8 
5-OH, H-8 
H- 5' 
H-6' 
H-2', H-5' 
H-2', H-5', H-6' 
 
H-2'  
 
 
 
 
 
 
 
 
 
6.66 (1H, s) 
 
 
 
7.76 (1H, d, 2.3) 
 
 
7.10 (1H, d, 8.6) 
7.64 (1H, dd, 2.3 
and 8.6) 
2.17 (3H, s) 
3.92 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
3-OMe 
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The structure of Compound P8 was therefore established as 3-methoxy-6-C-methyl-
5, 7, 3’, 4’-tetrahydroxyflavone (6-C-methylquercetin 3-methyl ether) (Figure 17). It 
had previously been isolated from Vellozia phalocarpa (Velloziaceae) by Harborne et 
al., (1994), and the UV and mass spectral data are in close agreement with those 
reported therein. The complete proton and carbon-13 NMR spectral assignments 
(Table 45) are reported here for the first time for this plant. 
 
 
 
 
 
4.3.8 Compound P9 (6, 8-di-C-methylkaempferol 3-methyl ether) 
Compound P9, a yellow waxy amorphous powder and melting at 250 – 
2530C, gave a [MH]+ peak at m/z 329 in the mass spectrum, consistent with a 
molecular formula C18H16O6. The Band I and Band II absorbances at 275.5 and 334.5 
nm respectively indicated a 3-O-substituted flavonol, while the large bathochromic 
shift in the presence of NaOH (+76.5nm, Band I) and the appearance of a new band at 
332.0 nm indicated the presence of a free 7-OH and 4'-OH group. 
Compound P9 had a very simple proton NMR spectrum, with two aryl methyl 
singlets at δ2.15 and 2.35, a methoxyl singlet at δ3.88, and AA'BB' doublets at δ7.10 
and 8.05 (J = 9Hz), as well as a chelated 5-OH signal at δ13.00. This, in conjunction 
with the UV data, indicated that P9 possessed a 4'-OH mono-substituted ring C as 
well as a fully substituted ring A with a 7-OH and 5-OH group. The methoxyl and 
two methyl groups could therefore only be at the three remaining free positions viz., 
C-3, C-6 and C-8. The UV spectrum was consistent with that of a 3-methoxyflavonol, 
thus implying that the two methyl groups were at C-6 and C-8. This was confirmed 
by the HMBC spectrum (Table 46) which clearly demonstrated the expected 
correlations: 5-OH/C-5, C-6, C-4a; OMe-3/C-3; Me-6/C-5, C-6, C-7 and Me-8/C-7, 
C-8, C-8a.  Compound P9 was therefore assigned as 3-methoxy-6,8-di-C-methyl-
5,7,4'-trihydroxyflavone (6,8-di-C-methylkaempferol-3-methyl ether) (Figure 18). 
Previously compound P9 had been isolated and reported (Voirin, 1983) and our UV 
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data are in agreement with those published therein. The 1H and 13C NMR spectra 
which are completely assigned in Table 46 are reported here for the first time.   
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Figure 18 – Structure of compound P9 
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TABLE 46: NMR spectroscopic data for compound P9  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C 
Assignment 
155.1 
137.4 
178.0 
155.6 
106.7 
160.0 
101.6 
151.5 
104.0 
120.9 
129.9 
115.7 
159.8 
8.0 
8.2 
59.6 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
Me-6, Me-8 
Me-8 
Me-8 
5-OH 
H-3', 5' 
H-2', 6' 
H-3', 5' 
H-2', 6'; H-3', 5' 
 
 
 
 
 
 
 
 
 
 
 
8.05 (2H, d, 9) 
7.10 (2H, d, 9) 
 
2.15 (3H, s) 
2.35 (3H, s) 
3.88 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2', 6' 
3', 5' 
4' 
6-Me 
8-Me 
3-OMe 
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4.3.9  Compound P13 (Quercetin) 
Compound P13 showed IR absorbtion bands at 1672 cm-1 (C=O), and 3400 cm-1 
(OH). It also exhibited UV Bands I and II at 374.0 and 256.0 nm respectively, 
characteristic of flavonols (Wollenweber, 1982). There were also large bathochromic 
shifts in the presence of AlCl3 (+62 nm), NaOAc (+13.5 nm) and NaOH (+51 nm), 
with a new band appearing at 322 nm in the MeOH + NaOH spectrum. These UV 
data are consistent with those of a flavonol possessing free 3, 7, 3' and 4' hydroxyl 
groups (Wollenweber, 1982; Voirin, 1983). 
The 1H NMR spectrum of compound P13 exhibited only aromatic signals, indicating 
the absence of aliphatic substituents on the flavonoid nucleus. The spectrum exhibited 
the characteristic 5-OH  signal at δ 13.36, as well as the m-coupled doublets of an AB 
system at δ 6.74 and 6.78 (J = 1.98 Hz )  consistent with a 5,7-disubstituted ring A. 
An ABC system corresponding to a 3', 4'-disubstituted ring C was also evident from 
the three aromatic signals at δ 7.40 (1H, d, J = 8.25 Hz), 8.14 (1H, dd, J = 2.31 and 
8.25 Hz) and 8.64 (1H, d, J = 2.31 Hz). The 13C NMR spectrum of P13 also exhibited 
only aromatic signals, with the typical C-3 signal of a flavonol at δ 137.9. In the 
spectrum (Table 38), the signals for C-2' and C-5' were coincident at δ 116.6, 
pointing to these two carbons being ortho to hydroxyl groups (Roitman and James, 
1985). These observations, in conjunction with the UV data and the proton spectrum, 
indicated that P13 was a flavonol with free 3, 5, 7, 3’, 4’-pentahydroxy groups i.e. 
quercetin (Figure 19). This was confirmed by co-TLC with authentic quercetin 
(Sigma) and by comparison of its 13C NMR spectrum with the published spectrum of 
quercetin (Markham and Ternai, 1976; Markham and Chari, 1982). 
Quercetin is a flavonoid which is widely distributed in the plant kingdom, occurring 
as the free aglycone or more commonly as glycosides (Wollenweber and Dietz, 
1981). It had previously been isolated from Piliostigma thonningii (Bomardelli et al., 
1973), a report which has now been reconfirmed in this plant P. reticulatum. 
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Fig. 19 – Structure of compound P13 
 
In conclusion the products P3, P7, P8, P9 and P13 are compounds that were very 
similar to those  already reported in literatures and can be found in the references 
(Rasamoelisendra et al., 1989; Rabesa and Voirin, 1985; Harborne et al., 1994; 
Voirin, 1983 and Bombardelli et al., 1973) respectively. The UV and IR data were in 
agreement with that of the literature, as well as the 1H NMR data for the compounds 
after critical comparison. The 13C NMR and HMBC spectra completely supported the 
structures of these C- methylflavonols in the same way it supported the new isolates. 
Thus 4 new flavonoids P1, P2, P4 and P5 have been isolated and fully characterized 
from Piliostigma reticulatum while a further 5 known flavonoids, P3, P7, P8, P9 and 
P13 were isolated and are reported for first time to be present in the extracts of this 
plant to the best of our knowledge. 
 
4.4.  BIOLOGICAL EVALUATION 
4.4.1  Brine shrimp lethality bioassay 
High doses of bioactive compounds have on occasion been found to be toxic and 
hence the pharmacology of bioactive compounds can be preliminarily tested or 
detected from their toxicology results. Thus the in vivo lethality in a simple zoologic 
organism, the brine shrimp larvae (nauplii), has been used as a convenient monitor 
for the screening of bioactive natural products   (Meyer et al., 1982).  
The brine shrimp nauplii have been used for a number of bioassay systems in which 
natural product extracts, fractions or pure compounds are tested at three 
concentrations viz., 10, 100 and 1000ppm or µg/ml in vials with ten nauplii in 
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triplicate for each concentration. The number of survivors counted after 24hours were 
used in estimating the LC50 with a 95% confidence using the Finney probit analysis 
computer programme. The brine shrimp toxicity bioassay was conducted on ten 
samples, namely, the three extracts hexane, ethyl acetate and methanol and 7 isolates 
P1, P2, P4, P5, P7, P8 and P9. The results (Table 47) showed that all the extracts and 
nearly all the isolates were active (AC) (LC50 < 1000 µg/ml), except P5 and P7 which 
were inactive (IA).  Compound P2 (LC50 = 0.43) showed the highest activity (very 
active, VA) being active at all the concentration levels tested. Since the lethality of a 
test substance to brine shrimp nauplii has been linked to the possible ability of such 
substances to kill cancer cells (antitumor activity), as well as pesticidal and 
antibacterial activities (Meyer et al., 1982). It may be deduced that all the VA and AC 
samples should be good candidates for such applications. Some of the compounds 
merely slow down the activity of the nauplii as shown in the hexane extract and P1 
(Table 48) in which such compounds are usually suspected to have an adverse effect 
on the Central Nervous System (CNS) (Meyer et al., 1982; Aderogba et al., 2006). 
 
 
 
 
 144
 
Table 47: LC50 and average dead nauplii after 24hours for P. reticulatum 
The results were classified based on the regressional finney probit analysis 
programme of the LC50 as Very active (VA), Active (AC) and Inactive (IA) at the 
three test concentrations. 
 
Test material        1000 µg/ml     100 µg/ml        10 µg/ml            LC50            Remarks  
Hex                           9                  7                        3                   33.39              AC  
EtOAc                      10                 8                        6                       *                 AC  
MeOH                      10                10                       7                    3.38               VA 
P1                             9                   7                       4                    23.15              AC 
P2                            10                10                       9                    0.44               VA  
P4                            10                 8                        6                    6.12               AC  
P5                             5                   3                       1                    989.29           IA  
P7      4                   1         0                    1756.39         IA  
P8      10                 8                        7                    2.41              VA 
P9                            10                10                       6                    6.25              AC  
* Data did not converge and therefore could not be regressed by the finnery probit analysis 
programme.  
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Table 48:  Average number of survived nauplii after 24hours for P. reticulatum 
 
                  Vial at          % at          vial at       % at         vial at      % at        vial for 
Test mat     1000µg/ml1000µg/ml 100µg/ml 100µg/ml 10µg/ml 10 µg/ml  control expt %                  
 
Hex               0.67          6.67            3.33          33.33        7.0        70.0           100       
EtOAc           0.33          3.33            2.33          23.33        3.67      36.67         100       
MeOH            0               0                0.33         3.33          2.67      26.67         100  
P1                  0.67        6.67            3.33          33.33         6.0        60.0           100    
P2                  0               0                 0              0              1.33      13.33          100                                                                   
P4                  0               0               1.67           16.67        4.33      43.33         100           
P5                  5             50.0             7               70.0          8.67      86.67         100           
P7                 6.0           60.0             8.67          86.67        10.0       100           100 
P8                 0.33         3.33             1.67          16.67        3.33      33.33         100 
P9                  0              0                 0.33          3.33          4.0         40.0          100            
Hex: hexane extract, EtOAc: ethyl acetate extract, MeOH: methanol extract. 
 
 
4.4.2 Antimicrobial screening 
 Antimicrobial analysis was carried out by using microdilution titre techniques as 
shown in section 3.10.3.2 (Drummond and Waigh, 2000; Rahman and Gray, 2005) in 
which 96 well plates were used for the analysis with two Gram-positive bacteria 
(Staphylococcus aureus NCTC 6571 and Bacillus subtilis NCTC 8236) and two 
Gram-negative bacteria (Escherchia coli NCTC 10418 and Proteus vulgaris NCTC 
4175). The two fungi used as microorganism for this analysis were Aspergillus niger 
ATCC 10578 and Candida albicans ATCC 10231. 
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MIC were calculated using the excel spread sheet. The results of the antimicrobial 
activities were considered for compounds P1 – P9 and the 3 extracts as shown in 
Table 49. Generally all the extracts and isolates showed some level of activity except 
compounds P5 and P7. It was also evident from the table that the trend observed 
resemble that reported for the cytotoxicity tests, where Piliostigmol P2 showed the 
highest activity against E. coli (MIC = 2.57 µg/ml ; 0.006 µmol)  which interestingly 
enough 3 times more active than Amoxicillin whereas P5 and P7 showed the least 
activity in which no activity was observed for P7 against Gram negative bacteria and 
the fungus A. niger.  
 In molar concentration, the order of activity against the Gram-positive bacteria, S. 
aureus was P2 > P4 > P8 >P 9 >P1 >P5 >P7 while B. subtilis gave the order P4 > P8 
>P 1 >P5 which followed the same trend except that no activity was observed for P7 
in this case. The sequence of relative potencies against the Gram-negative E. coli 
was: P2 > P1 > P9 > P4 > P8> P5 > P7 and that for P.vulgaris was: P2 > P8 > P4 > 
P9 > P1> P5 > P7. The activity order against the fungi C. albicans was:  P2> P9 > 
P4 > P1 > P8 > P5 > P7 while that for A. niger was:  P1 > P9 > P2 > P4> P8 > P7. 
Generally, flavonoids and oxychromones are known to exhibit a wide range of 
activities including anti-inflammatory, antithrombotic, antiviral and hepatoprotection 
which may, in some measure, we and others believe to be due to their ability to 
scavenge free-radicals (Aderogba et al., 2006; Akdemir et al., 2001; Saija et al., 
1995). Indeed some specific flavonoids were reported to be potent inhibitors of 
indole-3-acetic acid oxidase activity (Ferrer et al., 1992) while a selection of 
quercetins have also been reported to have strong lipid peroxidation inhibitory effects 
and cytotoxicity (Cos et al., 2001) when tested against oral microorganisms.  
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Thus, the present findings on the antimicrobial activities of the C-methylflavonols 
and oxychromonol isolated from P. reticulatum (Babajide et. al., 2008; Ibewuike et 
al., 1997) have further strengthened the previous and present findings about the 
effectiveness of certain flavonoids and isoflavanoids as vectors against microbial 
infections and thus makes a degree of sense regarding the folk medicinal uses of this 
plant for the treatment of viral infections, oral sores and inflammations (Iinuma et al., 
1994; Kirtikar et al., 1993; Yusuf et al., 1994; Liu et al., 1990;   Babajide, 2008; Shai 
et al., 2008; Mukhlesur et al., 2007; Ibewuike et al., 1997). 
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Table 49: Minimum inhibitory concentrations (MIC) of the constituents of Piliostigma reticulatum 
 
Compounds            S. aureus                 B. subtilis                 E. coli              P. vulgaris                A.  niger              C.  albicans 
                        µg/ml         µmol        µg/ml       µmol      µg/ml     µmol      µg/ml     µmol       µg/ml     µmol       µg/ml        µmol 
 
Hex                06.50          0.018       12.50        0.032     25.00     0.083     10.50     0.031       25.00     0.081        12.50       0.027 
EtOAc           12.50           0.035       25.00        0.102    50.00      0.203     12.50     0.051       25.00     0.102        50.00      0.203 
MeOH            12.50           0.025       20.00        0.067    25.00      0.074     12.50     0.035       25.00     0.072        10.50      0.038 
P1                  10.50           0.037       20.00        0.058    12.50      0.033     20.00     0.076       12.50     0.028        25.00      0.102 
P2                  03.25           0.008        NoT         NoT       02.57      0.006     06.50     0.018       20.00     0.063        10.50      0.033 
P4                   06.50           0.015       10.50        0.034    25.00      0.075     12.50     0.038       25.00     0.075        20.00      0.058 
P5                   50.00           0.156       25.00        0.075    200.0      0.443     100.0     0.321        NoT       NoT         200.0      0.413 
P7                   300.0           0.479           -               -           -              -             -            -               -            -              300.0      0.483 
P8                   10.50           0.034       12.50        0.037    25.00      0.076     12.50     0.033       25.00     0.088         50.00      0.161 
P9                   12.50           0.036        NoT         NoT      12.50      0.035      25.00     0.072       20.00     0.061         12.50      0.037 
Am                  03.25          0.008        06.50         0.018   10.50      0.032      06.50    0.016          –            –                –              – 
Flu                      –                 –              –                –         –              –              –         –               –            –              20.00      0.062 
 
Hex: hexane extract , EtOAc: ethyl acetate extract, MeOH: methanol extract  
P1 – P9 are the isolated compounds 1 – 9  
Am: Amoxicillin standard, Flu: Fluconazole,  NoT: Not Tested 
 
Test Organisms are:- 
Gram-positive  bacteria:  Staphylococcus aureus (S. aureus) and  Bacillus subtilis (B. subtilis)    
Gram-negative bacteria: Escherichia coli (E. coli) and Proteus vulgaris (P. vulgaris)      
Fungi :  Aspergillus niger (A. niger) and Candida  albicans (C. albicans) 
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4.5 CHEMICAL EVALUATION 
4.5.1  The antioxidant assay 
Total antioxidant evaluation was carried out on the P. reticulatum extracts and 
isolates by first evaluating the antioxidant content present in the extracts i.e 
(polyphenols, flavonols, flavanols, anthocyanins and flavanones). This was 
followed by evaluating antioxidant capacity in terms of ORAC (Oxygen radical 
absorption capacity), FRAP (Ferric reducing antioxidant power) and TEAC 
(Trolox equivalent antioxidant capacity)  
 
4.5.2 Polyphenolic content of P. reticulatum 
The presence and amount of polyphenols in the extracts was determined by using 
gallic acid as a standard because polyphenols are generally a diverse class of 
compounds produced by plants that are characterized by the presence of more 
than one phenol ring in which gallic acid is known to be one of them. The class is 
subdivided into acetophenones, benzofurans, chromones, coumarins, flavonoids, 
phenolic acids, phenylacetic acids, phenylpropanoids, quinones, stilbenes and 
xanthones. Polyphenols found in vegetables, fruits, and teas are known to prevent 
degenerative diseases including cancers through antioxidative action and the 
modulation of several protein functions. The number of natural polyphenols has 
been estimated to number over one million; because they generally occur as 
glycosides which show great variety. However, the bioactivity is attributed mainly 
to the aglycon moieties and not the sugar moieties. The antioxidative potency is 
mainly ascribed to the catechin molecule of the aglycons and these can be 
classified into polycyclic types such as flavonoids, anthraquinones and others 
simple polyphenols. The amount of polyphenols present was evaluated as shown 
in 3.11.2 using the Folin Ciocalteu reagent with gallic acid as the standard. The 
results illustrated that the quantity of polyphenols present in the extracts varied as 
shown in Figure 20A in which there is appreciable amount of polyphenols in all 
the three extracts with the highest value recorded for ethyl acetate while the 
lowest was recorded for hexane extract. This means the ethyl acetate and 
methanol extracts are better sources of polyphenolics antioxidant. 
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Figure 20A – Bar chart illustrating and comparing the amount of polyphenols and 
flavonols present in the various extracts of P. reticulatum.  
 
4.5.3 Flavonoid content 
A similar trend for the distribution of flavonoids consisting of flavonols, flavanols 
and flavanones was observed. Flavonoids are found in most dietary intakes 
because of their potential beneficial cardiovascular effects and also for their 
prophylactic effects against hypertension. A wide variety of dietary flavonoid 
sources includes apples, cranberries, purple grapes, red wine, teas, cocoas and 
chocolates. Evaluation of flavonol content was made using quercetin as the 
standard as shown in 3.11.3 while flavanols make use of catechin as listed in 
3.11.4 and flavanone makes use of Naringenin as standard (3.11.6). 
The results are illustrated in Figures 20A, 20B and 20C Graphs where it was 
evident that there was the presence of flavonols and some flavanol but that 
flavanones were found in either trace amounts or not at all when compared with 
the standard. This finding confirmed the present project viz., that no flavanone 
was detected nor isolated from the plant extracts.  
Amount present 
measured in mg/g 
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Figure 20B – Bar chart showing the amount of flavanols present in the various 
extracts of P. reticulatum.  
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Figure 20C – Bar chart illustrating and comparing the amount of flavanones and 
the Trolox equivalent antioxidant capacity present in the various extracts of P. 
reticulatum.  
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4.5.4  Anthocyanin content  
The anthocyanin content was evaluated by measuring the amount of pigments 
present. These pigments are known to be responsible for the attractive red to 
purple to blue colours of many fruits and vegetables. The pigments are now 
known to play an important role in the health sector because of their nutraceutical 
health benefits. They play a vital role in the reduction of coronary heart disease 
and increased visual acuity, and also have antioxidant and anticancer properties as 
explained in 1.6.4.  
The total anthocyanin content in the plant extracts were determined by measuring 
absorptivity of the solution at a wavelength between 490 to 550 nm by differential 
measurement of the absorbance at two different pH values as shown in 3.11.5. 
The result obtained is illustrated in Figure 20D in which it is evident that 
anthocyanins were absent in the plant except for the traces observed in the EtOAc 
extract. 
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Figure 20D – Bar chart showing the amount of anthocyanins present in the 
various extracts of P. reticulatum.  
 
 
4.5.5  The Oxygen radical absorbance capacity assay (ORAC) 
The ORAC is another method for quantification of the amount of antioxidant in a 
material. This fluorescence-based method utilizes the fact that the fluorescence of  
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present 
measured 
in mg/L 
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phycoerythrin (PE) changes with respect to time upon damage caused by peroxyl 
or hydroxyl radical attack (Prior et al., 1995; 2001). The ORAC method is a 
simple, sensitive, and reliable way to measure the peroxyl radical absorbing 
capacity (with AAPH) of antioxidants and has successfully been performed using 
the ORAC method with H2O2-Cu2+.  The ORAC method was performed using a 
fluorescence spectrophotometer until zero fluorescence occurs. The results are 
reported as the ORAC value, which refers to the net protection area under the 
quenching curve of β-PE (fluorescein) in the presence of an antioxidant. The 
ORAC value was calculated by dividing the area under the sample curve by the 
area under the Trolox curve with both areas being corrected by subtracting the 
area under the blank curve. One ORAC unit is assigned as being the net protection 
area provided by 1 µM Trolox in final concentration. When the area under the 
curve for the sample is compared to the area under the curve for Trolox, the result 
is given in Trolox equivalents as shown in 3.11.7.  The results showed that P. 
reticulatum has high antioxidant values and this can be attributed to the high 
flavonoid content in them as shown in Figure 20E where P2 recorded the highest 
value and  P5 and P8 having the lowest antioxidant properties. The implication is 
that in formulating a good antioxidant agent, the methanolic extract and 
Piliostigmol (P2) are good candidates to choose from. 
Piliostigma reticulatum
0
5000
10000
15000
20000
25000
30000
H
ex
Et
OA
c
M
eO
H P1 P2 P3 P4 P5 P7 P8 P9 P1
3
St
d
m
ic
ro
m
o
le
/g
ORAC
 
Extracts and isolates of P.reticulatum 
 
Figure 20E – Bar chart showing the ORAC values (The antioxidant capacity) of 
some extracts and isolates present in P. reticulatum.  
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4.5.6 The Ferric reducing antioxidant power (FRAP) assay 
The FRAP assay uses an oxidation/reduction potential to measure the ability of a 
sample to reduce FeIII to FeII. Antioxidants are known to donate electrons in the 
same manner as a reductant in an oxidation/ reduction reaction does and thus it 
may be assumed that the FRAP assay is a good method for evaluating antioxidant 
capacity. However, it does not directly measure the antioxidant capacity of a 
potential antioxidant. In addition, since there are no free radicals introduced into 
the system, there is no way of comparing the antioxidant capacity towards 
different kinds of radicals. The FRAP assay uses antioxidants as reductants in a 
redox-linked colorimetric method by employing an easily reduced oxidant present 
in stoichiometric excess. At low pH, reduction of a ferric tripyridyltriazine (FeIII-
TPTZ) complex to the ferrous form, which has an intense blue colour, was 
monitored by measuring the change in absorption at 593nm with time as 
explained in 3.11.8. The change in absorbance was directly related to the reducing 
power of the electron donating antioxidants present in the reaction mixture.   
It should be noted that the FRAP assay cannot measure the antioxidant capacity of 
certain antioxidants accurately such as ascorbic acid, which can react with FeII 
and SH group-containing antioxidants (glutathione) and also the FRAP assay does 
not take into account the quantity of inhibition and thus leaves out an important 
component of the total antioxidant capacity but it easy to generate the capacitating 
power of the antioxidant factor in the sample through FRAP than ORAC. The 
result of this investigation is as shown in Figure 20F where P5 and P8 recorded 
very low activity. The FRAP assay at a glance reconfirmed the consistency in the 
antioxidant capacity of the extracts and isolates as observed in ORAC in which 
the same high values were recorded for both the methanolic extract and P2 
whereas P5 and P8 still show the same trend of low antioxidant power.  
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Figure 20F – Bar chart showing the FRAP values (Ferric reducing antioxidant 
power) of some extracts and isolates present in P. reticulatum.  
 
 
 
4.5.7  The Abts Trolox equivalent antioxidant capacity (TEAC) assay 
The TEAC assay was carried out using the ABTS (2,2’-azino-di-3-
ethylbenzthialozine sulphonate) radical cation scavenging power which has the 
ability to determine the total antioxidant status (TAS) of a sample. The radical 
cation was monitored by measurement of its characteristic absorption maxima at 
640, 734 and 820nm. Antioxidants added to the system can either scavenge the 
ABTS•+ formed or interfere in the radical generating process. Measurement of the 
absorbance at a specific time after addition of the sample enables the calculation 
of a percentage scavenging power (3.11.9). The results as illustrated in Figure 
20C demonstrate a fair scavenging power and similar profile as observed in 
ORAC.  
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CHAPTER 5 
RESULTS AND DISCUSSION 
5.1 CISSAMPELOS CAPENSIS 
The aerial shoot (3.5kg) and roots (2.6kg) of C. capensis were used in this project. 
The extractions and isolations were specifically targeted towards the alkaloids and 
flavonoids present in the plant as shown by the preliminary phytochemical 
screening results below. The total tertiary alkaloid (TTA) was extracted from the 
aerial shoot (500g) of the plant. This afforded TTA (1.85g, 0.37%). The residual 
aqueous fraction generated a BTA (48.7g, 9.74%) after concentration as shown in 
section 3.7.1.0.  
 
5.1.2 Sequential extraction of the aerial shoot and root  
In a further isolation, 1kg of the aerial shoot was sequentially extracted with 
hexane, dichloromethane, ethyl acetate, methanol and water. This afforded the 
hexane (17.35g, 1.74%), dichloromethane (26.33g 2.63%), ethyl acetate (32.84g, 
3.28%), methanol (56.24g, 5.62%) and water extracts (25.71g, 2.57%) (3.7.2.0). 
Again, 1kg of the root powder was sequentially extracted as described above to 
afford the hexane (7.38g, 0.74%), dichloromethane (12.65g, 1.27%), ethyl acetate 
(27.19g, 2.72%), methanol (53.05g, 5.31%) and water extracts (26.44g, 2.64%) 
(3.7.3.0).  
 All the extracts were phytochemically screened for detection of secondary plant 
metabolites using the Wagner TLC method (Wagner and Bladt, 2001). The result 
in Table 50 showed clearly the distribution profile of the plant metabolite in the 
various extracts in which all the extracts showed the presence of flavonoids and 
phenolics while anthraquinones and essential oils were absent except the presence 
of essential oils in CCAH and CCAD while flavonoid being absent in TTA. 
Tannins and saponin were absent in the TTA, BTA, hexane and DCM extracts 
while the TTA, EtOAc, MeOH and water extracts showed the presence of alkaloid 
as shown in Table 50.  
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Table 50:- Phytochemical screening result of the C. capensis extracts  
 
Test 
materials  Tann Phen Glyc Sapo Flav Alka Anth Esse 
CCRH N-ve P+ve N-ve N-ve P+ve N-ve N-ve N-ve 
CCRD N-ve P+ve N-ve N-ve P+ve N-ve N-ve N-ve 
CCRE P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
CCRM P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
CCRW P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
         
CCAH N-ve P+ve N-ve N-ve P+ve N-ve N-ve P+ve 
CCAD N-ve P+ve N-ve N-ve P+ve N-ve N-ve P+ve 
CCAE P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
CCAM P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
CCAW P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
 
        
CCET P+ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
TTA N-ve P+ve N-ve N-ve N-ve P+ve N-ve N-ve 
BTA N-ve P+ve N-ve P+ve P+ve P+ve N-ve N-ve 
         
 
CCRH = C. capensis root hexane extract; CCRD = C. capensis root DCM extract; CCRE = C. 
capensis root EtOAc extract; CCRM = C. capensis root MeOH extract; CCRW = C. capensis 
root H2O extract; CCAH = C. capensis aerial shoot Hexane extract; CCAD = C. capensis aerial 
shoot DCM extract; CCAE = C. capensis aerial shoot EtOAc extract; CCAM = C. capensis aerial 
shoot MeOH extract; CCAW = C. capensis aerial shoot H2O extract                                                          
 
CCET = C. capensis aerial shoot 80% EtOH extract; TTA = C. capensis aerial shoot total tertiary 
alkaloid; BTA = C. capensis aerial shoot neutralized aqueous residual fraction 
 
Tannins (Tann), Phenolics (Phen), Glycosides (Glyc), Saponins (Sapo), Flavonoids (Flav), 
Alkaloids (Alka), Anthraquinones (Anth) and Essential oils (Esse) 
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5.1.3. Isolation of the constituents 
5.13.1 Isolation of constituents in TTA 
Column gradient chromatography (CGC) of the TTA (1.6g) gave 7 fractions 
coded A – G as shown in section 3.7.1.1 and Table 12 on page 77  with their  LC50 
value in the brine shrimp lethality assay which was used in monitoring the 
fractionation of the plant extracts. From Table 12, fraction E shows the highest 
activity VA (very active) although it is not in the highest yield as used in the case 
of P. reticulatum. Three fractions A, C and G were found to be inactive (IA) as 
shown in Table 12 in section 3.7.1.1. Based on the activity observed in fraction E, 
it was further chromatographed yielding five subfractions coded TI – TV as 
shown in Table 13. Using similar activity guided methods as described earlier, 
fractions TIII and TIV were repeatedly and separately chromatographed on PTLC 
to afford compounds C1 (0.058 g) and C2 (0.021g) as shown in sections 3.7.1.1 – 
3.7.1.4.  
 
5.1.3.2  Isolation of the major constituents in the methanol extract of the aerial 
shoot 
The CGC of the methanol extract (25.6g) gave 10 fractions coded A – J as shown 
in Table 14 on page 79. Using the observed cytotoxicity results in Table 14, 
fraction F was rechromatographed which finally yielded C3 (0.04 g), C4 (0.028 
g), C5 (0.026 g) and C6 (0.024 g) as shown in section 3.7.2.1 – 3.7.2.6.  
 
5.1.3.3  Isolation of the major constituents in the methanol extract of the root 
The methanol extract (30.0g) also yielded 5 Fractions coded K – O as shown in 
Table 16 on page 81. Based on their observed activity pattern for the cytotoxicity 
test fractions M and N were rechromatographed to afford C7 (0.078 g), C8 (0.065 
g), C9, (0.088 g) for fraction M while fraction N afforded C10 (0.068 g) and C11 
(0.0163 g) as shown in the experimental procedure in section 3.7.3.1 – 3.7.3.9.  
Critical examination and comparisons in terms of colour, texture, Rf value and 
melting points of compounds C1 – C11 resulted in the following assessment.   
C1, C4 and C7 displayed similar properties; C2 and C8 displayed similar 
properties; C6 and C9 displayed similar properties and finally C5 and C10 
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displayed similar properties. After combining these fractions it thus resulted in 6 
compounds labeled as C1, C2, C3, C5, C6 and C11.  
TLC investigations of these 6 compounds revealed C1, C2 and C3 to be alkaloids 
as demonstrated by their positive test to Dragendorff using berberine as plate 
marker while C5, C6 and C11 were flavonoids due to their positive test to vanillin 
in sulphuric acid using quercetin as a marker. 
 
5.2 PHYSICO-CHEMICAL DATA OF ISOLATED COMPOUNDS 
5.2.1 C1 (dihydromorphinandienone alkaloid)   
A reddish yellow powder with m.p 85 – 870C. 
TLC: Hex: CHCl3: MeOH (3:10:2), C1 Rf (Solvent): 0.58  
UV λmax nm (log ε): 222, 260, 304. 
 IR νmax cm-1 pronounced peaks: 3485, 2940, 1685, 1615, 1500.  
EIMS: molecular ion peak (M)+. m/z  375.0216 ( calculated mol. formula 
C20H25O6N).  
The 1H NMR and 13C NMR see Table 51 
 
5.2.2  C2 (9, 10 – dimethoxyaporphine alkaloid) 
A reddish-brown fluffy powder with m.p 221 – 2230C,   
 TLC in Hex: CHCl3: MeOH (3:10:2), C2 Rf (Solvent): 0.67  
UV λmax nm (log ε): 225, 243, 277, 300 (shoulder). 
IR νmax cm-1 pronounced peaks: 3420, 3050, 2925, 1636, 1458, 1387, 1060. 
EIMS: molecular ion peak (M)+. m/z 341.0112. ( calculated mol. formula 
C19H19O5N). 
The 1H NMR and 13C NMR  see Table 52 
 
5.2.3  C3 (8, 14-dihydromorphinandienone alkaloid) 
A golden brown powder with m.p 77 – 80 °C.  
TLC: Hex: CHCl3: MeOH (3:10:2), C3 Rf (Solvent): 0.42  
UV λmax nm (log ε): 226, 261,302 
IR (ν cm-1) pronounced peaks: 3517, 2952, 1685, 1616, and 1510. 
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EIMS: the molecular ion base peak (M)+ m/z  329.2133  ( calculated frag. gave 
C19H23O4N).  
The 1H NMR and 13C NMR see Table 53 
 
5.2.4  C5 (6 -C-methylquercetin 3, 3',7, 8 -tetramethyl ether) 
A Yellow amorphous powder with m.p. 234 – 236°C.     
Rf (Solvent): 0.28 (A), 0.60 (B) 
UV λmax nm (log ε): 255 (4.64), 357 (4.62); +NaOAc: 271, 365; +NaOH: 276, 
343, 410. +AlCl3: 279, 440.  
IR (ν cm-1) pronounced peaks: 3401, 2932, 1653, 1612, 1556     
EIMS: molecular ion peak (M)+. m/z  388.0103. ( calculated mol. formula 
C20H20O8 ).  
1H NMR: δ 2.14 (3H, s, Me-6), 3.74 (3H, s, OMe-3), 3.96 (3H, s, OMe-3'), 4.01 
(3H, s, OMe-7); 4.56 (3H, s, OMe-8), 6.91 (1H, d, J= 8.5 Hz, H-5'), 7.60 (1H, dd, 
J = 2.3, 8.4 Hz, H-6'), 7.70 (1H, d, J= 2.3 Hz, H-2'), 10.90 (1H, s, 4'-OH), 12.92 
(1H, s, 5-OH).  13C NMR: see Table 54 
 
5.2.5  C6 (methylenedioxyisoflavanone)   
A yellow waxy powder with m.p. 185 – 1870C 
TLC Hex : EtOAc
 
: MeOH (2:7:1) C6  Rf (Solvent) 0.48  
UV λmax nm (log ε): 214(4.10), 218 (4.12), 288 (4.00), 333 (sh) (3.25).  
IR νmax cm−1 pronounced peaks at :  3421, 2914, 1634, 1472, 1386, 1358, 1257, 
1224, 1161, 1100, 1068, 925;   
EIMS :  molecular ion peak (M)+.  m/z 378.0625 (calcd for C18H18O9, 378.0623).  
1H NMR, 13C NMR and HMBC are as shown in Tables 55 and 56 respectively.  
 
5.2.6  C11 (6-C-methylquercetin 3-methyl ether)  
A creamy yellow powder with m.p. 217 – 219 °C.   
 Rf (Solvent): 0.63 (A), 0.40 (B) 
UV λmax nm (log ε): 260 (4.62), 351 (4.60); +NaOAc: 260, 355; +NaOH: 270, 
405; +A1C13: 277, 435.  
IR (ν cm-1) pronounced peaks: 3500 – 3400, 1652, 1613, 1568, 1556     
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EIMS: molecular ion peak (M)+. m/z  346.0752. ( calculated mol. formula 
C17H14O8 ).  
1H NMR: δ 2.11 (3H, s, Me-6),  3.87 (3H, s, OMe-3),  7.03 (1H, d, J=8.6Hz, H-
5'), 7.62 (1H, dd, J= 2.3, 8.6 Hz, H-6'), 7.75 (1H, d, J= 2.3Hz, H-2'), 10.23 (1H, s, 
4'-OH), 11.15 (1H, s, 3’-OH).12.05 (1H, s, 8-OH), 12.90 (1H, s, 7-OH), 13.05 
(1H, s, 5-OH).  
13C NMR: see Table 57. 
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5.3 STRUCTURAL ELUCIDATION OF COMPOUNDS C1 – C11 
5.3.1  C1 (dihydromorphinandienone alkaloid)  
Compound C1, a combination of C1, C4 and C7, is a reddish yellow powder with 
average melting point of 860C. The UV spectrum has a λmax values at 222 nm 
which is known to be associated with an α,β -unsaturated carbonyl chromophore 
(Stuart, K.L., 1971) and that at 260 nm should be for a typical aromatic ring 
system. The shoulder observed at 304 nm is a general characteristic of 8,14-
dihydromorphinandienone alkaloids (Freitas et al., 1995).  The IR spectrum 
showed pronounced bands at 3485 cm-1 (hydroxyl group), 2940 (C-H of an 
olefinic group), 1685 cm-1 (α, β -unsaturated carbonyl), 1615 cm-1 (C=C olefinic) 
and 1500 cm-1 (C=C aromatic). The El mass spectrum indicated the molecular 
formula to be C20H25NO6. From the base peak of M+ [375], the following 
fragments were observed:  360 [M- CH3] +, 332 [360 - CO] +, 238 [M – C8H902] + 
and 42 [H2C=C=O] + , being characteristic of the morphinandienone alkaloids 
(Wheeler et. al 1967). The complete analysis of 1H NMR, 13C NMR, HMBC, 
COSY and NOESY were used in assigning the structure of C1. The 1H NMR (400 
MHz, pyridine- d5) showed only one aromatic signal at δ6.91 which implies that 
the aromatic ring is penta-substituted. The four singlets which integrated for three 
protons each were observed at δ 2.26 for (N-Me), with the other three at δ3.69 for 
MeO-6, 3.76 for MeO-3 and 3.83 for MeO-1. The two single proton signals at 
10.75 and 11.50 were attributable to HO-4 and HO-5 respectively. 
The 13CNMR (100MHz, pyridine-d5) similarly showed a signal at δ194.7 (s, C-7) 
for the α,β-unsaturated carbonyl, δ43.1 (s, N-Me), δ55.3 (s, C-6-OMe), δ56.5 (s, 
C-3-OMe) and δ57.2 (s, C-1-OMe). The complete assignments of all the protons 
and carbons are given in Table 51. This was compared with literature and found to 
be correct (Blasko and Cordell 1988, and Vecchietti et al., 1981). The 
spectroscopic analysis above confirmed compound C1 to be 5,6-dehydro-4,5-
dihydroxy-1,3,6-trimethoxy- 17-methylmorphinan-7-one (Figure 21). 
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Fig. 21-Structure of compound C1 
(C1) 5, 6-dehydro-4,5-dihydroxy-1,3,6-trimethoxy- 17-methylmorphinan-7-
one. 
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Table 51: 1H NMR (400 MHz) data of C1 and 13C NMR (100 MHz) data of 
C1 in C5D5N 
 
               C                    1H                                                                                 
1             146.4               --                                                
2             111.2            6.91 s (1H)                                       
3             148.3                 -- 
4             145.6                 -- 
5             125.3                 --                                                                         
6             152.2                 -- 
7             194.7                 -- 
8              40.3        ax 3.63 dd (J = 14.2, 17.4 Hz)                     
                               eq. 2.64 dd (J = 17.4, 4.6 Hz) 
9              56.9         2.83 br d (J = 5.6 Hz)                                   
10            28.5         ax 3.12 d (J = 17.0 Hz)                              
                                eq 2.74 dd (J = 17.0, 5.6 Hz) 
11            131.2             -- 
12            128.7             -- 
13            38.5               -- 
14            42.7           2.40 m 
15            32.3           2.21 - 2.11 m (2H)                                               
16            46.5           2.40 m (1H)/2.30 m (1H)                                        
MeO-1    57.2           3.83 s (3H) 
MeO-3    56.5           3.76 s (3H)                                                                    
MeO-6    55.3           3.69 s (3H)                                                                     
Me-N      43.1           2.26 s (3H)                                                                       
HO-4        --             10.75 br s (1H) 
HO-5        --             11.50 br s (1H) 
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5.3.2 C2  (methoxyaporphine alkaloid) 
The TTA (C2) and (C8) of the methanolic extract of the root of C. capensis 
generated a compound represented by C2, a reddish-brown fluffy powder with 
average mp of 2220C. Its UV spectrum showed absorptions at 225, 243, 277 and 
300 (shoulder) nm which are characteristic of 1, 2, 3-trisubstituted aporphinoid 
systems (Guinaudeau et al., 1979 and Guinaudeau and Bruneton, 1993). The IR 
spectrum showed bands at 3420, 3050, 2925, 1636, 1458, 1387 and 1060 cm-1 
confirming the aporphinic skeleton of C2. The [EIMS] showed an [M]+  at 
(341.0112) which suggested the molecular formula of C19H19O5N.  An intense 
analysis of the 1HNMR, 13CNMR, HMBC, COSY and NOESY spectra were used 
in assigning the structure. The 1H NMR (400 MHz, C5D5N) spectrum showed an 
AB set of doublets at δ5.94 and 6.13 (J = 1.2 Hz), characteristic of a 
methylenedioxy group at positions C-1 and C-2 in aporphines (Guinaudeau and 
Bruneton, 1993). The presence of an ABCD tetra substituted ring system with 
signals at δ 7.31 (br s) and 8.32 (br s) is a strong indication that ring D is 
disubstituted. The 13C NMR (100 MHz, C5D5N) spectrum showed a signal at 
δ101.3 (s, C-1, 2 methylenedioxy). In the 1H - 1H NOESY spectrum one of the 
methylenedioxy protons (δ 6.13) showed a correlation with H-11 (δ8.32) while H-
8 (δ7.31) correlated with the H-7 methylene protons at (δ2.95-3.10). Complete 
assignments of all protons and carbon atoms are listed in Table 52. The 
spectroscopic analysis above established the structure of C2 as 1, 2-
methylenedioxy-3- hydroxy -9, 10-dimethoxyaporphine (Figure 22) 
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Fig. 22 – Structure of compound C2 
1,2-methylenedioxy-3- hydroxy -9,10-dimethoxyaporphine  
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Table 52: 1H NMR (400 MHz) data of C2 and 13C NMR (100 MHz) data of 
C2 in C5D5N 
C                    δ  13C                     1H                                                                                 
1                    144.8                        -                                                                                  
2                    134.3                        -                                                                                    
3                    140.2                       -    
3a                  118.0                       -                                                                                  
4                    25.3                      2.92-3.12  2H m                                                                                   
5                    44.1                      2.92-3.12  1Hm,  3.45  1H m                                                                                
6a                   54.7                     4.06 1H dd, (J = 5.2, 12.4 Hz)                                               
7                     37.1                     2.95-3.10  2H m                           
7a                   135.6                     -            
8                     128.9                   7.31 1H (br s)                                 
9                     160.2                     -                                                                                   
10                   161.9                     -                                                 
11                   127.1                    8.32  1H (br s)                                           
11a                 133..7                    -                                                  
11b                 107.1                     -                                                   
11c                 130.2                     -                                                                                     
                                                                                  
O-CH2-O       101.3                    5.94, 6.13 2H A-B qJ = 1.2 Hz                                    
MeO-9           56.5                      3.76 s (3H)                                                                    
MeO-10         55.3                      3.69 s (3H)                                                                                                                                       
HO-3               -                         10.75 br s (1H) 
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5.3.3 C3  (8, 14-dihydromorphinandienone alkaloid)  
Compound C3, a golden brown powder with m.p.77 – 80 °C was isolated from 
the methanolic extracts of the aerial shoot of C. capensis which showed a single 
spot at Rf : 0.42  in Hex: CHCl3: MeOH (3:10:2). This spot showed a 
characteristic orange colour of an alkaloid that is closely similar to the berberine 
standard TLC plate marker used when sprayed with dragendorff. The IR spectrum 
showed pronounced bands at 3517 cm-1 due to the presence of hydroxyl groups 
while that at 2952 cm-1 was assigned to C-H of an olefinic system. The band at 
1685 cm-1 is characteristic of an α,β-unsaturated carbonyl system as observed in 
C1, the band at1616 cm-1 is due to the C=C  while that at 1510 cm-1 is due to the 
C=C of an aromatic ring. Its UV spectrum showed absorptions at 226 nm which is 
known to be characteristic of an α,β-unsaturated carbonyl chromophore and at 261 
nm  due to an aromatic ring while the band at 302 nm is characteristic of the 8,14-
dihydromorphinandienone alkaloids as was noticed  in C1 (Stuart, K.L., 1971). 
The El mass spectrum of 329.2133 provided the molecular formula as C19H23O4N 
in which the following fragments were observed:- (1) 314 [M- CH3]+, (2) 286 
[314 – CO]+, (3) 192 [M – C8H9O2]+ and (4) 42 [H2C=C=O]+ confirming the 
characteristics of a morphinandienone alkaloid as observed in C1 (Wheeler et. al 
1967). The 1H NMR spectrum showed an AB doublet of doublets at δ 6.90 and 
6.78 (J = 8.4 Hz)  while the three 3-proton singlets  at δ 2.28 for N-Me, δ 3.62 for 
MeO-6 and δ 3.74 for MeO-3 were assigned as indicated. The singlet at δ 10.72 
was attributable to HO-4. The 13C NMR spectrum showed 19 carbon signals 
which supported the calculated molecular formula of C19H23O4N. The carbons 
were assigned as shown in Table 53 where δ 43.3 is for N-Me, δ 55.2 for C-6-
OMe, δ 56.6 for C-3-OMe and δ 194.5 for the C-7-C=O. Complete assignments of 
all the protons and carbons are given in Table 53.  
The structure of compound C3 was therefore established to be 5, 6-didehydro-4-
hydroxy-3, 6-dimethoxy-17-methylmorphinan-7-one (8, 14 
dihydromorhinandienone alkaloid) as shown in Figure 23. Literature shows that 
C3 has previously been isolated from Croton species (Vecchietti et al., 1981) and 
some Cissampelos such as C. sympodialis (Freitas et al., 1995) and C. pareira 
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(Amresh et al., 2007). This is however the first time the alkaloid has been reported 
to be found in C. capensis to the best of our knowledge.  
 
Table 53: 1H NMR (400 MHz) data of C3 and 13C NMR (100 MHz) data of 
C3 in C5D5N 
               C                    1H                                         NOESY                   HMBC                                
1             119.2          6.78 br d (J = 8.4 Hz)                                    C10, C12, C3            
2             112.0          6.90 d (J = 8.4 Hz)                       C1              C11, C4                                    
3             147.2                 --                                                         
4             145.6                 --                                           
5             125.3           8.30 s                                          C6               C14, C12, C7                                  
6             152.2                 -- 
7             194.5                 -- 
8              40.5        ax 3.64 dd (J = 14.0, 17.6 Hz)         C14, C7               C13                 
                               eq. 2.60 dd (J = 17.6, 4.4 Hz) 
9              57.4         2.80 br d (J = 5.8 Hz)                     C10, C14         C13, C14, 
C16, C11                      
10            28.4         ax 3.12 d (J = 17.2 Hz)                  C9, C11            C14, C1, 
C12             
                                eq 2.75 dd (J = 17.2, 5.8 Hz) 
11            132.2             -- 
12            128.2             -- 
13            38.5               -- 
14            42.0           2.40 m 
15            33.2           2.22 - 2.12 m (2H)                            C16               C12                           
16            47.6           2.42 m (1H)/2.30 m (1H)                   C15               C13, C9                               
MeO-3    56.6           3.74 s (3H)                                                               C3                           
MeO-6    55.2           3.62 s (3H)                                                                C6     
Me-N      43.3           2.28 s (3H)                                                                 C16, C9      
HO-4                        10.72 br s (1H) 
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Figure 23 – Structure of compound C3 
5, 6-didehydro-4-hydroxy-3, 6-dimethoxy-17-methylmorphinan-7-one 
 
5.3.4 C5 (6 -C-methylquercetin 3, 3', 7, 8 -tetramethyl ether)  
Compound C5, representing the combination of C5 and C10, is a yellow 
amorphous powder with an average m.p of 2350C. It had a molecular ion base 
peak (M)+. at m/z 388.0103 leading to a molecular formula of C20H2008. The IR 
spectrum showed pronounced bands at 3401 cm-1 (hydroxyl group), 2932 cm-1 
(C-H olefinic), 1653 cm-1 (carbonyl group), 1612 cm-1 (C=C olefinic) and 1556 
cm-1 (C=C aromatic). The UV spectrum showed two peak maxima at 357 and 255 
nm respectively. The band at 271 nm showed a large bathochromic shift in the 
presence of sodium acetate, and an additional band appeared at 343 nm in the 
methanol / NaOH spectrum which suggested a flavonol with a 7-OMe group. The 
1H NMR spectrum showed an aryl methyl singlet at δ 2.14 and four distinct 
methoxyl  singlet peaks at δ 3.74 ( OMe-3), 3.96 (OMe-3'), 4.01 (OMe-7) and 
4.56 (OMe-8). The spectrum further showed the presence of only three 1-proton 
aromatic signals at δ 6.91 (d, J = 2.3 Hz), 7.60 ( dd, J = 8.5 and 2.3 Hz) and 7.70 
(d, J = 8.5 Hz) suggesting a 3',4'-disubstituted aromatic ring C, and a fully 
substituted aromatic ring A. The characteristically chelated 5-OH group was 
observed at δ 12.92 while that of 4’-OH was observed δ 10.90. By carefull 
comparison of the 13C NMR data of C5 with existing literature (Roitman and 
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James, 1985 and Breitmeier and Voelter, 1990), the 4'-substituent was assigned to 
a hydroxyl group while that at the 3' position was assigned as a methoxyl group. 
Corroboration of this was evident from chemical shifts of the substituted carbons, 
viz., C-3' at δ 147.2 and C-4' at 148.5. The other methoxyl groups were attached at 
C-3 (δ 137.5), C-7 (δ 145.4) and to C-8 (δ at 149.5 ppm  which was in agreement 
with the HMBC correlations OMe-3/C-3 and OMe-7/C-7 and OMe-8/C-8.  
 
TABLE 54: NMR spectroscopic data for compound C5  
13C 
Signal 
(δ) 
DEPT 1H – 13C COSY HMBC 13C Assignment 
155.5 
137.5 
178.8 
156.3 
106.6 
145.4 
149.5 
151.4 
103.9 
121.6 
115.3 
147.2 
148.5 
115.8 
120.6 
 
59.5 
60.2 
63.5 
56.5 
8.1 
C 
C 
C 
C 
C 
C 
C 
C 
C 
C 
CH 
C 
C 
CH 
CH 
 
CH3 
CH3 
CH3 
CH3 
CH3 
 
 
 
 
 
 
 
 
 
 
7.70d (J = 2.3 Hz) 
 
 
6.91d (J = 8.5 Hz) 
7.60dd (J = 2.3 and 
8.4 Hz) 
3.74 s 
4.01 s 
4.56 s 
3.96 s 
2.14 s 
H-2', H-6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
7-OMe 
 C-7, C-9, C-10 
8-OMe 
5-OH 
H- 5' 
H-6' 
3'-OMe, H-5' 
H-5', H-6' 
 
H-2'  
 
C-5, C-6 
 C-7  
C-8 
C-3'  
 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1' 
2' 
3'  
4' 
5' 
6' 
 
3-OMe 
7-OMe 
8-OMe 
3'-OMe 
6-Me 
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The only methyl group present was assigned as being attached to C-6 at 106.6 
ppm as demonstrated by the HMBC cross peaks OH-5/C-5, C-6, C-10; Me-6/C-5, 
C-6, C-7. Other carbon peaks were equally assigned as shown in Table 54.  Based 
on the above information the structure of  C5 was suggested to be 3,7,8 3'-
tetramethoxy- 6 - C-methyl- 5,4'-dihydroxyflavone (6 -C-methylquercetin 3, 3',7, 
8 -tetramethyl ether)  as shown in Fig. 24.  
O
O
CH3
OH
OCH3
OH
OCH3
H3CO
OCH3
 
Figure 24 - Structure of compound C5 
3,7,8 3'-tetramethoxy- 6 - C-methyl- 5,4'-dihydroxyflavone (6 –C 
methylquercetin 3, 3',7, 8 -tetramethyl ether)   
 
5.3.5  C6 ( Isoflavanone)  
Compound C6 obtained from the methanolic extract of the aerial shoot and the 
methanolic extract of the root (C9) were combined to provide C6, a yellow waxy 
powder with m.p.185 – 1870C as a single spot with Rf of 0.48  in Hex : EtOAc : 
MeOH (2:7:1). The molecular formula of C6 was assigned as C18H18O9 based on 
the molecular ion peak obtained at m/z 378.0625 and the fragmentation pattern in 
the EIMS. An exhaustive comparative study of the data obtained, revealed the 
general features of an isoflavanone nucleus (Mabry et al., 1970; Markham and 
Chari, 1982 and Rahman et al., 2007). The UV absorption spectrum with maxima 
at 333 and 288 nm suggested an isoflavonoid.  The IR spectrum had a strong 
absorbance at 3421 cm−1 due to an O-H group present, 2914 cm−1 for the C=C-H 
group, and 1634 cm−1 for the C=O system. The 1H NMR spectrum  showed an 
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ABC pattern of 1-proton singlets viz., δ 4.69 (t, J = 11.0 Hz), δ 4.50 (dd, J = 10.5, 
5.6 Hz) and δ 4.43 (dd, J = 11.0, 5.6 Hz) in which the H-2 and H-3 protons were 
similar to that observed in Markham and Chari’s work in 1982 showing  an 
isoflavanone system. The 1H NMR spectrum as shown inTable 55 also exhibited 
three H-bonded groups viz., C-5 hydroxyl at δ 12.89, C-7 hydoxyl at 12.98 and C-
8 hydroxyl at δ 13.02. Two 1-proton singlets at δ 6.52 and δ 6.80 were assigned to 
H-6 of ring A and H-6′ of ring C of the isoflavanone. The presence of 2 methoxyl 
groups as well as a methylenedioxy group were apparent from their signals at δ 
3.96 (2’-OMe), 3.87 (5’-OMe) and δ 5.90 (–OCH2O–) respectively. The 13C NMR 
spectrum in Table 55 demonstrated that compound C6 contained a total of 18 
carbons including a carbonyl group as indicated by the IR absorption peak at 1634 
cm−1  and the EIMS for C=O+ fragment. The assignment of all carbons and the 
placement of the 2 methoxyl and a methylenedioxy group within the molecule 
were achieved by 2D analysis which was further confirmed by the HMBC. In 
Table 56 the HMBC for the C-5 hydroxyl group showed correlation to a methine 
at δ 97.7 and a quaternary carbon at δ 103.3 which were assigned for C-6 and C-
4a respectively. The signals at δ 168.6 was assigned to C-7, δ 164.7 to C-9  and 
that at δ 169.3 to C-8 as derived from its correlation with H-6 and its direct 
correlation from an HMQC data. Correlation of the methoxyl protons with the 
carbons at δ 142.5 and 145.6 in the HMBC data proved the presence of C-2′ and 
C-5′ methoxy groups in these positions. The methylenedioxy group exhibited 3J 
correlation with δ
 
values at 137.8 and 149.8 while the 3J correlation of H-6′ was 
also to δ 149.8 thereby placing the methylenedioxy between C-3′ and C-4′. The 
assignment of C-6′ at δ 125.1 was also confirmed by the direct coupling observed 
in the HMQC in which It was seen that in ring C a 3J for H-6′ to the methine 
carbon at δ 48.5 proved the latter’s identity as C-3. Furthermore, C-2 was 
assigned to the peak at δ 71.1 as it showed a 2J correlation to H-3 in the HMBC 
and HMQC spectra with direct coupling with H-2 in HMQC. The COSY 
spectrum   showed correlation between H-3 to the two non-equivalent protons at 
C-2. The large diaxial coupling (J = 11.0 Hz) observed between H-3 and H-2 
placed the aryl substituent at C-3 to be pseudo-equatorial Based on the above 
information the structure of compound C6 was therefore suggested to be 5, 7, 8 -
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trihydroxy-2′, 5′-dimethoxy-3′,4′- methylenedioxyisoflavanone (Figure 25) and 
appears to be a new compound since we have not been able to identify it from the 
literature. 
 
Table 55: 1H NMR (400 MHz) data of C6 and 13C NMR (100 MHz) data of C6 in 
C5D5N 
Position  
 
   
1H 13C  
2 4.69, t, J = 11.0 Hz 71.1 
 4.50, dd, J = 10.5, 5.6 Hz    - 
3 4.43, dd, J = 11.0, 5.6 Hz 48.5 
4 – 197.6 
5 – 166.0 
6 6.52, s 97.7 
7 – 168.6 
8 – 169.3 
8a – 164.7 
4a – 103.3 
1′ – 121.4 
2′ – 142.5 
3′ – 137.8 
4′ – 149.8 
5′ –  145.6 
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Position  
 
   
1H 13C  
6′ 6.80, s 125.1 
5-OH 12.89, br. s – 
7-OH 12.98, br. s – 
8-OH 13.02, br. s – 
2′-OMe 3.96, s 59.6 
5′-OMe 3.87, s 60.2 
–OCH2O– 5.90, s 102.0 
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Table 56: HMBC data (400 MHz, C5D5N) of C6  
Protons  
 
C6 (1H - 13C)  
 
 J2 J3 
H-2 C-3 C-9, C-4, C-1′ 
H-3 C-2, C-4, C-1′ C-2′, C-6′ 
H-6 C-5, C-7 C-10, C-8 
H-6′ C-5′ C-3, C-2′, C-4′ 
HO-5 C-5 C-6, C-10 
HO-7 C-7 C-6, C-8 
HO-8 C-8 C-7, C-9 
MeO-2′ – C-2′ 
MeO-5′ – C-5′ 
–OCH2O– – C-3′, C-4′ 
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Fig 25- 5, 7, 8- trihydroxy-2′5′-methoxy-3′, 4′- methylenedioxyisoflavanone 
(C6) 
5.3.6  C11 ( 6-C-methylquercetin 3-methyl ether)  
Solvent A:  toluene – ethyl acetate (19: 1); 
Solvent B: toluene – ethyl acetate – methanol (10: 7: 3) 
Compound C11, a creamy yellow powder with m.p 217-219 °C was isolated from 
the methanolic extracts of the root which showed a single spot at Rf : 0.63 and 
0.40 when ran in solvent system A and B respectively. These spots showed an 
intense yellow colour that is closely similar to that of pure Quercetin (Sigma) 
standard TLC plate marker used when sprayed with 1% vanillin–H2SO4 followed 
by heating at 110 0C for 4min.  
The molecular formula of   C11 was assigned as C17H1408 on the basis of the 
molecular ion peak at m/z 346.0752.  The UV spectrum with maxima at 351 and 
260 nm suggested a flavonol with a 7-OH group. A deep broad band observed in 
the IR spectrum at 3500 – 3400 cm-1 is indicative of the presence of a hydrogen-
bonded hydroxyl groups.  The 1H NMR spectrum exhibited two 3-proton singlets  
assignable to one aryl methyl group at δ 2.11 (Me-6) very similar to that of C5 
and one methoxyl group at δ 3.87  due to ( OMe-3). The aromatic region showed  
three 1-proton signals typical of a 3',4'-disubstituted ring C similar to that 
observed for C5 viz.,  δ 7.03 (d, J = 2.3 Hz), δ 7.62 (dd, J = 8.6 and 2.3 Hz) and δ 
7.75 (d, J = 2.3 Hz). A broad clustered of 1-proton siglets at δ 10.23 (4'-OH), 
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11.15 (3’-OH).12.05 (8-OH), 12.90 (7-OH) and 13.05 (5-OH) are due to five OH 
groups. The 13C spectrum (Table 57) demonstrated a pattern similar to that of 
compound C5, in which the C ring is di-substituted, having two hydroxyl groups 
at C-3’(163.6) and C-4'(164.5). The HMBC data for ring A was, as expected and 
slightly different from that of C5, with the C-7(159.2) position showing the 
presence of an OH group.  The HMBC cross peaks observed for OH-5/C-5, C-6, 
C-4a and Me-6/C-5, C-6, C-7;  OH-8/C-7, C-8, C-8a indicated that the OH groups 
were located at C-7 and C-8 due to their respective coupling effects.  The location 
of the single available methoxyl group and methyl group at C-3 and C-6 
respectively, were further verified by their HMBC correlations with C-3 and C-6 
respectively.  Consequently the structure  of C11 was assigned as 3 -methoxy-6 -
C-methyl-3',4',5,7,8 -pentahydroxyflavone (6 -C- methylquercetin -3-methyl 
ether) (Fig. 26). 
 
O
O
CH3
OH
OCH3
OH
OH
OH
OH
 
Figure 26 –Structure of compound C11 
3 -methoxy-6 -C-methyl-3',4',5,7,8 -pentahydroxyflavone (6 -C- 
methylquercetin -3-methyl ether)
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TABLE 57: The NMR spectroscopic data for compound C11  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C Assignment 
155.0 
137.3 
177.9 
157.1 
107.3 
159.2 
162.8 
154.4 
104.8 
120.4 
115.4 
163.6 
164.5 
115.4 
120.8 
 
7.2 
59.2 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
Me-6, 8-OH 
7-OH, Me-6 
8-OH 
5-OH 
H- 5' 
H-6' 
H-2', H-5' 
H-2', H-5', H-6' 
 
H-2'  
 
 
 
 
 
 
 
 
 
 
 
 
 
7.75 (1H, d, 2.3) 
 
 
7.03 (1H, d, 8.6) 
7.62 (1H, dd, 2.3 and 8.6) 
 
2.11 (3H, s) 
3.87 (3H, s) 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1' 
2' 
3'  
4' 
5' 
6' 
 
6-Me 
3-OMe 
 
The whole process in this case confirm the isolation and characterization of 6 
compounds C1, C2, C3, C5, C6 and C11 from the TTA and methanolic extracts 
of Cissampelos capensis aerial shoot and root in which only C3 was found to be 
already isolated from some few Cissampelos (Vecchietti et al., 1981; Freitas et al., 
1995 and Amresh et al., 2007) while the remaining 5 compounds seems new to 
the best of our knowledge. It should be noted that there were several extracts, 
fractions and subfractions that were not analysed due to insufficient tests and 
information.  
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5.4  BIOLOGICAL EVALUATION 
5.4.1 Brine shrimp lethality bioassay 
The brine shrimp lethality bioassay was performed on all the extracts, fractions 
and some of the isolates as shown in sections 3.10.2.0 and 4.5.3 for P. 
reticulatum. Using the same procedure, the LC50 with 95% confidence were 
estimated for the different extracts used in the phytochemical screening and the 6 
isolates viz., C1, C2, C3, C5, C6 and C11.  
The distribution pattern of the plant metabolites in the extracts were clearly 
evident in their brine shrimp cytotoxicity behaviour (Tables 58, 59 and 60), where 
three test bands were used viz., Inactive (LC50 > 700), Active (LC50 < 700) and 
Very active (LC50 < 10). The results demonstrated that all the hexane extracts 
showed no activity. Clearly evident was the finding that the highest bioactivity is 
found in the methanolic extracts, both in the root and the aerial shoot of this plant. 
The total tertiary alkaloid (TTA) showed a very high active value of 0.32 (Table 
60) indicating that is much better than the BTA with a value of 64.87. This was 
further confirmed by the highly active compound generated from the TTA as 
shown in compound C1. It should be noted that all the extracts and isolates (C1, 
C3 and C6) that are very active should be considered as good candidates for 
antimicrobial and antiviral agents since the lethality of a test substance to brine 
shrimp nauplii has been linked to the possible ability of such substances to kill 
cancer cells (antitumor activity) and possess anti-inflammatory properties (Mc 
Laughlin et al., 1991; Babajide et al., 2008; Farthing M.J., 2000). However, this 
does not mean that the inactive compounds (C11 and hexane extract) would not 
be useful for some other purposes such as good antioxidant agents. 
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Table 58:  Average number of dead nauplii after 24hours for C. capensis 
 
Test 
materials 
Vials at 
1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials for 
control 
expt. 
 1 2 3 1 2 3 1 2 3  
           
CCRH 9 9 10 10 10 10 10 10 10 10 
CCRD 2 2 1 4 4 6 7 9 7 10 
CCRE 2 3 3 5 5 6 7 6 8 10 
CCRM 0 0 0 0 0 0 1 1 1 10 
CCRW 2 3 2 4 4 4 6 7 8 10 
           
CCAH 6 7 5 9 6 6 9 10 9 10 
CCAD 2 1 2 5 4 4 7 6 7 10 
CCAE 1 3 2 4 3 4 6 6 7 10 
CCAM 0 0 0 0 1 0 2 3 2 10 
CCAW 6 6 7 8 10 8 10 10 10 10 
 
          
CCET 0 0 0 1 2 2 4 3 4 10 
TTA 0 0 0 0 0 0 1 0 1 10 
BTA 3 2 3 5 4 5 7 6 7 10 
           
C1 0 0 0 0 0 0 0 1 0 10 
C2 1 1 1 3 4 4 7 6 7 10 
C3 0 0 0 0 1 1 3 3 4 10 
C5 2 2 2 4 3 4 6 7 8 10 
C6 0 1 0 1 1 0 3 4 4 10 
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Table 59: Average number of survived nauplii after 24hours for C. capensis 
 
Test 
materials Vials at 
 1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials 
for 
control 
expt. 
Ave. 
surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
% surv. 
         
 
 
CCRH 9.33 93.33  10 100  10 100 100 
CCRD 1.67 16.67  4.67 46.67  7.67 76.67 100 
CCRE 2.67 26.67  5.33 53.33  7 70 100 
CCRM 0 0  0 0  1 10 100 
CCRW 2.33 23.33  4 40  7 70 100 
          
CCAH 6 60  7 70  9.33 93.33 100 
CCAD 1.67 16.67  4.33 43.33  6.67 66.67 100 
CCAE 2 20  3.67 36.67  6.33 63.33 100 
CCAM 0 0  0.33 3.33  2.33 23.33 100 
CCAW 6.33 63.33  8.67 86.67  10 100 100 
 
         
CCET 0 0  1.67 16.67  3.67 36.67 100 
TTA 0 0  0 0  0.67 6.67 100 
BTA 2.67 26.67  4.67 46.67  6.67 66.67 100 
          
C1 0 0  0 0  0.33 3.33 100 
C2 1 10  3.67 36.67  6.67 66.67 100 
C3 0 0  0.67 6.67  3.33 33.33 100 
C5 2 20  3.67 36.67  7 70 100 
C6 0.33 3.33  0.67 6.67  3.67 36.67 100 
 
C11 6 60  8.67 86.67  10 100  100 
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Table 60: LC50 and average number of dead nauplii after 24hours for C. 
capensis 
 
* Data did not converge and therefore could not be regressed by the finnery probit 
analysis programme. 
Test 
materials 
Vials at 
1000 
µg/ml 
Vials at 
100 µg/ml 
Vials at 10 
µg/ml LC50 
General 
remarks 
CCRH 1 0 0 3526.22 Inactive 
CCRD 8 5 2 120.48 Active 
CCRE 7 5 3 71.33 Active 
CCRM 10 10 9 3.75 Very active 
CCRW 8 6 3 100.03 Active 
CCAH 4 3 1 * Inactive 
CCAD 8 6 3 145.86 Active 
CCAE 8 6 4 58.64 Active 
CCAM 10 10 8 6.15 Very active 
CCAW 4 1 0 2446.33 Inactive 
CCET 10 8 6 * Very active 
TTA 10 10 9 0.32 Very active 
BTA 7 5 3 64.87 Active 
C1 10 10 10 0.82 Very active 
C2 9 6 3 320.66 Active 
C3 10 9 7 6.20 Very active 
C5 8 6 3 199.55 Active 
C6 10 9 6 3.23 Very active 
C11 4 1 0 1159.62 Inactive 
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5.5. ANTIMICROBIAL ACTIVITY EVALUATIONS 
The antimicrobial evaluation was carried out using the diffusion method in which 
three organisms were used in each case. For Gram-negative bacteria: 
Pseudomonas aeruginosa, Proteus vulgaris and Escherichia coli Sero type 1 were 
used while for Gram-positive, Bacillus subtilis, Staphylococcus aureus and 
Bacillus licheniformis were used. The fungal species used were Candida albicans, 
Candida eropiralis and Aspergillus niger. The assay was set up as described in 
section 3.10.3.1 and the inhibition zone for both the bacteria and the fungi were 
measured in triplicate for all the extracts and the 6 identified isolates as was done 
in the brine shrimp cytotoxicity assay above. The average was determined and 
compared to the positive controls used (Amoxicillin; 40µg/ml for bacteria and 
Fluconazole; 120µg/ml for fungi). The results, which were generated based on the 
average inhibition zones of the microbial growth (mm), are presented in Table 61. 
Similar patterns were observed in the microbial analysis except in very few cases 
as shown in Table 61. The three (3) test organisms used in each case was to allow 
for a wider spectrum of antimicrobial activities of the extracts and isolates. S. 
aureus, a pyrogenic bacterium known to play a significant role in invasive skin 
diseases was selected as part of the test organism while C. albicans was chosen 
for this study since it causes serious systemic infections, including an 
opportunistic infection in patients infected with HIV. 
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Table 61: Antimicrobial profile of Cissampelos capensis (The inhibition 
zones)  
  Psa Prv Esc  Bas Sta Bal  Caa Cae Asn 
CCRH 0 0 0  0 0 0  0 0 0 
CCRD 0 12 11  13 18 15  0 0 0 
CCRE 14 0 15  17 33 19  17 14 20 
CCRM 32 28 28  43 35 27  30 36 23 
CCRW 0 0 0  11 17 12  25 26 25 
            
CCAH 0 0 0  0 0 0  0 0 0 
CCAD 15 18 16  11 13 11  0 0 0 
CCAE 14 12 12  17 18 0  0 0 0 
CCAM 25 21 20  35 40 44  23 22 19 
CCAW 11 12 11  10 24 11  17 15 29 
 
           
CCET 24 22 31  37 35 28  36 33 34 
TTA 36 38 37  45 40 36  38 33 35 
BTA 15 17 17  23 28 24  30 32 29 
            
C1 41 34 29  32 30 33  0 0 0 
C2 16 19 19  22 19 14  19 15 17 
C3 18 0 26  19 0 18  10 11 11 
C5 10 13 11  12 10 11  0 0 14 
C6 15 13 19  22 28 30  35 29 27 
C11 10 11 15  0 0 21  20 26 29 
Amx 61 44 49  42 53 47  0 0 0 
Flu 0 0 0  0 0 0  46 53 39 
 
*Gram –ve bacteria: - Pseudomonas aeruginosa (Psa) , Proteus vulgaris (Prv)  and Escherichia 
coli (Esc) Gram +ve bacteria: - Bacillus subtilis (Bas), Staphylococcus aureus (Sta) and Bacillus 
licheniformis (Bal) Fungi: - Candida albicans (Caa), Candida eropiralis (Cae) and Aspergillus 
niger (Asn) Ref. standards:-  Amx:-  Ammoxicilin and Flu:-  Fluconazole 
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The results in Table 61 showed that different levels of activity were observed for 
both the extracts and the isolates. Any value > 20 mm is assumed to be 
moderately active. There was more antibacterial than antifungal activity. The 
highest activity was recorded for the Gram +ve bacteria while that of Gram –ve 
bacteria is more than that of the fungi. The maximum zone (45 mm) of 
antibacterial effect was observed in the TTA fraction against the Gram +ve 
organism B. subtilis which may be due to the strong antimicrobial and antiviral 
activities of the alkaloid in the plant which is well known for treatment of malaria, 
fungal infections, inflammations and cancer (Kaur et al., 2009 and Mc Gaw et al., 
2000). No activity was recorded for the hexane extracts against all nine 
organisms. High values of activity were recorded for the drug resistance breed of 
bacteria P. aeuruginosa, where 36mm was recorded for TTA (36mm), CCAM 
(25mm) and CCRM (32mm).  
Some preferential activity is observed in cases where activity was preferentially 
selected on the organisms (Babajide et al., 2008 and Shai et al., 2008). For 
example, it can be noted that CCRD was only active against Gram +ve and –ve 
bacteria. A similar observation can be found in CCAE which is only active against 
5 out of the 9 organisms with no antifungal effect on all 3 fungi used. Similar 
observation can be found for CCRW which is only active against 6 of the 
organisms with no Gram –ve activities. 
The above observed biological activities may be due to the behavior of both 
alkaloids and flavonoids which are known to exhibit a wide range of activities 
which includes anti inflammatory, antithrombotic and antiviral due to their ability 
to scavenge free-radicals (Babajide et al., 2008; Shai et al., 2008; Rahman et al., 
2007; Ibewuike et al., 1997 and Liu et al., 1990).  
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5.6 CHEMICAL EVALUATION 
5.6.1  The antioxidant assay 
Total antioxidant evaluation was conducted on the C. capensis extracts and 
isolates by evaluating the antioxidant content in  the extracts and the antioxidant 
capacity in both the extracts and isolates as did  in P.reticulatum and described in 
section in 3.11.1 – 3.11.9.  
5.6.2  Polyphenolic content 
The polyphenolic content was determined by using gallic acid as a standard and 
Folin Ciocalteu reagent as the antioxidant marker as shown in 3.11.2. The results 
showed that the amount of polyphenols present in the extracts were in various 
concentrations as shown in Figure 27A in which the 80% ethanolic extract 
(CCET) has the highest content while CCAE and the TTA has the lowest. This 
result futher confirmed the enrich nature of the methanolic extracts for both the 
aerial shoot and the root as a good source of polyphenols because of their high 
values as shown in Figure 27A.  
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Figure 27A – Bar chart illustrating and comparing the amount of polyphenols and 
flavonols present in the various extracts of C. capensis 
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5.6.3 Flavonoid content 
Closely related profiles were observed for flavonoids which consist of flavonols, 
flavanols and flavanones. Evaluation of flavonol content was made using 
quercetin as the standard as shown in 3.11.3 while the flavanol content  made use 
of catechin as listed in 3.11.4 and flavanone content made use of the Naringenin 
standard (3.11.6). 
Results are shown in Figures 27A, 27B and 27C From these it is evident that the 
presence of flavonols, some flavanols and traces of flavanones are present when 
compared with the standard and this  confirms the actual isolation of a flavanone 
(C6). The results further show the consistency of the methanolic extract in both 
the root and the aerial shoot with high values as shown in Figures 27A and 27B. 
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Figure 27B – Bar chart showing the amount of flavanols present in the various 
extracts of C. capensis 
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Figure 27C – Bar chart illustrating and comparing the amount of flavanones and 
the Trolox equivalent antioxidant capacity present in the various extracts of C. 
capensis.  
 
5.6.4 Anthocyanins contents  
The anthocyanin content was also evaluated by measuring the amount of pigments 
present as shown in 3.11.5.The result obtain is as shown in Figure 27D in which it 
was observed that anthocyanins were absent in the plant except for the traces 
observed in CCAE, CCAW, TTA and CCET. 
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Figure 27D – Bar chart showing the amount of anthocyanins present in the 
various extracts of C. capensis 
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5.6.5 The Oxygen radical absorbance capacity assay (ORAC) 
The ORAC (3.11.7) results showed that C. capensis also have high antioxidant 
values and this can be attributed to the flavonoids found in them as shown in 
Figure 27E. This is clearly evident in C11. It can also be observed that the 
methanolic extracts of both the root and aerial shoot possesses high antioxidant 
capacity as shown by Figure 27E  
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Figure 27E – Bar chart showing the ORAC values (The antioxidant capacity) of 
some extracts and isolates present in C. capensis.  
 
5.6.6  The Ferric reducing antioxidant power assay (FRAP) 
The FRAP redox potential was clearly exhibited by C5 and the methanolic 
extracts as shown in Figure 27F where C5 recorded the highest value for the 
isolates and CCAM for the extracts. 
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Figure 27F – Bar chart showing the FRAP values (Ferric reducing antioxidant 
power) of some extracts and isolates present in C. capensis 
 
5.6.7  The Abts Trolox equivalent antioxidant capacity (TEAC) assay 
The TEAC assay (3.11.9) results can also be found in Figure27C which showed a 
fair scavenging power as observed in CCRM and CCAM which is an indication 
that the methanolic extracts is a better choice for formulating a viable and active 
antioxidant.  
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CHAPTER 6  
RESULTS AND DISCUSSION 
6.1 GERANIUM INCANUM 
The whole plant of G. incanum was collected at two different periods, one in 
winter and the other in summer. The plant was washed, dried and milled 
separately as shown in section 3.3.0. This afforded 3.98kg for the winter and 
4.0kg for the summer collection. A similar extraction procedure as described 
earlier was followed for the summer collection (2kg) to afford a hexane (29.45 g, 
1.47%), dichloromethane (37.69 g, 1.89%), ethyl acetate (125.28 g, 6.26%), 
methanol (183.25g, 9.16%) and water extract (86.11g, 4.31%) (Section 3.8.0). For 
the isolation of constituents in the ethyl acetate fraction of the summer collection, 
25.0 g of the extract was chromatographed to afford compounds G1, G2 and G3 
as shown in Section 3.8.1.0 – 3.8.1.4. The appearance of the fractions was as 
follows: G1; a bright yellow powder (0.049 g); G2: an off-white powder (0.088 g) 
and G3, a creamy off-white powder (0.044 g). Similarly, 20.0g of the methanol 
fraction of the summer collection was chromatographed. This afforded 
compounds G4 and G5 as shown in Section 3.8.2.0 – 3.8.2.3. In this case G4 was 
a white powder (0.048 g) and G5 turned out to be a light yellow amorphous 
powder (0.038 g).  
The winter collection (2kg) gave a hexane (48.35 g, 2.42%), dichloromethane 
(34.43 g, 1.72%), ethyl acetate (107.26 g, 5.36%), methanol (211.77g, 10.59%) 
and water extract (79.32g, 3.97%). CGC of the ethyl acetate extract afforded 
compounds G6, G7 and G8 as shown in Section 3.8.3.0 – 3.8.3.6. G6 was 
obtained as a brownish yellow powder (0.038 g); G7 as an off-white powder 
(0.055 g) and G8 as a bright yellow amorphous powder (0.077 g). The 
chromatographic profile of the methanolic fraction of the winter collection 
afforded compounds G9, G10, G11and G12 as shown in Section 3.8.4.0 – 3.8.4.6.   
In this case G9 was obtained as a bright yellow powder (0.067g); G10 as an off-
white powder (0.0532 g); G11 is a light yellow amorphous powder (0.098 g) and 
G12 as a creamy yellow powder (0.0658g). 
All extracts were subjected to preliminary phytochemical screening for the 
presence of secondary plant metabolites as shown in Section 3.5.0.  Results of this 
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analysis showed that G. incanum collected during summer was phytochemically 
different from that collected during winter as shown in Table 62. The reason for 
this variation is presumed to be due to the high nutrient absorption rates and water 
intake by the plant during winter which is greater than that available during 
summer in South Africa (Clark et al., 2009; Alireza et al., 2009). Phytochemical 
screening for the detection of natural plant products in the extracts were 
specifically targeted for tannins, phenolics, glycosides, saponins, flavonoids, 
alkaloids, anthraquinones and essential oils which were performed according to 
the method used by Wagner (Wagner and Bladt,  2001). 
Results indicate the presence of saponins, tannins, flavonoids, phenolics as well as 
essential oils found only in the hexane and DCM extracts of the summer 
collection. Cardiac glycosides, alkaloids and anthraquinones were evidently 
absent in all the extracts as shown in Table 62.  
These observations confirmed the phytochemical profile recorded in the literature 
for this plant (De Wet and Van Wyk, 2008; Dic. of Nat. Prod., 1996; VanWyk, 
2008; Amabeoku, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 194
 
Table 62:- Phytochemical screening result of the G. incanum extracts  
Test 
materials  Tann Phen Glyc Sapo Flav Alka Anth Esse 
GISH P+ve P+ve N-ve N-ve N-ve N-ve N-ve P+ve 
GISD P+ve P+ve N-ve P+ve P+ve N-ve N-ve P+ve 
GISE P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
GISM P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
GISW P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
 
        
GIWH P+ve P+ve N-ve N-ve N-ve N-ve N-ve N-ve 
GIWD P+ve P+ve N-ve N-ve N-ve N-ve N-ve N-ve 
GIWE P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
GIWM P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
GIWW P+ve P+ve N-ve P+ve P+ve N-ve N-ve N-ve 
         
GISH = G. incanum summer collection Hexane extract;  GISD = G. incanum summer collection 
DCM extract; GISE = G. incanum summer collection EtOAc extract;    GISM = G. incanum 
summer collection MeOH extract, GISW = G. incanum summer collection H2O extract;     GIWH 
= G. incanum winter collection Hexane extract; GIWD = G. incanum winter collection DCM 
extract; GIWE = G. incanum winter collection EtOAc extract; GIWM = G. incanum winter 
collection MeOH extract;  GIWW = G. incanum winter collection H2O extract; While Tannins 
(Tann), Phenolics (Phen), Glycosides (Glyc), Saponins (Sapo), Flavonoids (Flav), Alkaloids 
(Alka), Anthraquinones (Anth) and Essential oils (Esse) 
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A total of 12 compounds were successfully isolated from both the summer and 
winter collections of the G. incanum plant material viz., (G1 – G12), with only 
G5, G10 and G12 being fully analysed and reported in this thesis while the 
remainder cannot be conclusively identified due to insufficient spectral data and 
other physicochemical parameters needed to completely justify the nature and 
structure of the compounds. Some data available is given here. G2 is an off white 
powder with m.p. 196-198°C.  Rf value of 0.35 and 0.60 in solvent system A and 
B respectively. The UV λmax nm (log ε): 217 (5.14), 267 (4.77), 238, 263, 285 
while in the EIMS the molecular ion base peak (M)+ m/z is 972.1017. ( calculated 
frag. gave C41H30O27 ).  
G3 is a creamy off white crystal with m.p. 147 -1490C. TLC in Hex: EtOAc: 
MeOH (3:7:1) gave a Rf of 0.45. The UV λmax (log ε): 241, 286 and 400 and the 
IR: νmax cm-1 pronounced peaks were found at 3430 (b) (OH), 1645 (s) (C=O), 
1617 (s), 1492, 1380, 1320, 1284, 1249, 1213, 1176 and 1084. The EIMS: 
molecular ion peak (M)+. M/z 274.0102. ( calculated mol. formula C15H14O5 ).  
G2 and G3 were strongly suspected to be tannins because they were both positive 
to feric chloride test. 
Results of G5, G10 and G12 are hereby presented. 
 
6.2. PHYSICO-CHEMICAL DATA OF ISOLATED COMPOUNDS 
6.2.1 G5 (Quercetin) 
A light yellow amorphous powder with m.p. 314 - 316˚C, Rf (Solvent): 0.79 (A), 
0.47 (B). 
IR (ν cm-1) pronounced peaks: 3420, 3271, 1675, 1624, and 1511.   
UV λmax nm (log ε): 255 (4.76), 376 (4.80); +NaOAc: 261, 388; +AlCl3: 271, 
437; +NaOH: 282, 426. 
EIMS: the molecular ion base peak (M)+ m/z  302.0113  ( calculated frag. gave 
C15H10O7 ).  
1H NMR (400 MHz in pyridine-d5): δ 6.75 (1H, d, J = 1.98 Hz, H-8), 6.78 (1H, d, 
J= 1.98 Hz, H-6), 7.41 (1H, d, J = 8.25 Hz, H-5'), 8.20 (1H, dd, J = 2.31, 8.25 Hz, 
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H-6'), 8.65 (1H, d, J = 2.31 Hz, H-2'), 10.40 (1H, s, 4'-OH), 10.95 (1H, s, 3'-OH) 
11.65 (1H, s, 3-OH). 12.75 (1H, s, 7-OH), 13.35 (1H, s, 5-OH).   
13C NMR ran at (100 MHz in DMSO-d6) : see Table 63. 
 
6.2.2  G10 (16α-hydroxy-(-)-kauran-18-oic acid) 
An off white powder, m.p. 224 - 226˚C, Rf (Solvent): 0.63 (A), 0.42 (B), 0.21 (C).  
IR (ν cm-1) pronounced peaks: 3383, 2928, and 1692.  
EIMS: the molecular ion base peak (M)+ m/z  321.2113  ( calculated frag. gave 
C15H10O7 ). 
¹H NMR (600 MHz, pyridine-d5): δ 1.90 (1H, bd, J = 12.8 Hz, H-1α), 1.02 (1H, 
ddd, J = 13.5, 12.8, 3.2 Hz, H-1β), 1.82 (1H, m, H-2α), 1.62 (1H, m, H-2β), 1.87 
(1H, m, H-3α), 2.25 (1H, ddd, J = 13.6, 12.7, 4.8 Hz, H-3β), 2.16 (1H,bd, J = 12.0 
Hz, H-5), 1.70 (1H, m, H-6α),1.62 (1H, dt, J = 14.4 Hz, H-6β), 1.75 (1H, m, H-
7α), 1.65 (1H, m, H-7β), 1.24 (1H, d, J = 6.4 Hz, H-9), 1.70 (1H, m, H-11α), 1.67 
(1H, m, H-11β), 1.67 (1H, m, H-12α), 1.75 (1H, m, H-12β), 2.30 (1H, bs, H-13), 
2.16 (1H, d, J = 12.0 Hz, H-14a), 2.10 (1H,d, J=12.0 Hz, H-14b), 2.05 (1H, d, J = 
14.3 Hz, H-15α), 1.78 (1H, d, J=14.3 Hz, H-15β), 1.69 (3H, s, Me-17), 1.54 (3H, 
s, Me-19), 1.20 (3H, s, Me-19), 1.20 (3H, s, Me-20). ¹³C-NMR: Table 64. 
 
6.2.3 G12 (6, 8-di-C-methylquercetin 3, 7-dimethyl ether) 
A creamy yellow powder with m.p. 201 - 203˚C, Rf (Solvent): 0.44 (B), 0.26 (C). 
UV λmax nm (log ε): 262 (4.67), 364 (4.63); +NaOAc: 263, 366; +AlCl3: 280, 446; 
+NaOH: 268, 413. 
IR (ν cm-1) pronounced peaks: 3400, 2931, 1656, 1615 and 1556.     
EIMS: the molecular ion base peak (M)+ m/z  359.1103. ( calculated frag. gave 
C19H18O7 ).  
1H NMR (400 MHz in DMSO-d6): δ 2.21 (3H, s, Me-6), 2.42 (3H, s, Me-8), 3.86 
(3H, s, OMe-3), 3.91 (1H, s, OMe-7), 7.03 (1H, d, J = 8.6 Hz, H-5'), 7.63 (1H, dd, 
J = 2.31, 8.6 Hz, H-6'), 7.75 (1H, d, J = 2.31 Hz, H-2'), 10.56 (1H, s, 4'-OH), 
10.92 (1H, s, 3'-OH), 13.00 (1H, s, 5-OH). ¹³C-NMR: see Table 63. 
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TABLE 63: ¹³C NMR data for compounds G5 and G12 
Carbon G5 G12 
2 
3 
4 
5 
6 
7 
8 
8a 
4a 
1’ 
2’ 
3’ 
4’ 
5’ 
6’ 
3-OMe 
7-OMe 
3’-OMe 
6-Me 
8-Me 
147.0 
137.7 
177.3 
157.5 
99.2 
165.4 
94.3 
162.4 
104.4 
123.8 
115.2 
147.7 
149.6 
115.2 
121.0 
 
 
155.9 
137.8 
178.5 
155.9 
112.5 
162.0 
108.4 
151.3 
107.0 
120.8 
115.2 
145.3 
148.9 
115.8 
120.6 
59.5 
60.3 
 
8.0 
8.2 
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6.3 STRUCTURAL ELUCIDATION OF COMPOUNDS G5, G10 AND 
G12 
6.3.1  G5 (Quercetin)  
Compound G5 showed IR absorbtion bands at 1675 cm-1 (C=O), and 3420 cm-1 
(OH). It also exhibited UV Bands I and II at 376.0 and 255.0 nm respectively, 
maxima characteristic typical of flavonols (Wollenweber, 1982). Large 
bathochromic shifts in the presence of AlCl3 (+62nm). NaOAc (+13.5nm) and 
NaOH (+51nm), with a new band appearing at 282nm in the MeOH + NaOH 
spectrum were also apparent. These UV data are consistent with those of a 
flavonol possessing free 3, 7, 3’, and 4' hydroxyl groups (Wollenweber, 1982; 
Voirin, 1983). 
The proton NMR spectrum of compound G5 showed only aromatic signals, 
indicating the absence of aliphatic substituents on the flavonoid nucleus. The 
spectrum exhibited the characteristic 5-OH proton signal at δ 13.35 and four 
singlets at δ 10.40 (4'-OH); 10.95 (3'-OH); 11.65 (3-OH) and 12.75 (7-OH). Meta-
coupled doublets of an AB system were observed at δ 6.75 and 6.78 (J = 1.98 Hz) 
which are consistent with a 5,7-disubstituted ring A. An aryl ABC trisubstituted 
system corresponding to a 3', 4'- disubstituted ring C was also evident from the 
three 1-proton aromatic signals at δ 7.41 (d, J = 8.25 Hz), 8.20 (dd, J = 2.31 and 
8.25 Hz) and 8.65 (d, J = 2.31 Hz). The 13C NMR spectrum of G5 also exhibited 
only aromatic signals, with the typical C-3 signal of a flavonol at δ 137.7. In the 
pyridine- d5 spectrum (Table 63), the signals for C-2' and C-5' were coincident at 
δ 115.2, indicating that these two carbons were ortho to hydroxyl groups 
(Roitman and James, 1985). These observations, in conjunction with the UV data 
and the proton spectrum, indicated that compound G5 was a flavonol with free 
3,5,7,3',4'-pentahydroxy groups identical to P13 which was identified as 
quercetin. Confirmation was provided by co-TLC with pure quercetin. The 
complete analysis and spectral comparison shows that G5 is a quercetin (Figure 
28) which to the best of our knowledge is been reported for the first time to be 
present in this plant. 
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Fig. 28  Structure of compound G5 
 
6.3.2  G10- 16α-hydroxy-(-) kauran-18-oic acid  
Compound G10, a white amorphous solid with m.p. 224 - 2260C, showed no 
maxima between 200- 550 nm in its ultraviolet spectrum, pointing to the absence 
of a chromophoric group. The IR spectrum showed a broad – OH band at 3383 
cm-1 and a carbonyl resonance at 1692 cm-1, both indicative of a carboxylic acid 
group. The 13C NMR (Table 64) and DEPT spectra (Table 65) of G10 showed 20 
signals representing: three methyl, nine methylene, three methine and five 
quaternary carbons, while the EI mass spectrum exhibited an [M+H] + ion at m/z 
321.2113 (∆ – 0.6 mmu). All these data are consistent with a molecular formular 
of C20H32O3. Based on the IR spectrum, the completely aliphatic 1H NMR 
spectrum as well as the absence of any C=C bond as indicated by the 13C NMR 
spectrum (Table 64), the five degrees of unsaturated for G10 were assigned to a 
tetracyclic ring system with a carboxylic acid group. The presence in the 1H NMR 
spectrum (Table 65) of three methyl singlets (δ 1.20, 1.54 and 1.69) as well as the 
13C carbonyl resonance at δ 181.5 implies that the tetracyclic ring system is a 16-
carbon unit. In addition to this, the presence of an oxygen-bearing quaternary 
carbon at δ 78.0 as well as the base peak at m/z 303.2317 [MH-H2O] + (∆- 0.7 
mmu) in the mass spectrum indicated compound G10 to most likely be a kaurane 
diterpene acid possessing a tertiary hydroxyl group at C-16 (Serebryakov et al., 
1968; Tan et al., 1993). 
Using the DEPT and HMQC spectra of compound G10, it was possible to identify 
the carbon resonances as methyl, methylene or quaternary, and to assign their 
 
 
 
 
 200
corresponding proton signals (Table 65). Thus, the methyl singlets at δ 1.20, 1.54 
and 1.69 showed one bond correlations with the carbon resonances at δ 18.4, 17.2 
and 25.2, respectively. Other important proton/carbon HMQC correlations were 
CH (δ2.16, bd/51.0), CH2 (δ 1.78, d; 2.05, d/58.9), CH 2 (δ2.10, d/38.2) and CH2 
(δ 1.87, m; 2.25, ddd/37.7) (Figure 30). The two/ three-bond connectivity 
information obtained from the HMBC (Figure 31) spectrum was further used to 
assign the carbon signals of the suggested 16-hydroxykauranioc acid. The methyl 
singlet at δ 1.54/17.2 showed a cross-peak with the carbonyl resonance at δ 181.5, 
thus identifying it as Me-19. Similarly, the methyl singlet at δ 1.69/25.2 correlated 
with the oxygen-bearing quaternary carbon (δ 78.0, C-16) and was assigned as 
Me-17. Other important HMBC correlations were Me-19/C-3, C-4, C-5;Me-17/C-
13, C-15; Me-20/C-1, C-9, C-10;H-5/C-4, C-6, C-19, C-20; CH2 -15/C-7, C-8, C-
16, C-17 and CH2-14/C-12 (Table 65; Figure 31). The 1H- 1H COSY spectrum of 
compound G10 (Table 65 ) was used to confirm the proton and carbon 
assignments from the HMBC spectra especially as the geminal methylene protons 
were non-equivalent, and showed large couplings with each other. Thus, the C-15 
protons appeared as two distinct doublets at δ 1.78 and 2.05 (Jgem = 14.3 HZ). 
Other 1H-1H correlations were CH2-2/H-1, H-3; CH2-1/CH2-1, CH2-2, Me-20; 
CH2-15/CH2-15; CH2-13/CH2- 13/CH2-11, CH2-14 and CH2-3, Me-20 (Table 65). 
All the above confirmed the structure of G10 to be 16α-hydroxykauranoic acid. 
The stereochemistry at C-4 was clarified by comparison of the 13C NMR spectrum 
with the published spectra of kauranoic acids (Delgado et al., 1985; Monte et al., 
1988; Tan et al., 1993). For kauran-18-oic acids (those in which the – COOH 
group is β i.e equatorial), the C-5 carbon is shielded, while it is deshielded in 
kauran-19-ioc acids (in which the-COOH is α i.e axial). Also the C-4 methyl 
group is strongly shielded (ca. 17- 18 ppm) in β-equatorial acids and deshielded 
(ca. 28 ppm) in α- axial acids. The peaks for C-4 at δ 47.9, C-5 at 51.0 and C-19 
at 17.2 all confirm the β-equatorial orientation of the carboxylic acid moiety at C-
4, making compound G10 16α –hydroxykauran-18-oic acid (Figure 29). 
The NOESY spectrum (Table 65) exhibited the expected H-5/H-9 cross-peak of 
the kaurane skeleton, while the Me-20/Me-19 correlation supported the α-axial 
orientation of Me-19. The 16α-hydroxy stereochemistry had been previously 
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established for the isomeric 16α-hydroxykauran-19-oic acid reported from the 
fermentation of Fusarium moniliforme Sheld (Serebryakov et al., 1968,) and was 
unambiguously proven further for compound G10 by the observed H-15β/ Me-17 
NOESY correlation (Table 65). It is also to the best of our knowledge the first 
kaurane- type diterpene to be isolated from Geranium incanum.  
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Figure 29: Structure of compound G10 
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TABLE 64: ¹³C NMR data for compound G10 
Carbon Chemical Shift (δ) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
40.1 
18.4 
37.7 
47.9 
51.0 
24.0 
42.3 
45.9 
57.6 
39.1 
18.4 
27.4 
49.6 
38.2 
58.9 
78.0 
25.2 
181.5 
17.2 
18.4 
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Figure 30-The HMQC correlations for compound G10 
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Figure 31-The HMBC correlations for G10 
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TABLE 65: NMR spectroscopic data for compound G10 
13C Signal DEPT HMQC (δ, J 
Hz) 
HMBC 1H-1H 
COSY 
NOESY 13C 
40.1 
 
 
 
 
18.4 
 
37.7 
 
 
 
47.9 
51.0 
 
24.0 
 
 
42.3 
 
45.9 
57.6 
39.1 
18.4 
 
27.4 
 
 
49.6 
38.2 
CH2 
 
 
 
 
CH2 
 
CH2 
 
 
 
C 
CH 
 
CH2 
 
 
CH2 
 
C 
CH 
C 
CH2 
 
CH2 
 
 
CH 
CH2 
α1.90 bd 
(12.8) 
β 1.02 ddd 
(13.5, 12.8, 
3.2) 
α 1.82 m 
β 1.62 m 
α 1.87 m 
β 2.25 ddd 
(13.6, 12.7, 
4.8) 
 
2.16 bd 
(12.0) 
α 1.70 m 
β 1.62 dt 
(14.4) 
α 1.75 m  
β 1.65 m  
 
1.24 d (6.4) 
 
α 1.70 m  
β 1.67 m  
α 1.67 m 
 
β 1.75 m 
2.30 bs 
a 2.16 d 
2,9,10 
 
2, 10 
 
 
 
10 
5 
2, 4, 18, 19 
 
 
 
4, 6, 7, 10, 
19, 20 
 
 
 
5 
5 
 
1,10, 12 
 
12 
12 
 
 
 
 
8, 12, 13 
1β, 2, 
20 
 
1α 
 
 
1, 3 
 
2, 3, 20 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
9 
 
 
 
 
14 
1β, 11, 20 
 
3β, 5, 9 
 
 
2β, 19, 20 
3α 
3β, 19 
5, 9 
 
 
 
6β, 7β, 9 
 
6β, 19, 20 
 
 
7β, 14a 
9 
 
12α, 15β 
 
11β 
 
12β, 13, 14a 
13 
14a, 14b 
14b 
 
1 
 
 
 
 
2 
 
3 
 
 
 
4 
5 
 
6 
 
 
7 
 
8 
9 
10 
11 
 
12 
 
 
13 
14 
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58.9 
 
 
 
78.0 
25.2 
181.5 
17.2 
18.4 
 
 
 
CH2 
 
 
 
C 
CH3 
C 
CH3 
CH3 
(12.0) 
b 2.10 d 
(12.0) 
α 2.05 d 
(14.3) 
β 1.78 d 
(14.3) 
 
1.69 s 
 
1.54 s 
1.20 s 
 
8, 12, 13, 
15, 16 
7, 8, 9, 13, 
16 
8, 9, 14, 17 
 
 
13, 15, 16 
 
3, 4, 5, 18 
1, 5, 9, 10  
 
 
 
 
15β 
 
15α 
20 
 
15β 
 
17 
 
 
 
15 
 
 
 
16 
17 
18 
19 
20 
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6.3.3  G12 ( 6, 8-di-C-methylquercetin 3, 7-dimethyl ether  
The UV spectrum of compound G12 indicated that it was a 3-O-substituted 
flavonol, with Band I and Band II absorbances at 364 and 262 nm, respectively. 
The absence of a significant NaOAc shift as well as the +49 nm bathochromic 
shift of Band I in the presence of NaOH indicated a 7-O-substitution and a free 4'-
OH group, respectively. The EIMS mass spectrum showed a [MH]+ peak at m/z 
359.1141 (∆ 1.0mmu), corresponding to a molecular formular C19H18O7 . The 1H 
NMR spectrum (Table 66) showed two aryl methyl singlets at δ 2.21 and 2.42, as 
well as two methoxyl singlets (δ 3.86 and 3.91). The aromatic region still showed 
the typical pattern of a 3’, 4’-disubstituited ring C with three signals at δ 7.03 (1H, 
d, J=8.6 Hz), 7.63 (1H, dd, J=2.3 and 8.6 Hz) and 7.75 (1H, d, J=2.3 Hz). The 
absence of any other aromatic signal implied that compound G12 had a fully 
substituted ring A, while the singlet at δ 13.0 was also typical of a H–bonded 5-
OH. The 13C NMR signals for G12 are as shown in Table 63. Ring A showed the 
expected substituent effects of an additional C-8 methyl group i.e. large 
deshielding effects at C-8 and C-6 (ipso, +18.5 ppm; meta, +5.5 ppm) with 
smaller shielding effects at C-7 (-1.0 ppm, ortho), C-8a (-3.1ppm, ortho) and C-5 
(-1.2 ppm, para). All these were further confirmed by the observed HMBC 
correlations of 5-OH/C-5, C-6, C-4a, Me-6/C-5, C-6, C-7 and Me-8/C-7, C-8, C-
8a thus establishing the two methyl groups to be positioned at C-6 and C-8. The 
methoxyl groups were located at C-3 and C-7 by the OMe-3/C-3 and OMe7/C-7 
correlations, respectively. 
Compound G12 was therefore identified as 3, 7-dimethoxy-6, 8-dimethyl-5, 3’, 
4’-trihydroxyflavone (6, 8-di—C-methylquercetin- 3, 7- dimethyl ether) (Figure 
32). The proton and carbon signals in the HMBC spectrum are given in Table 66. 
Compound G12 is thus reported for the first time as a new C-methylflavonol 
isolated from Geranium incanum.   
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Figure 32 – Structure of compound G12 
 
TABLE 66: NMR spectroscopic data for compound G12  
13C Signal (δ) HMBC 1H (δ, J Hz) 13C 
Assignment 
155.9 
137.8 
178.5 
155.9 
112.5 
162.0 
 
108.4 
151.3 
107.0 
120.8 
115.2 
145.3 
148.9 
115.8 
120.6 
 
8.0 
H-2', 6' 
3-OMe 
 
5-OH, Me-6 
5-OH, Me-6 
Me-6, Me-8,        
7-OMe 
Me-8 
Me-8 
5-OH 
H-5' 
 
H-2', H-5' 
H-2', H-6' 
H-6', 
 H-2' 
 
 
 
 
 
 
 
 
 
 
 
 
7.75 (1H, d, 2.31) 
 
 
7.03 (1H, d, 8.6) 
7.63 (1H, dd, 2.31 and 
8.6) 
2.21 (3H, s) 
2 
3 
4 
5 
6 
7 
 
8 
8a 
4a 
1’ 
2’ 
3’ 
4’ 
5’ 
6’ 
 
6-Me 
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8.2 
59.5 
60.3 
2.42 (3H, s) 
3.86 (3H, s) 
3.91 (3H, s) 
8-Me 
3-OMe 
7-OMe 
 
 
 
6.4  BIOLOGICAL EVALUATION 
6.4.1 Brine shrimp lethality bioassay 
The brine shrimp lethality bioassay was carried out on all the extracts and some 
selected isolates as shown in section 3.10.2.0. Using identical procedures, the 
LC50 with 95% confidence was estimated for the different extracts used in the 
phytochemical screening as well as G2, G3, G5, G10 and G12. The distribution 
pattern of the plant metabolites in the extracts were also clearly shown in their 
brine shrimp cytotoxicity behaviour as shown in the results (Tables 67, 68 and 69) 
which demonstrated that both the winter and summer hexane extracts showed no 
activity. Clearly shown is that the methanolic extracts from both periods were 
very active. The climatic variation however can be seen in the DCM and EtOAc 
extracts in which the DCM summer extract is inactive while the winter extract is 
active. The EtOAc extract of the summer collection is active while that of winter 
was found to be very active. Compounds G2 and G12 were found to be inactive 
while G3, G5 and G10 were found to be active and G10 was the only isolate that 
was very active (Table 69).  
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Table 67: Average number of dead nauplii after 24hours for G. incanum 
 
Test 
materials 
Vials at 
 1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials 
for 
control 
expt. 
 1 2 3 1 2 3 1 2 3  
GISH 6 8 4 9 7 10 10 10 10 10 
GISD 10 8 8 8 9 10 10 10 10 10 
GISE 2 3 3 5 5 6 8 6 8 10 
GISM 0 0 0 1 2 2 4 5 4 10 
GISW 1 2 2 4 4 5 9 6 8 10 
 
          
GIWH 6 7 8 8 10 8 10 9 10 10 
GIWD 2 2 1 4 4 6 7 9 7 10 
GIWE 0 0 0 1 2 1 4 5 4 10 
GIWM 0 0 0 0 0 0 1 2 1 10 
GIWW 3 1 1 4 5 5 7 7 7 10 
           
G2 6 7 5 9 6 6 9 10 9 10 
G3 2 1 2 5 4 4 7 6 7 10 
G5 1 3 2 4 3 4 6 6 7 10 
G10 0 0 0 0 1 0 2 3 2 10 
G12 6 6 7 8 10 8 10 10 10 10 
  
 
 
 
 
 
 
 
 
 210
 
Table 68: Average number of survived nauplii after 24hours for G. incanum 
 
Test 
materials 
Vials at 
 1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials 
for 
control 
expt. 
Ave. 
surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
% surv. 
GISH 6 60  8.67 86.67  10 100 
 
100 
GISD 8.67 86.67  9 90  10 100 100 
GISE 2.67 26.67  5.33 53.33  7.33 73.33 100 
GISM 0 0  1.67 16.67  4.33 43.33 100 
GISW 1.67 16.67  4.33 43.33  7.67 76.67 100 
 
         
GIWH 7 70  8.67 86.67  9.67 96.67 100 
GIWD 1.67 16.67  4.67 46.67  7.67 76.67 100 
GIWE 0 0  1.33 13.33  4.33 43.33 100 
GIWM 0 0  0 0  1.33 13.33 100 
GIWW 1.67 16.67  4.67 46.67  7 70 100 
          
          
G2 6 60  7 70  9.33 93.33 100 
G3 1.67 16.67  4.33 43.33  6.67 66.67 100 
G5 2 20  3.67 36.67  6.33 63.33 100 
G10 0 0  0.33 3.33  2.33 23.33 100 
G12 6.33 63.33  8.67 86.67  10 100 100 
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Table 69: LC50 and average number of dead nauplii after 24hours for G. 
incanum 
 
* Data did not converge and therefore could not be regressed by the finnery probit 
analysis programme 
Test 
materials 
Vials at 
1000 
µg/ml 
Vials at 
100 
µg/ml 
Vials at 
10 µg/ml LC50 
General 
remarks 
GISH 4 1 0 1759.62 Inactive 
GISD 1 1 0 989.66 Inactive 
GISE 7 5 3 110.25 Active 
GISM 10 8 6 6.18 Very active 
GISW 8 6 2 88.35 Active 
 
     
GIWH 3 1 0 4156.21 Inactive 
GIWD 8 5 2 * Active 
GIWE 10 9 6 5.63 Very active 
GIWM 10 10 9 0.44 Very active 
GIWW 8 5 3 76.24 Active 
      
G2 4 3 1 * Inactive 
G3 8 6 3 120.86 Active 
G5 8 6 4 50.62 Active 
G10 10 10 8 8.11 Very active 
G12 4 1 0 1126.45 Inactive 
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6.4.2 Antimicrobial evaluation 
The antimicrobial evaluation was carried out using the same diffusion method as 
used in Cissampelos capensis. The assay was set up as described in section 
3.10.3.1 and the inhibition zones for both the bacteria and the fungi were also 
measured.  
 
Table 70:  Antimicrobial profile of Geranium incanum (The inhibition zones) 
  Psa Prv Esc  Bas Sta Bal  Caa Cae Asn 
GISH 0 0 0  0 0 0  0 0 0 
GISD 0 0 0  0 0 12  22 0 0 
GISE 19 24 18  26 0 28  0 0 0 
GISM 27 32 32  38 29 33  30 23 27 
GISW 0 0 12  15 13 0  18 21 15 
GIWH 0 0 0  0 0 0  0 0 0 
GIWD 0 0 0  19 15 22  26 20 23 
GIWE 29 26 35  38 30 18  15 17 22 
GIWM 34 41 28  36 36 31  30 27 29 
GIWW 10 11 15  0 0 20  22 23 28 
G2 16 0 15  18 32 19  17 19 23 
G3 15 18 16  11 13 11  0 0 0 
G5 14 12 12  17 18 0  22 21 28 
G10 25 21 20  30 40 37  33 27 29 
G12 11 12 11  10 24 11  17 15 38 
Amx 61 44 49  42 53 47  0 0 0 
Flu 0 0 0  0 0 0  46 53 39 
*Gram –ve bacteria: - Pseudomonas aeruginosa (Psa) , Proteus vulgaris (Prv)  and Escherichia 
coli (Esc) Gram +ve bacteria: - Bacillus subtilis (Bas), Staphylococcus aureus (Sta) and Bacillus 
licheniformis (Bal)  Fungi: - Candida albicans (Caa), Candida eropiralis (Cae) and Aspergillus 
niger (Asn) Amx:-  Ammoxicilin and Flu:-  Fluconazole 
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The results in table 70 show different level of activity for both the extracts and the 
isolates. The highest activity was recorded for the Gram +ve bacteria while that of 
Gram –ve is greater than that of the fungi. The maximum zone (40 mm) of 
antibacterial activity was observed for compound G10 against the Gram-positive 
organism Staphylococcus aureus. No activities however were observed for the 
hexane extracts against all nine organisms tested. The preferential activity 
observed in C. capensis was also observed in this plant. For example, G3 was 
only active against Gram +ve and –ve bacteria. A similar observation is found in 
GISE which is active against only 5 out of the 9 organisms tested with no 
antifungal effect. A similar observation can be found in GIWD which is only 
active against 6 of the 9 organisms tested with no Gram –ve activities as shown in 
table 70.     
 
 
6.5. CHEMICAL EVALUATION 
6.5.1 The antioxidant assay 
Total antioxidant evaluation were also carried out on G. incanum extracts and 
isolates by evaluating both the antioxidant content and the antioxidant capacity as 
shown in 3.11.1 – 3.11.9. 
 
6.5.2 Polyphenolic content  
The polyphenolic content was also evaluated as shown in 3.11.2. The results 
showed that the amount of polyphenols present in the extracts varied quite a bit as 
shown in Figure 33A in which GIWM has the highest amount while the lowest 
was recorded for GIWW which presumably meant that the methanol extraction 
process removed a large portion of the polyphenols present. 
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Figure 33A – Bar chart illustrating and comparing the amount of polyphenols and 
flavonols present in the various extracts of G. incanum.  
 
6.5.3  Flavonoid content  
Flavonoid which consist of flavonols, flavanols and flavanones were detrmined as 
described ealier and the results are shown in Figures 33A, 33B and 33C. From 
these it is evident that more flavonols were present in the ethyl acetate extract of 
the summer collection and the methanolic extract of the winter collection. The 
flavanol content is greater in the water extract of the summer than in winter while 
the methanolic extract of the winter plant recorded a significant presence of 
flavanols. Flavanones were found in trace amounts only as shown in Figure 33C. 
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Figure 33B – Bar chart showing the amount of flavanols present in the various 
extracts of G. incanum. 
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Figure 33C – Bar chart illustrating and comparing the amount of flavanones and 
the Trolox equivalent antioxidant capacity present in the various extracts of G. 
incanum. 
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6.5.4  Anthocyanin content  
Results obtained (Figure 33D) clearly showed the absence of anthocyanins. 
Traces observed during winter in the methanol and water extracts were the only 
ones.  
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Figure 33D – Bar chart showing the amount of anthocyanins present in the 
various extracts of G. incanum.  
 
The ORAC (Figure 33E), FRAP (Figure 33F)  and TEAC (Figure 33C)  
followed the same pattern, where the antioxidant capacity or power were fairly 
distributed  except for compounds G1, G2 and G4 with very low ORAC values as 
shown in Figure 33E.  The same pattern is found in the FRAP and TEAC 
evaluations as shown in Figures 33F and 33C respectively. There is a reasonable 
indication that the methanolic extract of the winter collection would be a strong 
antioxidant as shown by the high value in Figure 33F.  
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Figure 33E – Bar chart showing the ORAC values (The antioxidant capacity) of 
some extracts and isolates present in G. incanum.  
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Figure 33F – Bar chart showing the FRAP values (Ferric reducing antioxidant 
power) of some extracts and isolates present in G. incanum.  
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CHAPTER 7 
RESULTS AND DISCUSSION 
7.1 GETHYLLIS SPECIES 
The whole plants of G. multifolia, G. villosa and G. gregoriana were harvested in 
September 2007 from the Western Province in South Africa. These were dried, 
milled and extracted as illustrated in section 3.9.1 – 3.9.3 where only water, 
methanol and 70% ethanol were used in the extraction. The 70% ethanol was used 
just to mimic the method used in preparing the Koekemakranka brandy, a popular 
alcohol infusion drink used in traditional medicine to treat colic, flatulence and 
indigestion (Smith, C.A., 1966; Cillie, A.M., 1992; Rood, B., 1994; Watt and 
Breyer-Brandwijk 1962 and Van Wyk and Gericke, 2000).  
Gethyllis gregoriana afforded a methanol (26.79 g, 8.37%) and water extract 
(18.92 g, 5.91%), Gethyllis multifolia afforded a methanol (17.98 g, 8.36%) and 
water extract (21.11g, 9.82%) and Gethyllis villosa yielded a methanol (10.65 g, 
10.14%) and water extracts (7.43g, 7.08%). 
 The extracts were subjected to phytochemical screening as shown in section 
3.5.0.  Results indicated the presence of tannins, flavonoids, phenolics, saponins, 
anthraquinones, glycosides as well as essential oils in all the extracts while 
alkaloids were absent (Table 71) which is interestingly contrary to the observed 
trend in the Amaryllidaceae family acclaimed to contain alkaloids (Elgorashi and 
Van Staden, 2004).  
 
Table 71:- Phytochemical screening result of the Gethyllis species  
Test 
materials  Tann Phen Glyc Sapo Flav Alka Anth Esse 
         
GGM P+ve P+ve P+ve P+ve P+ve N-ve P+ve P+ve 
GGW P+ve P+ve P+ve N-ve P+ve N-ve N-ve P+ve 
GMM P+ve P+ve P+ve P+ve P+ve N-ve P+ve P+ve 
GMW P+ve P+ve P+ve N-ve P+ve N-ve N-ve P+ve 
GVM P+ve P+ve P+ve P+ve P+ve N-ve P+ve P+ve 
GVW P+ve P+ve P+ve N-ve P+ve N-ve N-ve P+ve 
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GGM = G. gregoriana MeOH extract; GGW = G. gregoriana H2O extract; GMM = G. multifolia 
MeOH extract;GMW = G. multifolia H2O extract;GVM = G. villosa MeOH extract;GVW = G. 
villosa H2O extract 
 
7.2 BIOLOGICAL EVALUATION 
7.2.1 Brine shrimp lethality bioassay of Gethyllis species 
The brine shrimp lethality bioassay was conducted on all the extracts as shown in 
section 3.10.2.0.  Results indicated that all the Gethyllis extracts were active 
except the water extract of G. villosa (Tables 72, 73 and 74). The highest value in 
this evaluation was recorded for G. gregoriana (0.223; Table 74) which 
confirmed the highly toxic nature of the Amarydaceae family (Muller-Doblies, 
1986; Elgorashi and Van Staden, 2004). It should be noted that G. gregoriana was 
very active at all the concentration levels tested which is a clear indication that it 
may be a good antimicrobial and antiviral agent (Mc Laughlin et al., 1991; Kaur 
et al., 2009). It is further noteworthy that to the best of our knowledge, this is the 
first time G. gregoriana will be reported on for any bioassay and that cytotoxicity 
will be evaluated for the 3 plants in this report using the brine shrimp bioassay.  
 
Table 72: Average number of dead nauplii after 24hours for Gethyllis species  
 
Test 
materials 
Vials at  
1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials 
for 
control 
expt. 
 1 2 3 1 2 3 1 2 3  
GGM 0 0 0 0 0 0 0 1 0 10 
GGW 1 1 1 3 4 4 7 6 7 10 
GMM 0 0 0 0 1 1 3 3 4 10 
GMW 2 2 2 4 3 4 6 7 8 10 
GVM 0 1 0 1 1 0 3 4 4 10 
GVW 9 8 9 10 9 10 10 10 10 10 
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Table 73: Average number of survived nauplii after 24hours for Gethyllis 
species 
 
Test 
materials 
Vials at  
1000 µg/ml Vials at 100 µg/ml Vials at 10 µg/ml 
Vials 
for 
control 
expt. 
Ave. 
surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
Ave. surv. 
% 
surv. 
 
% 
surv. 
         
 
 
GGM 0 0  0 0  0.33 3.33 100 
GGW 1 10  3.67 36.67  6.67 66.67 100 
GMM 0 0  0.67 6.67  3.33 33.33 100 
GMW 2 20  3.67 36.67  7 70 100 
GVM 0.33 3.33  0.67 6.67  3.67 36.67 100 
GVW 8.67 86.67  9.67 96.67  10 100 100 
 
 
 
 
Table 74: LC50 and average number of dead nauplii after 24hours for 
Gethyllis species 
 
 
Test materials 
Vials  
at  
1000 
µg/ml 
Vials  
at  
100 µg/ml 
Vials at 
 10 
µg/ml LC50 
General 
remarks 
      
GGM 10 10 10 0.23 Very active 
GGW 9 6 3 120.66 Active 
GMM 10 9 7 6.20 Very active 
GMW 8 6 3 139.55 Active 
GVM 10 9 6 4.23 Very active 
GVW 1 0 0 1956.39 Inactive 
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7.2.2 Antimicrobial evaluation 
The antimicrobial evaluation was carried out using the same diffusion method 
described for Cissampelos capensis. The assay was set up as described in section 
3.10.3.1.  
Table 75: Antimicrobial profile of Gethyllis species (The inhibition zones)  
  Psa Prv Esc  Bas Sta Bal  Caa Cae Asn 
            
GGM 41 34 29  32 30 33  27 29 23 
GGW 16 19 19  22 19 14  19 15 17 
GMM 18 21 26  19 18 18  10 11 11 
GMW 10 13 11  12 10 11  0 0 14 
GVM 15 13 19  22 28 30  15 17 17 
GVW 0 0 0  0 0 0  0 0 0 
Amx 61 44 49  42 53 47  0 0 0 
Flu 0 0 0  0 0 0  46 53 39 
 
The results showed that only G. villosa was inactive for all 9 organisms tested 
(Table 75). The maximum zone (41 mm) of antibacterial effect was observed in 
the methanolic extract of G. gregoriana against the Gram-negative organism 
Pseudomonas aeruginosa. The results obtained for the antimicrobial evaluation 
showed fair similarities with that of the cytotoxicity test.  
 
7.3. CHEMICAL EVALUATION (ANTIOXIDANT ASSAY) 
Total antioxidant evaluations were also carried out on all the extracts of Gethyllis 
species and which included the 70% ethanolic extracts. This was carried out in 
order to mimic the way the traditional healers usually administer the extract of 
Gethyllis (Muller-Doblies, 1986; Elgorashi and Van Staden, 2004).  
7.3.1 Polyphenolic content  
The polyphenolic content was also determined as shown in 3.11.2. The results 
showed that the amount of polyphenols present in the extracts were varied as 
shown in Figure 34A in which G. gregoriana has both the highest amount in the 
methanolic and ethanolic extracts while the lowest was recorded for G. villosa. 
This result further confirms the fact that methanol is a better solvent for the 
extraction of the polyphenolic content in Gethyllis as it was observed in most of 
the plant extracts in this project. 
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Figure 34A – Bar chart illustrating and comparing the amount of polyphenols and 
flavonols present in the various extracts of Gethyllis species. 
 
GEV = Gethyllis villosa ethanolic extract   
GEG = Gethyllis gregoriana ethanolic extract 
GEM = Gethyllis multifolia ethanolic extract 
  
7.3.2  Flavonoid content 
A closely related profile was observed for the presence of flavonoids in the three 
plants except for flavanol which is higher in G. multifolia than in G. gregoriana 
(Figures 34A, 34B and 34C). The results further showed the presence of 
flavanone in higher concentration when compared to the standard (Figure 34C).  
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Figure 34B – Bar chart showing the amount of flavanols present in the various 
extracts of Gethyllis species.  
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Figure 34C – Bar chart illustrating and comparing the amount of flavanones and 
the Trolox equivalent antioxidant capacity present in the various extracts of 
Gethyllis species.
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7.3.4 Anthocyanin content  
Results for anthocyanin content (Figure 34D) showed that only G. multifolia has 
an appreciable amount of anthocyanins in the methanol, water and ethanol 
extracts while it is completely absent in the water and methanol extracts of G. 
gregoriana but is present in fair concentration in its ethanolic extract as shown in 
Figure 34D.  
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Figure 34D – Bar chart showing the amount of anthocyanin present in the various 
extracts of Gethyllis species.  
 
The results for ORAC (Figure 34E), FRAP (Figure 34F) and TEAC (Figure 
34C) follow a similar profile, where G. gregoriana still has the higest capacity 
except for some minor deviation in some cases as shown by FRAP where the G. 
gregoriana water and methanol extracts were nearly the same and the G. 
multifolia water extract was low as shown in Figure 34F. 
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Figure 34E – Bar chart showing the ORAC values (The antioxidant capacity) of 
some extracts present in Gethyllis species. 
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Figure 34F – Bar chart showing the FRAP values (Ferric reducing antioxidant 
power) of some extracts present in Gethyllis species.  
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CHAPTER 8 
SUMMARY AND CONCLUDING REMARKS 
In screening several plant species from an inventory of common medicinal plants 
from both South and West Africa for diverse medicinal purposes, 6 plants were 
selected because of their interesting and useful ethnomedicinal values. These 
plants are Piliostigma reticulatum, Cissampelos capensis, Geranium incanum, 
Gethyllis gregoriana, Gethyllis multifolia and Gethyllis villosa. This study 
successfully attempt to relate specific constituents present in these plants with 
their widespread ethnomedicinal uses. The extractions were carried out using 
hexane, dichloromethane, ethyl acetate, methanol and water. All the extracts were 
phytochemically screened for identification of secondary plant metabolites. The 
results revealed a variety of profiles indicating plants with or without alkaloids, 
tannins, flavonoids, glycosides, saponins, anthocyanins and essential oils. It was 
generally evident that anthocyanins was virtually absent in most of the extracts of 
the plants except Gethyllis while it was only C. capensis that contained alkaloid. 
Nearly all the plants contain flavonoids, saponins and polyphenols. Fractionation 
was carried out using standard chromatographic techniques. A total of thirthy 
seven (37) compounds were isolated from three of the plants namely: Piliostigma 
reticulatum,  while only extractions were carried out on the Gethyllis species. 
Total of 18 isolates were characterised and their structures were unambiguously 
established by spectroscopic methods including infrared and ultraviolet 
spectroscopy, high resolution mass spectrometry and one- and two-dimensional 
nuclear magnetic resonance experiment. (P1) 6,8-di-C-methylquercetin- 3,7,3'-
trimethyl ether, (P2) Piliostigmol.  (P3) 6, 8-di-C-methylkaempferol- 3,7-dimethyl 
ether , (P4) 6,8-di-C-methylquercetin -3,3'-dimethyl ether, (P5) 6,8,3'-tri-C-
methylquercetin- 3,7-dimethyl ether,  (P7)    6-C-methylquercetin -3,7,3'-trimethyl 
ether, (P8)   6-C-methylquercetin- 3-methyl ether,  (P9) 6,8-di-C-
methylkaempferol- 3-methyl ether and (P13) Quercetin were isolated from P. 
reticulatum while C1) 5,6-dehydro-4,5-dihydroxy-1,3,6-trimethoxy-17-
methylmorphinan-7-one, (C2) 1,2-methylenedioxy-3-hydroxy-9,10-
imethoxyaporphine, (C3) 5,6-didehydro-4-hydroxy-3,6-dimethoxy-17-
methylmorphinan-7-one, (C5)  3,7,8 3'-tetramethoxy- 6 - C-methyl- 5,4'-
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dihydroxyflavone (6 -C-methylquercetin 3, 3',7, 8 –tetramethyl ether), (C6) 5,7,8 -
trihydroxy-2′, 5′-dimethoxy-3′,4′ methylenedioxyisoflavanone and (C11) 3 -
methoxy-6 -C-methyl-3',4',5,7,8 -pentahydroxyflavone (6 -C- methylquercetin -3-
methyl ether) were from C. capensis G. incanum offered (G5) Quercetin, 
(G10)16α-hydroxy-(-) kauran-18-oic acid, and (G12) 6,8-di-C-methylquercetin 3, 
7-dimethyl ether. Ten (10) of the isolated compounds were novel, including the 
first ever C-methyl-2-phenoxychromonol, Piliostigmol(2-O-(p-hydroxyphenyl)-
3,5-dihydroxy-6-C-methyl-7-methoxychromone), the diterpene16α-hydroxy-(-)-
kauran-18-oic acid, and five C-methylflavonols, isoflavanone, aporphine and a 
dehydromorphinandienone. The different extracts fractions, and isolates were 
tested for cytotoxicity using brine shrimp lethality test and antimicrobial 
capability using Nine microbes with three Gram –ve and +ve bacteria and three 
fungi which are Gram-negative bacteria were Pseudomonas aeruginosa (NCTC 
10332), Proteus vulgaris (NCTC 4175) and Escherichia coli Sero type 1 (NCTC 
09001), while the Gram-positive were  Bacillus subtilis (NCTC 8236), 
Staphylococcus aureus (NCTC 13134) and Bacillus licheniformis (NCTC 01097).  
The fungal species used were Candida albicans (ATCC 90028), Candida 
eropiralis (ATCC 750) and Aspergillus niger ATCC 10578. Gethyllis gregoriana 
showed the highest cytotoxicity level of LC50 = 0.23 where as it was observed that 
all the hexane fractions were not active while most activities resides in the 
methanolic extracts. The total tertiary alkaloid (TTA) showed the highest activity 
against the Bacillus substillis a Gram +ve bacteria at 45mm while the same trend 
in the cytotoxicity were equally observed in the antimicrobial where all the 
hexane fractions showed no activity against any of the nine pathogens. The 
Piliostigma reticulatum was also found to exhibit antimicrobial activity against 
some bacteria and fungi such as Staphylococcus aureus (NCTC 6571), 
Escherichia coli (NCTC 10418), Bacillus subtilis (NCTC 8236), Proteus vulgaris 
(NCTC 4175), Aspergillus niger (ATCC 10578) and Candida albicans (ATCC 
10231). Piliostigmol, showed the highest activity against E. coli (MIC = 2.57 
µg/ml, 0.006 µmol), which was found out to be three times more active than the 
Amoxicillin standard used. The total antioxidant assay also reveal a huge amount 
of information into the nature and properties of each extracts and isolates in which 
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the distribution of polyphenols, flavonoids and anthocyanins present in the plant 
extracts were reavealed. The ORAC, FRAP and TEAC showed intensively the 
antioxidant capacity of the extracts and isolates in which it was evident that the 
methanolic extracts and isolates obtained from them are good antioxidant agents. 
The results obtained for this study give a useful profile for development of a good 
antimicrobial and antioxidant agents for the future from the results obtained. The 
observed antimicrobial and antioxidant activities of the isolated compounds were 
correlated with their structures, and the structural requirements for activity in both 
test systems were defined. Finally, the traditional use of the extracts in infections 
and inflammatory conditions was rationalized based on the content of the isolated 
compounds, and it has been proposed that the total crude extract, with its content 
of so many bioactive compounds, could be formulated for use in skin infections, 
microbial, viral and inflammatory conditions. 
This study has therefore contributed to the body of knowledge relating to the 
phytochemistry of some African medicinal plants in particular and the chemistry 
and biological activities of natural products in general. This research has 
successfully created a huge data bank concerning the nature and chemistry of the 
six plants especially the three plants that isolation and characterization were 
carried out on. The presence of large amount of flavonoids in Piliostigma 
reticulatum, alkaloids in Cissampelos capensis and tannins in Geranium incanum 
and the revelation of possessing both antimicrobial and antioxidant activities from 
the results generated has been used to rationalized the traditional uses of the plant 
in infections and inflammatory conditions. This rationalization is further 
supported by the high activity of these C-methylflavonols, especially Piliostigmol 
and 6-C-methylquercetin-3-methyl ether against the common wound pathogen 
Staphylococcus aureus, alkaloid from Cissampelos in treatment of cancer and 
related tumor cells as well as the finding that many of these compounds were 
potent as antioxidants as well as antimicrobial.  
Since many of the isolated compounds are novel, and the biological activities of 
all the flavonoids have not been completely and extensively studied, there is a 
need to evaluate futher these compounds isolated from all the plants in other 
biological test system. Thus, the effect of piliostigmol on biliary excretion should 
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be determined, as the first 2-phenoxychromone isolated (capillarisin) was found to 
be a potent biliary excretion stimulant. The compounds should especially be 
evaluated in those conditions for which the plant is widely used, including cough, 
diarrhea and dysentery as recorded for Geranium incanum by Amabeoku 2009 
and Cissampelos species (Amresh et al., 2004; 2007a; 2007b; 2007c). 
It is also of interest to investigate the non-occurrence of an alkaloid in the 
Gethyllis species which are known to contain alkaloid from the family they came 
from (Elgorashi and Van staden, 2004; Viladomat et al., 1997; Van Wyk et al., 
2008). It should be noted that there were so many extracts, fractions, subfractions 
and even isolates that has not been worked on which would be of interest to work 
on in the nearest future.  
Finally, it can be expected that many of the crude extract, especially the 
methanolic extracts with its content of so many bioactive compounds will be more 
effective in treatment of various infections and inflammations than any individual 
constituent. The suggestion has therefore been made to formulate the various 
crude extracts into a suitable preparation for use in both microbial and viral 
infections especially in bacterial skin infections as indicated for P. reticulatum. 
Such a preparation will, if effective, provide a cheaper and less toxic alternative to 
the currently available drugs which are known to be expensive.  
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